US5843129A - Electrical circuit for equipment requiring redundant flow paths and method of use - Google Patents
Electrical circuit for equipment requiring redundant flow paths and method of use Download PDFInfo
- Publication number
- US5843129A US5843129A US08/477,905 US47790595A US5843129A US 5843129 A US5843129 A US 5843129A US 47790595 A US47790595 A US 47790595A US 5843129 A US5843129 A US 5843129A
- Authority
- US
- United States
- Prior art keywords
- piston
- current
- pump
- switch means
- state
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims description 6
- 239000004020 conductor Substances 0.000 claims description 18
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 210000002216 heart Anatomy 0.000 abstract description 40
- 210000000709 aorta Anatomy 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 230000002792 vascular Effects 0.000 abstract description 3
- 210000001367 artery Anatomy 0.000 abstract description 2
- 210000001147 pulmonary artery Anatomy 0.000 abstract 1
- 238000004804 winding Methods 0.000 description 103
- 210000004369 blood Anatomy 0.000 description 24
- 239000008280 blood Substances 0.000 description 24
- 238000005086 pumping Methods 0.000 description 24
- 230000005291 magnetic effect Effects 0.000 description 23
- 208000006011 Stroke Diseases 0.000 description 19
- 239000012530 fluid Substances 0.000 description 18
- 230000033001 locomotion Effects 0.000 description 16
- 230000002861 ventricular Effects 0.000 description 16
- 239000000463 material Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 230000004907 flux Effects 0.000 description 11
- 238000009958 sewing Methods 0.000 description 11
- 230000000747 cardiac effect Effects 0.000 description 9
- 230000006378 damage Effects 0.000 description 9
- 238000013461 design Methods 0.000 description 8
- 238000003475 lamination Methods 0.000 description 8
- 230000009471 action Effects 0.000 description 7
- 230000000670 limiting effect Effects 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 210000005240 left ventricle Anatomy 0.000 description 6
- 239000004065 semiconductor Substances 0.000 description 6
- 210000000601 blood cell Anatomy 0.000 description 5
- 210000004351 coronary vessel Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000002513 implantation Methods 0.000 description 5
- 230000001360 synchronised effect Effects 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 101150104680 MCH1 gene Proteins 0.000 description 4
- 101100382379 Rattus norvegicus Cap1 gene Proteins 0.000 description 4
- 208000001871 Tachycardia Diseases 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 4
- 210000001765 aortic valve Anatomy 0.000 description 4
- 230000007797 corrosion Effects 0.000 description 4
- 238000005260 corrosion Methods 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000004217 heart function Effects 0.000 description 4
- 230000007257 malfunction Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 230000006794 tachycardia Effects 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- 208000009729 Ventricular Premature Complexes Diseases 0.000 description 3
- 206010047289 Ventricular extrasystoles Diseases 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000005355 Hall effect Effects 0.000 description 2
- 208000010496 Heart Arrest Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000003190 augmentative effect Effects 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000003990 capacitor Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 210000002837 heart atrium Anatomy 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000028161 membrane depolarization Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000002250 progressing effect Effects 0.000 description 2
- 229910052761 rare earth metal Inorganic materials 0.000 description 2
- 150000002910 rare earth metals Chemical class 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 229940126655 NDI-034858 Drugs 0.000 description 1
- 241000290929 Nimbus Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 229910018503 SF6 Inorganic materials 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- QJVKUMXDEUEQLH-UHFFFAOYSA-N [B].[Fe].[Nd] Chemical compound [B].[Fe].[Nd] QJVKUMXDEUEQLH-UHFFFAOYSA-N 0.000 description 1
- QVYYOKWPCQYKEY-UHFFFAOYSA-N [Fe].[Co] Chemical group [Fe].[Co] QVYYOKWPCQYKEY-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000007253 cellular alteration Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 229920006334 epoxy coating Polymers 0.000 description 1
- 239000003302 ferromagnetic material Substances 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 210000001308 heart ventricle Anatomy 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- XWHPIFXRKKHEKR-UHFFFAOYSA-N iron silicon Chemical compound [Si].[Fe] XWHPIFXRKKHEKR-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229910001172 neodymium magnet Inorganic materials 0.000 description 1
- 230000001453 nonthrombogenic effect Effects 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000010118 platelet activation Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 239000002296 pyrolytic carbon Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000002336 repolarization Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000001013 sinoatrial node Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- SFZCNBIFKDRMGX-UHFFFAOYSA-N sulfur hexafluoride Chemical compound FS(F)(F)(F)(F)F SFZCNBIFKDRMGX-UHFFFAOYSA-N 0.000 description 1
- 229960000909 sulfur hexafluoride Drugs 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000005019 vapor deposition process Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Classifications
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02K—DYNAMO-ELECTRIC MACHINES
- H02K41/00—Propulsion systems in which a rigid body is moved along a path due to dynamo-electric interaction between the body and a magnetic field travelling along the path
- H02K41/02—Linear motors; Sectional motors
- H02K41/03—Synchronous motors; Motors moving step by step; Reluctance motors
- H02K41/031—Synchronous motors; Motors moving step by step; Reluctance motors of the permanent magnet type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
- A61M60/148—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/165—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart
- A61M60/178—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart drawing blood from a ventricle and returning the blood to the arterial system via a cannula external to the ventricle, e.g. left or right ventricular assist devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/196—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body replacing the entire heart, e.g. total artificial hearts [TAH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/205—Non-positive displacement blood pumps
- A61M60/216—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller
- A61M60/226—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller the blood flow through the rotating member having mainly radial components
- A61M60/232—Centrifugal pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/205—Non-positive displacement blood pumps
- A61M60/216—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller
- A61M60/237—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller the blood flow through the rotating member having mainly axial components, e.g. axial flow pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/247—Positive displacement blood pumps
- A61M60/253—Positive displacement blood pumps including a displacement member directly acting on the blood
- A61M60/258—Piston pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/40—Details relating to driving
- A61M60/424—Details relating to driving for positive displacement blood pumps
- A61M60/438—Details relating to driving for positive displacement blood pumps the force acting on the blood contacting member being mechanical
- A61M60/441—Details relating to driving for positive displacement blood pumps the force acting on the blood contacting member being mechanical generated by an electromotor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/40—Details relating to driving
- A61M60/424—Details relating to driving for positive displacement blood pumps
- A61M60/457—Details relating to driving for positive displacement blood pumps the force acting on the blood contacting member being magnetic
- A61M60/462—Electromagnetic force
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/50—Details relating to control
- A61M60/508—Electronic control means, e.g. for feedback regulation
- A61M60/538—Regulation using real-time blood pump operational parameter data, e.g. motor current
- A61M60/554—Regulation using real-time blood pump operational parameter data, e.g. motor current of blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/50—Details relating to control
- A61M60/508—Electronic control means, e.g. for feedback regulation
- A61M60/562—Electronic control means, e.g. for feedback regulation for making blood flow pulsatile in blood pumps that do not intrinsically create pulsatile flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/871—Energy supply devices; Converters therefor
- A61M60/876—Implantable batteries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/89—Valves
- A61M60/894—Passive valves, i.e. valves actuated by the blood
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
- F16C19/00—Bearings with rolling contact, for exclusively rotary movement
- F16C19/52—Bearings with rolling contact, for exclusively rotary movement with devices affected by abnormal or undesired conditions
- F16C19/525—Bearings with rolling contact, for exclusively rotary movement with devices affected by abnormal or undesired conditions related to temperature and heat, e.g. insulation
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02K—DYNAMO-ELECTRIC MACHINES
- H02K7/00—Arrangements for handling mechanical energy structurally associated with dynamo-electric machines, e.g. structural association with mechanical driving motors or auxiliary dynamo-electric machines
- H02K7/14—Structural association with mechanical loads, e.g. with hand-held machine tools or fans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8237—Charging means
- A61M2205/8243—Charging means by induction
Definitions
- This invention relates to reciprocating pump arrangements for pumping fluids such as blood in a controlled manner. More specifically, this invention is directed to a reciprocating pump capable of providing optimal assistance for ventricular or cardiac support such as that for an ailing ventricle. It produces effective pumping action under minimum shear conditions.
- Red blood cells are particularly susceptible to shear stress damage as their cell membranes do not include a reinforcing cytoskeleton to maintain cell shape. Lysis of white blood cells and platelets also occurs upon application of high shear stress. Lysis of red blood cells can result in release of cell contents which trigger subsequent platelet aggregation. Sublytic shear stress leads to cellular alterations and direct activation and aggregation of platelets and white blood cells.
- VADs ventricular assist devices
- Other types of pumps such as the so-called “Jarvik heart,” can be used to completely replace a heart which has been surgically removed.
- Centrifugal pumps which include pumps marketed by Sarns (a subsidiary of the 3M Company) and Biomedicus (a subsidiary of Medtronic, Eden Prairie, Minn.), direct blood into a chamber, against a spinning interior wall (which is a smooth disk in the Medtronic pump). A flow channel is provided so that the centrifugal force exerted on the blood generates flow.
- impeller blades mounted on a center axle, which is mounted inside a tubular conduit. As the blade assembly spins, it functions like a fan, or an outboard motor propeller.
- impeller refers to angled vanes (also called blades) which are constrained inside a flow conduit; an impeller imparts force to a fluid that flows through the conduit which encloses the impeller.
- propeller usually refers to non-enclosed devices, which typically are used to propel vehicles such as boats or airplanes.
- Centrifugal or axial pumps are commonly used in three situations: (1) for brief support during cardiopulmonary operations, (2) for short-term support while awaiting recovery of the heart from surgery, or (3) as a bridge to keep a patient alive while awaiting heart transplantation.
- rotary pumps generally are not well tolerated for any prolonged period. Patients who must rely on these units for a substantial length of time often suffer from strokes, renal (kidney) failure, and other organ dysfunction. This is due to the fact that rotary devices, which must operate at relatively high speeds, may impose unacceptably high levels of turbulent and laminar shear forces on blood cells. These forces can damage or lyse (break apart) red blood cells. A low blood count (anemia) may result, and the disgorged contents of lysed blood cells (which include large quantities of hemoglobin) can cause renal failure and lead to platelet activation that can cause embolisms and stroke.
- ventricular assist devices are designed to assume complete circulatory responsibilities for the ventricle they are "assisting.” As such, there is no need, nor presumably any advantage, for the device to interact in harmony with the assisted ventricle. Typically, these devices utilize a "fill-to-empty" mode that, for the most part, results in emptying of the device in random association with native heart contraction. This type of interaction between the device and assisted ventricle ignores the fact that the overwhelming majority of patients who would be candidates for mechanical assistance have at least some significant residual cardiac function.
- assist devices it is preferable to allow the natural heart, no matter how badly damaged or diseased it may be, to continue contributing to the required cardiac output whenever possible so that ventricular hemodynamics are disturbed as little as possible. This points away from the use of total cardiac replacements and suggests the use of "assist" devices whenever possible.
- assist devices also poses a very difficult problem: in patients suffering from severe heart disease, temporary or intermittent crises often require artificial pumps to provide "bridging" support which is sufficient to entirely replace ventricular pumping capacity for limited periods of time, such as in the hours or days following a heart attack or cardiac arrest, or during periods of severe tachycardia or fibrillation.
- an important goal during development of the described method of pump implantation and use and of the surgically implantable reciprocating pump was to design a method and a device which could cover a wide spectrum of requirements by providing two different and distinct functions.
- an ideal cardiac pumping device should be able to provide "total” or “complete” pumping support which can keep the patient alive for brief or even prolonged periods, if the patient's heart suffers from a period of total failure or severe inadequacy.
- the pump in addition to being able to provide total pumping support for the body during brief periods, the pump should also be able to provide a limited "assist" function. It should be able to interact with a beating heart in a cooperative manner, with minimal disruption of the blood flow generated by the natural heartbeat.
- a ventricle is still functional and able to contribute to cardiac output, as is the case in the overwhelming majority of clinical applications, then the pump will assist or augment the residual cardiac output. This allows it to take advantage of the natural, non-hemolytic pumping action of the heart to the fullest extent possible; it minimizes red blood cell lysis, it reduces mechanical stress on the pump, and it allows longer pump life and longer battery life.
- Pat. No. 3,842,440 to Karlson discloses an implantable linear motor prosthetic heart and control system containing a pump having a piston-like member which is reciprocal within a magnetic field.
- the piston-like member includes a compressible chamber in the prosthetic heart which communicates with the vein or aorta.
- Pat. Nos. 3,911,897 and 3,911,898 to Leachman, Jr. disclose heart assist devices controlled in the normal mode of operation to copulsate and counterpulsate with the heart, respectively, and produce a blood flow waveform corresponding to the blood flow waveform of the heart being assisted.
- the heart assist device is a pump connected serially between the discharge of a heart ventricle and the vascular system.
- the pump may be connected to the aorta between the left ventricle discharge immediately adjacent the aortic valve and a ligation in the aorta a short distance from the discharge.
- This pump has coaxially aligned cylindrical inlet and discharge pumping chambers of the same diameter and a reciprocating piston in one chamber fixedly connected with a reciprocating piston of the other chamber.
- the piston pump further includes a passageway leading between the inlet and discharge chambers and a check valve in the passageway preventing flow from the discharge chamber into the inlet chamber. There is no flow through the movable element of the piston.
- Pat. No. 4,102,610 to Taboada et al. discloses a magnetically operated constant volume reciprocating pump which can be used as a surgically implantable heart pump or assist.
- the reciprocating member is a piston carrying a tilting-disk type check valve positioned in a cylinder. While a tilting disk valve results in less turbulence and applied shear to surrounding fluid than a squeezed flexible sack or rotating impeller, the shear applied may still be sufficiently excessive so as to cause damage to red blood cells.
- Pat. Nos. 4,210,409 and 4,375,941 to Child disclose a pump used to assist pumping action of the heart having a piston movable in a cylindrical casing in response to magnetic forces.
- a tilting-disk type check valve carried by the piston provides for flow of fluid into the cylindrical casing and restricts reverse flow.
- a plurality of longitudinal vanes integral with the inner wall of the cylindrical casing allow for limited reverse movement of blood around the piston which may result in compression and additional shearing of red blood cells.
- a second fixed valve is present in the inlet of the valve to prevent reversal of flow during piston reversal.
- Pat. No. 4,965,864 to Roth discloses a linear motor using multiple coils and a reciprocating element containing permanent magnets which is driven by microprocessor-controlled power semiconductors. A plurality of permanent magnets is mounted on the reciprocating member.
- This design does not provide for self-synchronization of the linear motor in the event the stroke of the linear motor is greater than twice the pole pitch on the reciprocating element.
- the reciprocating element may slip from its synchronous position by any multiple of two times the pole pitch.
- a sensing arrangement must be included in the design to detect the position of the piston so that the controller will not drive it into one end of the closed cylinder.
- this design having equal pole pitch and slot pitch results in a "jumpy" motion of the reciprocating element along its stroke.
- the Roth design may also include a temperature sensor and a pressure sensor as well as control circuitry responsive to the sensors to produce the intended piston motion.
- a temperature sensor and a pressure sensor as well as control circuitry responsive to the sensors to produce the intended piston motion.
- control circuitry responsive to the sensors to produce the intended piston motion.
- the Roth controller circuit uses only NPN transistors thereby restricting current flow to the motor windings to one direction only.
- Pat. No. 4,541,787 to Delong describes a pump configuration wherein a piston containing a permanent magnet is driven in a reciprocating fashion along the length of a cylinder by energizing a sequence of coils positioned around the outside of the cylinder.
- the coil and control system configurations disclosed only allow current to flow through one individual winding at a time. This does not make effective use of the magnetic flux produced by each pole of the magnet in the piston.
- current must flow in one direction in the coils surrounding the vicinity of the north pole of the permanent magnet while current flows in the opposite direction in the coils surrounding the vicinity of the south pole of the permanent magnet.
- Pat. No. 4,610,658 to Buchwald et al. discloses an implantable fluid displacement peritoneovenous shunt system.
- the system comprises a magnetically driven pump having a spool piston fitted with a disc flap valve.
- Pat. No. 5,089,017 to Young et al. discloses a drive system for artificial hearts and left ventricular assist devices comprising one or more implantable pumps driven by external electromagnets.
- the pump utilizes working fluid, such as sulfur hexafluoride to apply pneumatic pressure to increase blood pressure and flow rate.
- the invention also provides an electrical circuit for use in equipment requiring redundancy comprising redundant parallel current paths for current flow between a higher voltage level conductor and a lower voltage level conductor.
- a plurality of switches in each current path is connected in series between the higher and lower voltage level conductors for controlling current flow between the higher and lower voltage level conductors.
- Each of the parallel current paths has sensing points between adjacent switches. The current flowing through each path provides a voltage level at each sensing point.
- a comparator detects voltage differences between corresponding sensing points in the parallel current paths to indicate when one switch is not in the same state as another switch.
- FIG. 1 is a longitudinal sectional view illustrating a representative surgically implantable pump with a reciprocating piston-valve arranged in accordance with the invention
- FIG. 2 is a perspective view illustrating a representative arrangement for attachment of vascular grafts to a surgically implantable pump in accordance with the invention
- FIG. 2(a) is an enlarged fragmentary view illustrating another alternative arrangement for attachment of the pump to a blood vessel
- FIG. 3 is an enlarged fragmentary sectional view illustrating a representative quick connect locking system for attaching a surgically implantable pump with a blood vessel arranged in accordance with the invention
- FIG. 4 is an exploded perspective view showing the arrangement of a typical piston-valve for use in a surgically implantable pump in accordance with the invention.
- FIG. 5 is an exploded view showing an alternate configuration for assembling a piston-valve for use in a surgically implantable pump in accordance with the invention.
- FIG. 6 is a fragmentary cross-sectional view showing an alternate magnet arrangement for use in a surgically implantable pump in accordance with the invention
- FIGS. 7(a)-7(j) are fragmentary cross-sectional views illustrating the stages in the energization of the coils of a linear motor drive in accordance with the invention.
- FIGS. 8 and 8(a) are graphical representatives showing the timing of the application potential to the coils of the linear motor of FIG. 1 in accordance with the invention and a typical electrocardiogram signal respectively;
- FIGS. 9(a)-9(c) are schematic circuit diagrams of a controller circuit in accordance with the invention.
- FIGS. 10(a) and 10(b) are perspective views showing the opposite sides of an implantable controller arrangement in accordance with the invention.
- FIG. 11 is a schematic illustration showing the anatomical arrangement of a surgically implantable pump with a reciprocating piston-valve in accordance with the invention implanted as a left ventricular assist device;
- FIG. 12 is a schematic illustration showing the anatomical arrangement of a surgically implantable pump with a reciprocating piston-valve in accordance with the invention implanted as a simplex right ventricular assist device;
- FIG. 13 is a schematic illustration showing the anatomical arrangement of a surgically implantable pump arrangement in accordance with the invention implanted as a duplex right ventricular assist device;
- FIG. 14 is a longitudinal sectional view illustrating another embodiment of a surgically implantable pump arranged in accordance with the invention.
- FIG. 15 is a schematic illustration showing the anatomical disposition of a surgically implantable pump arrangement in accordance with the invention in a duplex total artificial heart implantation;
- FIG. 16 is a representative alternate surgically implantable pump arrangement in accordance with the invention in a duplex total artificial heart implantation
- FIG. 17 is a longitudinal sectional view showing a surgically implantable pump arranged in accordance with the invention and configured as a simplex total artificial heart;
- FIG. 18 is a schematic illustration showing the anatomical arrangement of the surgically implantable pump shown in FIG. 17 implanted in a simplex total artificial heart configuration
- a pump module arrangement 34 which is for example, no more than 6 cm in diameter and 7.5 cm long, includes a reciprocating piston-valve assembly 1 consisting of an annular piston with a central flow passage containing two pivoting valve leaflets 2 which act as a check valve to limit flow through the central passage during reciprocation to one direction only.
- the piston-valve assembly 1 is driven back and forth through an internal cylinder 3 in the pump module 34 to displace fluid from an inlet end to an outlet end. Smooth and vibration-free motion can be ensured by providing close-clearance, low friction interfaces between the cylinder inner diameter and the piston-valve.
- the piston-valve 1, leaflets 2 and internal cylinder 3 are all preferably fabricated from highly corrosion-resistant material such as titanium or carbon, and are coated with low-friction, wear-resistant, non-thrombogenic material.
- highly corrosion-resistant material such as titanium or carbon
- pyrolytic carbon which is used to coat the housing and leaflets of various types of prosthetic heart valves, such as the St. Jude valve.
- the coating can be applied by a conventional vapor deposition process, resulting in a layer containing about 90% carbon and 10% silicon on the surface of a graphite structure.
- the pump module 34 When used as an implantable left ventricular assist device (LVAD), the pump module 34 is attached at its inlet end using a sewing cuff 4 to a patient's aorta 5 immediately downstream of the aortic valve (not shown in FIG. 1) using a suture 6.
- the sewing cuff 4 is made from a synthetic surgical graft material such as woven DacronTM available from the Dupont Corporation.
- the sewing cuff 4 can be attached to the LVAD using a retaining ring 7 which snaps into cantilevered barbs 8 or other similar retaining arrangements.
- the sewing cuff has an enlarged end 9 which becomes physically captured or entrapped by the retaining ring 7 when it is snapped into place. Compression of the sewing cuff 9 by the retaining ring 7 against the cylinder 3 forms a hemostatic seal.
- a retaining ring 15 is used in conjunction with a sewing cuff 16 in a similar manner as described herein above.
- the sewing cuff 16 is attached using a suture 17 to the patient's distal ascending aorta 18.
- a high energy density rare earth permanent magnet 19 having axially spaced north and south pole pieces 21 is mounted on the circumference of the piston-valve 1.
- a hermetically sealed enclosure 20 made from a highly corrosion-resistant material such as titanium surrounds the permanent magnet 19 and its pole pieces 21.
- the high energy density rare earth material is neodymium-iron-boron.
- the pole pieces 21, which are made from soft ferromagnetic material, direct the magnetic flux so as to project outward radially from the axially oriented permanent magnet toward the circumference of the piston-valve.
- the radial magnetic flux thus intercepts the windings 12 of a linear motor that surrounds the cylinder 3 through which the piston-valve 1 slides, the windings being formed in slots separated by magnetically soft lamination material 14 of the type commonly used in commercial motors, generators and transformers.
- a magnetically soft backing 13 surrounds the winding slots to provide a low reluctance path for the flux generated by the piston-valve magnet to link the windings.
- the laminations are positioned so as to avoid slot harmonics which would cause non-uniform motion of the piston-valve and are sized to minimize the effective air gap across which the magnetic flux must pass. Particularly smooth motion is obtained by using odd/even ratios of winding slot pitch to magnetic pole pitch on the piston-valve, respectively, or vice versa. In this regard, multiple phase windings are required.
- the linear motor windings and laminations are encased in a corrosion-resistant enclosure which includes a hermetically sealed penetration 26 for a linear motor lead bundle 30 leading to a linear motor controller 50 described hereinafter.
- This bundle further includes a pair of epicardial sensing leads 31.
- a seal weld 10 is provided at each end of the pump module 34 to form a hermetic seal between an outer housing 11 for the pump and the inner cylinder 3. The hermetic seal prevents moisture or other contaminants from attacking the linear motor windings 12, back iron material 13 or lamination material 14.
- Suitable voltage is provided to the windings of the linear motor by wires in the bundle 30 which are connected to a battery associated with the controller 50.
- the wires which supply power to the motor are positioned outside the aorta and thus do not contact blood flowing through the aorta.
- the outer housing 11 can be composed of any suitably hard biocompatible material, such as titanium, stainless steel, various other alloys, graphite, or plastic. It can be sealed with a standard waterproof epoxy coating.
- the retaining rings 7 and 15 are shaped so as to prevent the piston-valve from moving past the sewing cuffs 4.
- the shape of the retaining rings 7 and 15 is arranged so that the piston-valve will not become jammed in the sewing cuff or damage the sewing cuff in any way.
- a patient's aorta 32 bends sharply at the aorta arch 22.
- the retaining ring 15 may have a trimmed portion 23 at this location as shown in FIG. 1.
- the retaining rings 7 and 15 preferably have at least four equally spaced tool holes 24 to receive a tool for removing the retaining rings after they have been snapped into place as described above.
- the pump inlet is downstream of the left and right coronary artery ostia or openings.
- the piston travels back from the outlet end of the cylinder as slowly as possible during the patient's native heart diastole so that it arrives at the inlet end of the cylinder just before the patient's left ventricle begins to eject blood during systole. This ensures that the patient's coronary artery 32 receives adequate blood flow during diastole, when most of the blood that normally enters the coronary arteries is actually admitted.
- the slow motion of the piston-valve back toward the inlet end of the cylinder also limits shear stress in the blood flowing to the downstream side of the piston-valve and should result in a slight increased pressure at the inlet to the patient's coronary arteries, which will improve blood flow to the patient's native heart muscle during diastole. This is expected to compensate for the possibly slightly reduced pressure at the inlet to the patient's coronary arteries that will occur during systole caused by the pumping action of the piston-valve moving toward the outlet end of the cylinder.
- a seam 33 formed at the interfaces between each of the sewing cuffs 4 and 16 and the hollow cylinder 3 is compressed against the cylinder by the retaining rings 7 and 15. This ensures that the crevice formed at the seam will become covered with a smooth secure endothelial layer to preclude formation and release of blood clots in this area.
- the hermetically sealed cable penetration 26 which is made from a highly corrosion-resistant material such as titanium houses the linear motor winding leads 27 and is seal welded to the outer housing 11.
- the main lead bundle 30 contains a shielded multi-conductor cable with a polyurethane jacket material similar to insulation currently used for pacemaker leads. Such cable is commercially available for machine tool and robotics application, and is rated in excess of 6 million bend cycles from straight to its minimum bend radius without failure of the insulation or conductors.
- the main lead bundle incorporates approximately 24 conductors required to drive the linear motor in VAD applications.
- the main lead bundle terminates at a hermetically sealed cylindrical connector at the linear motor controller 50.
- a molded polyurethane strain relief 29 attaches the polyurethane jacket of the shielded multi-conductor cable 30 which constitutes the main lead bundle to the linear motor to the cable penetration.
- An optional second strain relief attached to the polyurethane jacket includes the leads 31 which are routed to epicardial electrodes used to provide an ECG signal to the linear motor controller 50.
- FIGS. 7(a)-7(j) show a diagrammatic cross-section of the linear motor drive for the pump module.
- a piston 194, containing a magnet assembly 195 is free to slide through a cylinder 196 as previously discussed.
- Magnetic flux 197 generated by the magnet assembly 195 is made to link several of the windings 198 by the magnetically soft radial laminations 199 and circumferential laminations 200, which separate and surround the windings 198.
- the laminations 199 and 200 can be manufactured from thin sheets of material such as silicon iron or iron-cobalt bonded together to the proper thickness to accommodate the magnetic flux produced by the magnet 195.
- the radial laminations 199 also include an axially enlarged portion near the outer surface of the inner cylinder 196 to improve magnetic coupling between the piston magnet 195 and the windings. This enlargement may not be necessary if the motor performance otherwise satisfies the operation requirements.
- FIG. 7(a) shows the piston 194 at the inlet end of the cylinder 196 with a series of windings 601-623 having energization leads 501-526 with the first five windings 601-605 all energized by current flowing in the same direction, i.e., into the plane of the drawings, represented by the symbol "+”, and all other windings 606-623 with no current represented by "x".
- This current is produced by the "high” potentials applied at the leads 501 and 502 (e.g., 12 volts, designated by "H”) and the "low” potential applied at the leads 507 and 508 (e.g., 0 volts designated by "L”). All other leads are connected to an open circuit (designated by "x").
- This energization pattern provides a holding mode to hold the piston 194 in a given position in the cylinder 196 until the next pumping or return stroke is initiated.
- Current through the windings at this stage is limited to a nominal level using pulse width modulation (PWM) or another efficient current limiting method to avoid excessive winding heating and power consumption.
- PWM pulse width modulation
- FIG. 7(b) shows the piston 194 at the inlet end of the cylinder with the first five windings 601-605 of the series of windings 601-623 energized to begin a pumping stroke.
- the windings 601 and 602 are energized with current flowing into the plane of the drawing "+” while the windings 604 and 605 are energized with current flowing out of the plane of the drawing, represented by " ⁇ ".
- the controller 50 includes a current limiting arrangement to prevent damage to the windings as discussed earlier, but such current limitation is not expected to be required once the piston begins to move along the cylinder and generate a counter emf.
- FIG. 7(c) shows the piston 194 progressing to the right.
- the winding 606 has been energized in the same direction as the windings 604 and 605 in anticipation of the leading edge of the magnet beginning to couple this winding.
- FIG. 7(d) shows a further progression of the piston to the right with the winding 603 energized like the windings 601 and 602 and the winding 604 being de-energized. All of the windings 601-623 are connected in series which allows the inductive flyback energy released when a winding such as the winding 604 is de-energized to be usefully transferred into the neighboring windings rather than being dissipated wastefully through the controller circuit.
- FIG. 7(c) shows the piston 194 progressing to the right.
- the winding 606 has been energized in the same direction as the windings 604 and 605 in anticipation of the leading edge of the magnet beginning to couple this winding.
- FIG. 7(d) shows a further progression of the piston to the
- FIG. 7(e) shows the piston progressing still further along its stroke with the winding 601 now de-energized.
- the pattern of windings energized is now the same as it was in FIG. 7(b), except offset to the right by one winding.
- the pattern described by FIGS. 7(b) through 7(e) repeats until the piston reaches the end of its stroke, where it may be held momentarily as shown in FIG. 7(f). The pattern then begins again, except with current directions in the windings reversed, when the piston is driven back toward the inlet end of the cylinder as shown in FIG. 7(g).
- the magnet pole pitch is not equal to an integral multiple of the winding slot pitch. This requires an out of phase energization of the coils which are being approached by the leading edge of the north pole of the magnet in contrast to those being approached by the south pole of the magnet. Although this complicates the timing used in the control circuit, the movement of the piston is smoother along its stroke when the energizing of approaching windings is divided into multiple transitions for a given displacement instead of one.
- the timing used in the control circuit for the motor could be simplified if desired if both the magnetic pole width and the pole pitch were made equal to an integral multiple of the winding slot pitch.
- the windings being approached by the leading edges of both magnetic poles can be energized at the same time that the windings being left behind by the trailing edges of both magnetic poles are de-energized.
- the piston will tend to move forward abruptly each time this combination of simultaneous energizing and de-energizing at multiple windings occurs. This would be undesirable for applications such as implantable circulatory assist devices where uniform motion of the piston is required to minimize vibration and high frequency pulsation of the fluid that could cause unnatural sensations.
- the most uniform motion of the piston can be obtained by making both the width and pitch of the magnetic poles unequal to an integral multiple of the slot pitch. This also results in the most complicated timing in the control circuit.
- the timing sequence proceeds as follows: the winding being approached by the leading edge of the first magnet pole is energized, then the winding being left by the trailing edge of the second magnet pole is de-energized, then the winding being left by the first pole is de-energized, then the winding being approached by the second pole is energized, and so on.
- large scale programmable logic devices such as microcontrollers, programmable gate arrays, etc., it is possible to implement such complex winding energization timing algorithms without much difficulty.
- the piston position will be automatically synchronized with the pattern of windings being energized during initial start-up of the motor, or if magnetic coupling between the piston and the windings is lost for some reason, without the piston ever being driven into the travel stops at the end of the cylinder.
- the pattern of energized windings is initially that shown in FIG. 7(g). As the pattern of energized windings shown in FIG. 7(g) progresses to the left, it will approach the stationary piston in the middle of the cylinder. As the windings at the leading edge of the pattern of energized windings begins to interact with the flux emanating from the north pole of the stationary piston, as shown in FIG.
- the piston will experience a force drawing it to the right, into the pattern of energized windings, even though the pattern is moving to the left. This is because the leading windings would normally act on the flux entering into the south pole of the piston magnet, which would cause the piston to experience a force drawing the piston to the left.
- the opposite direction of the magnetic flux emanating from the north pole causes the force acting on the piston to be reversed.
- the piston will continue to be drawn to the right until it becomes centered in the pattern of energized coils, as shown in FIG. 7(j), which is its normal synchronous position. Because of the energization pattern, it will continue, from that point on, to move synchronously in the same location with respect to the pattern of energized coils. This process of resynchronization will take place as long as the piston is anywhere within the travel limits of the cylinder which is physically ensured as long as end connections such as those depicted in FIGS. 2, 2(a) and 3 are provided.
- a fault detection algorithm can be incorporated into the controller 50 for the linear motor drive by using a current sensor that provides a signal representing total current flowing through the motor windings to the controller logic circuit, which compares this value to an expected value or an average of previous values for the active set of windings. Any discontinuity as a result of a change in winding impedance due to a failed lead will be manifested as a departure from the expected or time averaged current level as the failed lead is energized. The fault can then be annunciated by the controller so that corrective action to repair the failed lead can be taken before a complete malfunction of the motor occurs.
- the controller 50 can also be programmed to detect and flag a failed winding by monitoring for the associated discontinuity in electric current to the motor.
- the failed winding can then be selectively skipped over on subsequent cycles so that only one (i.e., the failed winding) out of the four or five windings in the pattern of energized windings influencing the piston at any one time will be lost. Further, the remaining windings may carry slightly greater current to compensate for the failed winding with no other adverse effects with the exception of slightly decreased efficiency and slightly increased winding operating temperature.
- winding 606 were to fail, then no current could pass from the leads 508 and 509 to the lead 505, but the windings 601 and 602 would still remain energized by the leads 501, 502 and 504.
- the current would be limited to these windings by the back emf generated by the moving magnetic pole or by the PWM current limiting feature discussed above.
- a motor designed for high reliability will incorporate windings rated to handle twice the normal current and permanent magnets that will not be demagnetized by this doubling of current so that a single failed winding will not cause a complete malfunction of the motor.
- the motor controller 50 can be designed to detect a failed winding using an algorithm similar to that described above for detecting a failed lead, so that replacement of the motor can be accomplished before a complete malfunction occurs.
- a further improvement of the failed winding detection algorithm would be to use the magnitude of the current discontinuity detected by the controller 50 to distinguish between a failed lead 501-526 and a failed winding 601-623. This is advantageous for determining whether the pump module 34 must be replaced (i.e., due to winding failure) or possibly only the controller 50 must be replaced (i.e., due to a lead failure near or within the controller).
- This failed winding detection algorithm can be yet further enhanced by modifying the timing of lead potentials applied to the motor when a failed winding is identified such that only that winding is lost from the desired pattern of windings to be energized. For instance, referring to FIG. 7(b), if the winding 606 has been identified as a failed winding as described above, the controller 50 will maintain a high potential on the lead 507 in FIGS. 7(c), 7(d) and 7(e), instead of isolating current flow to this lead. A low potential will be applied to the lead 507 when this would normally have occurred in a subsequent transition of lead potentials.
- FIG. 8 comprises a series of timing diagrams that show the successive lead potentials required at the leads 501-526 to produce the normal pattern of energized windings described in connection with FIG. 7(a)-7(j).
- a typical ECG signal is also shown in FIG. 8(a).
- the ECG signal shown in FIG. 8(a) illustrates the P, Q, R, S and T waves.
- This is an electrical signal generated by the heart and is sensed by ECG leads attached to the inner (endocardial) or outer (epicardial) surface of the heart muscles or may also be sensed on the outer surface of the body.
- the P wave is caused by the spread of depolarization of the atrial muscle, which initiates contraction of the atria.
- the QRS waves appear as a result of depolarization of the ventricular muscle, which initiates contraction of the ventricles.
- the T wave results from repolarization of the ventricles, which represents the onset of ventricular relaxation.
- the optimum starting point for the winding energization timing cycle in VAD applications to begin is expected to be on or about the R-wave peak 201.
- This peak value shown in FIG. 8(a) typically occurs just before the recipient's aortic (or pulmonary) valve would normally be pushed open by blood being ejected from the native left (or right) ventricle.
- the entire QRST complex will be missing from the ECG signal. Therefore, the timing cycle shown will have to be initiated at some predetermined delay interval referenced to the P-wave peak 202 generated by the recipient's native sinus node.
- This predetermined delay interval will be a programmable setting that can be adjusted, if needed, via the controller's telemetry interface.
- a pacemaker 39 (FIG. 11) may be used to trigger the timing cycle and restore heart rate.
- the linear motor controller 50 may incorporate a telemetry programmable lower limit for the cycle rate of the piston-valve to ensure that adequate blood flow is maintained. This feature may also provide vital circulation in the event of total cardiac arrest. Accelerated heart rates such as premature ventricular contractions (PVC) and tachycardia may also occur.
- PVC premature ventricular contractions
- tachycardia may also occur.
- An implantable pacemaker alone does not have the ability to correct heart rates that are too rapid.
- the linear motor controller 50 may optionally incorporate features similar to currently available implantable cardioverter/defibrillators to restore normal cardiac rhythm.
- the controller 50 may be adjusted to alter the motion of the piston-valve to minimize the damage to the blood cells due to high velocity flow through the piston-valve.
- This alteration in motion may consist of slowing down or stopping the piston-valve momentarily on its return stroke if a PVC or any type of tachycardia is detected.
- the piston-valve cycle rate may be adjusted to synchronize with every other or every third, etc., heart beat as well as adjusted to slow down or stop on the return stroke as necessary to minimize high velocity blood flow during ventricular ejection.
- FIGS. 9(a), 9(b) and 9(c) are schematic circuit diagrams of a controller circuit used to generate the lead outputs required, as shown in FIGS. 7(a)-7(j) and FIG. 8 as well as the failure mode correction, and fault indication previously discussed and the telemetry discussed hereinafter.
- the microcontroller 203 shown in FIG. 9(a) is used as the main logic unit. Many other types of programmable logic devices could be used in this application in place of the microcontroller 203, such as a programmable logic controller (PLC) or gate array (PGA) or even an application specific integrated circuit (ASIC). These could be arranged to perform the required control algorithms for the linear motor.
- PLC programmable logic controller
- PGA gate array
- ASIC application specific integrated circuit
- the microcontroller products currently available provide a relatively complete set of the features required for a controller for an implantable circulatory assist device using the linear motor drive described in FIGS. 1, 7 and 8.
- the components of the microcontroller 203 include:
- CPU Central Processing Unit
- C Central Processing Unit
- ROM Read Only Memory
- EPROM Electrically Programmable ROM
- EEPROM Erasable EPROM
- RAM Random Access Memory
- I/O Ports A-H--Connections through which digital or analog data may be transferred to or from the microcontroller. These ports are used to control the switching sequence of the power semiconductors that control electrical current to the motor windings, send and receive serial data that can be used to adjust program variables within the microcontroller or send out information identifying faults or other performance data, as well as various related tasks.
- An Analog and Digital (A/D) Converter--A portion of the microcontroller that converts analog signals acquired via the I/O ports, such as total current to the motor, to digital information that can be used by the CPU.
- Pulse Width Modulators PWM's--Special output ports which can be programmed to rapidly switch on and off power semiconductors or other devices for programmable durations (pulse widths) that can vary in response to some feedback signal or other control. PWM's are useful in motor controls for current limiting algorithms as discussed above.
- This serial information can be a digital representation of any of the analog signals being processed by the A/D converter being transmitted out to be interpreted for diagnostic purposes, or incoming data providing instructions to adjust variables in the linear motor control algorithm.
- a Computer Operating Properly Watchdog Timer (COP)--This timer counts to a specified value and then resets the microcontroller to the beginning of the program currently being run, or one being pointed to by a reset vector, unless the program currently being run continually resets the timer to zero before it reaches the specified value. This serves to "free-up” a controller that has “locked-up” due to a corruption of program instructions due to a voltage transient or other outside influence.
- the microcontroller 203 is provided with power from a regulated 5 volt voltage source. However, to minimize power consumption and heat generation, a 3 volt unit may be used, powered by a high efficiency 3 volt switching regulator. A reset circuit 205 with low voltage protection to avoid memory corruption is also used.
- the microcontroller shown includes a crystal or other timing reference 206 to drive the main clock.
- a voltage divider 207 provides a regulated voltage reference for the microcontroller's built-in analog-to-digital converter.
- a standby microcontroller 208 is included, which can automatically isolate power to the primary microcontroller 203 if more than a predetermined number of computer operating properly watchdog timer (COP) resets are detected on the primary microcontroller within a predetermined interval or it can be manually activated via a telemetry interface connected to the SCI on each microcontroller.
- the back-up microcontroller 208 operates in "stop-mode” until activated to ensure minimum power consumption. It requires a voltage regulator, reset circuit, reference crystal, and voltage reference, similar to the primary microcontroller 203.
- the microcontroller I/O ports A through H are used to drive a power semiconductor array 213, which controls current flow through the motor windings.
- Each motor lead is provided with a thermal circuit breaker or other passive over-current protection device 214, a complementary pair of power transistors 215 which permits current flow in either direction through each motor lead, and associated driver electronics 216, required for operation of the power transistors 215 by the logic level outputs from the microcontroller.
- the array of power transistors 215 may optionally be configured to passively or actively permit current flow in the reverse direction from the applied potential, on selected or all leads, thereby permitting the linear motor to be regenerative (i.e., if the load on the piston reverses such that an applied force is assisting movement rather than opposing movement, the controller can use the assisting force to return energy to the rechargeable battery cells, thereby reducing power consumption). This may be useful near the end of the piston travel where piston momentum will tend to drive the piston forward while the motor is trying to slow it down. The stored kinetic energy in the piston can be partially recovered using regeneration.
- Each microcontroller 203 and 208 is provided with independent signal conditioning and isolation arrangements 217 and 218 for all incoming analog signals.
- These analog signals comprise (1) an (amplified) ECG signal output from a separate implanted pacemaker (ECG1) which may be used as a synchronizing signal for reciprocation of the pump module in implantable applications (see FIG.
- a marker channel output from a pacemaker is a logic signal that indicates when the pacemaker control logic has detected a particular electrocardiological event such as a P wave, a QRS wave, or when the pacemaker has transmitted its own electrical stimulus to the heart.
- ECG2 epicardial lead
- ECG2 epicardial lead
- a voltage signal from the current sensor or other device indicating total current to the motor windings (CUR1) which may be used in conjunction with a PWM algorithm to efficiently limit motor current
- a voltage signal from the current sensor or other device indicating total current delivered to the internal rechargeable battery by the charging circuit (CUR2) which can be used to control charging rate efficiently using a PWM algorithm
- a voltage signal indicating battery temperature (TEMP) generated by the voltage drop across a thermistor
- any movement of the piston will generate an emf that can be detected from motor leads on either side of the piston.
- the signal (V2) may thus be used to detect ejection by the recipient's native ventricle(s) in VAD applications or native atria in TAH applications so that the motor may be synchronized when all ECG and marker channel signals (ECG1, ECG2 and MCH1) are lost. If no signals are detected from analog inputs ECG1, ECG2, MCH1 or V2, the controller will default to a fixed cycle rate of the piston back and forth through the hollow cylinder based on a value programmed in the microcontroller.
- the microcontroller includes programming to sense when the motor current indicated by CUR1 increases or decreases during a given piston stroke relative to previous strokes and will delay or advance subsequent strokes to minimize the current being drawn by the motor.
- the changes in current drawn by the motor in VAD applications could be caused by residual functioning of the recipient's native heart. For example, if the piston is returning down the cylinder toward the proximal end with the pump implanted as a VAD in a ventricular outflow vessel and the ventricle ejects, the current drawn by the motor will increase due to the flow of blood moving in the opposite direction that the piston is moving.
- the piston reciprocation can be indirectly synchronized with any residual cardiac function still present to the maximum extent possible.
- any adjustments made by the controller to the piston cycle rate in this mode of operation would not preclude the programmed minimum number of piston strokes per minute from being completed to maintain minimum circulatory system flow requirements.
- the reference ground for these analog inputs, as well as the reference ground for the microcontroller analog-to-digital converters, may be connected to an electrically conductive surface on the outside of the controller 50 so that charge equilibrium with the recipient's body is maintained.
- Two analog outputs provided from pacemaker units 219 and 219(a) connected to each microcontroller in FIG. 9(a) may also be incorporated for providing single or dual chamber pacing.
- the output threshold voltage for these signals may be programmable via the telemetry interface discussed in more detail later.
- the PWM current limiting algorithm in the microcontroller consists of a program segment that compares the current level indicated at analog input CUR1 to programmable upper and lower limits for current to the motor. As long as CUR1 is below the upper limit, no PWM current limiting will be active. Once the upper limit is exceeded, the PWM algorithm will shut off the power semiconductors in the bridge 222 until current drops below the lower limit, at which time, the power semiconductors in the bridge 222 will be turned back on. This will continue until CUR1 stops exceeding the upper limit for current.
- This independent circuit may provide stand alone supervision of internal battery charging, thereby reducing demand on the active microcontroller, or simply act as a redundant back-up to provide additional protection from overcharging.
- the active microcontroller 203 or 208 and the independent charging supervisory circuit 228 can act through an OR gate to PWM or isolate current from the internal battery using a power transistor 229.
- Power for the internal battery charging circuit is obtained via a subcutaneous secondary coil 230.
- This coil is connected to a capacitor/rectifier circuit 231 that is tuned to the carrier frequency being transmitted trancutaneously to the secondary coil 230.
- the rectifier may incorporate redundant diodes and a fault detection circuit as shown, which operates similar to the power transistor bridge 222 and logic circuit 223 of FIG. 9(a), except that the power transistors are replaced by diodes.
- This tuned capacitor/rectifier circuit may also incorporate a filter arrangement 211 to support serial communication interface (SCI) reception via the secondary coil 230.
- a level detection comparator 232 is provided to convert the analog signal produced by the filter 211 into a digital signal compatible with an SCI receiver 460.
- a power transistor 233 or other modulation device may also be incorporated to support SCI transmission via the secondary coil 230.
- a redundant transistor bridge such as the bridge 222 used for PWM current limiting may be used in place of the transistor 233 for improved fault tolerance.
- This SCI interface provides for changing programmable settings used by the control algorithm and monitoring of analog inputs to the microcontroller such as ECG1, ECG2, MCH1, CUR1, CUR2, TEMP, V1, and V2.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Mechanical Engineering (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Power Engineering (AREA)
- Electromagnetism (AREA)
- Physics & Mathematics (AREA)
- Combustion & Propulsion (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- External Artificial Organs (AREA)
- Prostheses (AREA)
- Reciprocating Pumps (AREA)
- Linear Motors (AREA)
- Control Of Linear Motors (AREA)
- Structures Of Non-Positive Displacement Pumps (AREA)
- Details Of Reciprocating Pumps (AREA)
Abstract
In one embodiment described in the specification, a surgically implantable reciprocating pump employs a check valve as the piston, which is driven by a permanent magnet linear electric motor to assist either side of the natural heart. The pump is implanted in the aorta or pulmonary artery using vascular attachment cuffs such as flexible cuffs for suturing at each end with the pump output directly in line with the artery. The pump is powered by surgically implanted rechargeable batteries. In another embodiment, pairs of pumps are provided to replace or assist the natural heart or to provide temporary blood flow throughout the body, for example, during operations to correct problems with the natural heart.
Description
This application is a division of U.S. Ser. No. 08/201,806 filed on Feb. 25, 1994, now U.S. Pat. No. 5,676,651 which is a continuation-in-part of U.S. Ser. No. 08/035,788 filed Mar. 23, 1993, which issued as U.S. Pat. No. 5,290,227 on Mar. 1, 1994, which is a continuation-in-part of U.S. Ser. No. 07/926,779 filed Aug. 6, 1992 now abandoned.
This invention relates to reciprocating pump arrangements for pumping fluids such as blood in a controlled manner. More specifically, this invention is directed to a reciprocating pump capable of providing optimal assistance for ventricular or cardiac support such as that for an ailing ventricle. It produces effective pumping action under minimum shear conditions.
Heretofore a number of pump designs have been proposed for pumping fluids such as blood. Such pumps must provide leak-free operation and must avoid contamination of the fluid by the pump components and the external environment. In addition, such pumps must effectively pump the fluid at a suitable rate without applying excessive Reynolds shear stress to the fluid. Damage due to excessive shear is particularly a problem when pumping fluids such as blood or blood products.
It is well known to those skilled in the art that lysis or cell destruction may result from application of shear stress to cell membranes. Red blood cells are particularly susceptible to shear stress damage as their cell membranes do not include a reinforcing cytoskeleton to maintain cell shape. Lysis of white blood cells and platelets also occurs upon application of high shear stress. Lysis of red blood cells can result in release of cell contents which trigger subsequent platelet aggregation. Sublytic shear stress leads to cellular alterations and direct activation and aggregation of platelets and white blood cells.
Several types of surgically implantable pumps have been developed in an effort to provide a mechanical device for augmenting or replacing the blood pumping action of damaged or diseased hearts. Some of these pumps are designed to support single ventricular function. Such pumps usually support the left ventricle, which pumps blood to the entire body except the lungs, since it becomes diseased far more commonly than the right ventricle, which pumps blood only to the lungs. Other devices have been tested and used for providing biventricular function.
Depending on the needs of a particular patient and the design of a pump, pumping units such as so-called "VADs" (ventricular assist devices) can be implanted to assist a functioning heart that does not have adequate pumping capability. Other types of pumps, such as the so-called "Jarvik heart," can be used to completely replace a heart which has been surgically removed.
Temporary as well as permanent implantable pumps have been developed. "Permanent" in this sense refers to the remaining life of the patient; after a patient's death, any artificial pumping device is usually removed for analysis. "Temporary" implantation usually involves (1) an attempt to reduce the stress on a heart while it recovers from surgery or some other short-term problem, or (2) use of a pump as a "bridge" to forestall the death of a patient until a suitable donor heart can be found for cardiac transplantation.
The most widely tested and commonly used implantable blood pumps employ variable forms of flexible sacks (also spelled sacs) or diaphragms which are squeezed and released in a cyclical manner to cause pulsatile ejection of blood. Such pumps are discussed in books or articles such as Hogness and Antwerp 1991, DeVries et al 1984, and Farrar et al 1988, and in U.S. Pat. Nos. 4,994,078 (Jarvik 1991), 4,704,120 (Slonina 1987), 4,936,758 (Coble 1990), and 4,969,864 (Schwarzmann et al 1990). Sack or diaphragm pumps are subject to fatigue failure of compliant elements and as such are mechanically and functionally quite different from the pump which is the subject of the present invention.
An entirely different class of implantable blood pumps uses rotary pumping mechanisms. Most rotary pumps can be classified into two categories: centrifugal pumps and axial pumps. Centrifugal pumps, which include pumps marketed by Sarns (a subsidiary of the 3M Company) and Biomedicus (a subsidiary of Medtronic, Eden Prairie, Minn.), direct blood into a chamber, against a spinning interior wall (which is a smooth disk in the Medtronic pump). A flow channel is provided so that the centrifugal force exerted on the blood generates flow.
By contrast, axial pumps provide blood flow along a cylindrical axis, which is in a straight (or nearly straight) line with the direction of the inflow and outflow. Depending on the pumping mechanism used inside an axial pump, this can in some cases reduce the shearing effects of the rapid acceleration and deceleration forces generated in centrifugal pumps. However, the mechanisms used by axial pumps can inflict other types of stress and damage on blood cells.
Some types of axial rotary pumps use impeller blades mounted on a center axle, which is mounted inside a tubular conduit. As the blade assembly spins, it functions like a fan, or an outboard motor propeller. As used herein, "impeller" refers to angled vanes (also called blades) which are constrained inside a flow conduit; an impeller imparts force to a fluid that flows through the conduit which encloses the impeller. By contrast, "propeller" usually refers to non-enclosed devices, which typically are used to propel vehicles such as boats or airplanes.
Another type of axial blood pump, called the "Haemopump" (sold by Nimbus) uses a screw-type impeller with a classic screw (also called an Archimedes screw; also called a helifoil, due to its helical shape and thin cross-section). Instead of using several relatively small vanes, the Haemopump screw-type impeller contains a single elongated helix, comparable to an auger used for drilling or digging holes. In screw-type axial pumps, the screw spins at very high speed (up to about 10,000 rpm). The entire Haemopump unit is usually less than a centimeter in diameter. The pump can be passed through a peripheral artery into the aorta, through the aortic valve, and into the left ventricle. It is powered by an external motor and drive unit.
Centrifugal or axial pumps are commonly used in three situations: (1) for brief support during cardiopulmonary operations, (2) for short-term support while awaiting recovery of the heart from surgery, or (3) as a bridge to keep a patient alive while awaiting heart transplantation. However, rotary pumps generally are not well tolerated for any prolonged period. Patients who must rely on these units for a substantial length of time often suffer from strokes, renal (kidney) failure, and other organ dysfunction. This is due to the fact that rotary devices, which must operate at relatively high speeds, may impose unacceptably high levels of turbulent and laminar shear forces on blood cells. These forces can damage or lyse (break apart) red blood cells. A low blood count (anemia) may result, and the disgorged contents of lysed blood cells (which include large quantities of hemoglobin) can cause renal failure and lead to platelet activation that can cause embolisms and stroke.
One of the most important problems in axial rotary pumps in the prior art involves the gaps that exist between the outer edges of the blades, and the walls of the flow conduit. These gaps are the site of severe turbulence and shear stresses, due to two factors. Since implantable axial pumps operate at very high speed, the outer edges of the blades move extremely fast and generate high levels of shear and turbulence. In addition, the gap between the blades and the wall is usually kept as small as possible to increase pumping efficiency and to reduce the number of cells that become entrained in the gap area. This can lead to high-speed compression of blood cells as they are caught in a narrow gap between the stationary interior wall of the conduit and the rapidly moving tips or edges of the blades.
An important factor that needs to be considered in the design and use of implantable blood pumps is "residual cardiac function," which is present in the overwhelming majority of patients who would be candidates for mechanical circulatory assistance. The patient's heart is still present and still beating, even though, in patients who need mechanical pumping assistance, its output is not adequate for the patient's needs. In many patients, residual cardiac functioning often approaches the level of adequacy required to support the body, as evidenced by the fact that the patient is still alive when implantation of an artificial pump must be considered and decided. If cardiac function drops to a level of severe inadequacy, death quickly becomes imminent, and the need for immediate intervention to avert death becomes acute.
Most conventional ventricular assist devices are designed to assume complete circulatory responsibilities for the ventricle they are "assisting." As such, there is no need, nor presumably any advantage, for the device to interact in harmony with the assisted ventricle. Typically, these devices utilize a "fill-to-empty" mode that, for the most part, results in emptying of the device in random association with native heart contraction. This type of interaction between the device and assisted ventricle ignores the fact that the overwhelming majority of patients who would be candidates for mechanical assistance have at least some significant residual cardiac function.
It is preferable to allow the natural heart, no matter how badly damaged or diseased it may be, to continue contributing to the required cardiac output whenever possible so that ventricular hemodynamics are disturbed as little as possible. This points away from the use of total cardiac replacements and suggests the use of "assist" devices whenever possible. However, the use of assist devices also poses a very difficult problem: in patients suffering from severe heart disease, temporary or intermittent crises often require artificial pumps to provide "bridging" support which is sufficient to entirely replace ventricular pumping capacity for limited periods of time, such as in the hours or days following a heart attack or cardiac arrest, or during periods of severe tachycardia or fibrillation.
Accordingly, an important goal during development of the described method of pump implantation and use and of the surgically implantable reciprocating pump was to design a method and a device which could cover a wide spectrum of requirements by providing two different and distinct functions. First, an ideal cardiac pumping device should be able to provide "total" or "complete" pumping support which can keep the patient alive for brief or even prolonged periods, if the patient's heart suffers from a period of total failure or severe inadequacy. Second, in addition to being able to provide total pumping support for the body during brief periods, the pump should also be able to provide a limited "assist" function. It should be able to interact with a beating heart in a cooperative manner, with minimal disruption of the blood flow generated by the natural heartbeat. If a ventricle is still functional and able to contribute to cardiac output, as is the case in the overwhelming majority of clinical applications, then the pump will assist or augment the residual cardiac output. This allows it to take advantage of the natural, non-hemolytic pumping action of the heart to the fullest extent possible; it minimizes red blood cell lysis, it reduces mechanical stress on the pump, and it allows longer pump life and longer battery life.
Several types of surgically implantable blood pumps containing a piston-like member have been developed to provide a mechanical device for augmenting or even totally replacing the blood pumping action of a damaged or diseased mammalian heart.
Pat. No. 3,842,440 to Karlson discloses an implantable linear motor prosthetic heart and control system containing a pump having a piston-like member which is reciprocal within a magnetic field. The piston-like member includes a compressible chamber in the prosthetic heart which communicates with the vein or aorta.
Pat. Nos. 3,911,897 and 3,911,898 to Leachman, Jr. disclose heart assist devices controlled in the normal mode of operation to copulsate and counterpulsate with the heart, respectively, and produce a blood flow waveform corresponding to the blood flow waveform of the heart being assisted. The heart assist device is a pump connected serially between the discharge of a heart ventricle and the vascular system. The pump may be connected to the aorta between the left ventricle discharge immediately adjacent the aortic valve and a ligation in the aorta a short distance from the discharge. This pump has coaxially aligned cylindrical inlet and discharge pumping chambers of the same diameter and a reciprocating piston in one chamber fixedly connected with a reciprocating piston of the other chamber. The piston pump further includes a passageway leading between the inlet and discharge chambers and a check valve in the passageway preventing flow from the discharge chamber into the inlet chamber. There is no flow through the movable element of the piston.
Pat. No. 4,102,610 to Taboada et al. discloses a magnetically operated constant volume reciprocating pump which can be used as a surgically implantable heart pump or assist. The reciprocating member is a piston carrying a tilting-disk type check valve positioned in a cylinder. While a tilting disk valve results in less turbulence and applied shear to surrounding fluid than a squeezed flexible sack or rotating impeller, the shear applied may still be sufficiently excessive so as to cause damage to red blood cells.
Pat. Nos. 4,210,409 and 4,375,941 to Child disclose a pump used to assist pumping action of the heart having a piston movable in a cylindrical casing in response to magnetic forces. A tilting-disk type check valve carried by the piston provides for flow of fluid into the cylindrical casing and restricts reverse flow. A plurality of longitudinal vanes integral with the inner wall of the cylindrical casing allow for limited reverse movement of blood around the piston which may result in compression and additional shearing of red blood cells. A second fixed valve is present in the inlet of the valve to prevent reversal of flow during piston reversal.
Pat. No. 4,965,864 to Roth discloses a linear motor using multiple coils and a reciprocating element containing permanent magnets which is driven by microprocessor-controlled power semiconductors. A plurality of permanent magnets is mounted on the reciprocating member. This design does not provide for self-synchronization of the linear motor in the event the stroke of the linear motor is greater than twice the pole pitch on the reciprocating element. During start-up of the motor, or if magnetic coupling is lost, the reciprocating element may slip from its synchronous position by any multiple of two times the pole pitch. As a result, a sensing arrangement must be included in the design to detect the position of the piston so that the controller will not drive it into one end of the closed cylinder. In addition, this design having equal pole pitch and slot pitch results in a "jumpy" motion of the reciprocating element along its stroke.
In addition to the piston position sensing arrangement discussed above, the Roth design may also include a temperature sensor and a pressure sensor as well as control circuitry responsive to the sensors to produce the intended piston motion. For applications such as implantable blood pumps where replacement of failed or malfunctioning sensors requires open heart surgery, it is unacceptable to have a linear motor drive and controller that relies on any such sensors. In addition, the Roth controller circuit uses only NPN transistors thereby restricting current flow to the motor windings to one direction only.
Pat. No. 4,541,787 to Delong describes a pump configuration wherein a piston containing a permanent magnet is driven in a reciprocating fashion along the length of a cylinder by energizing a sequence of coils positioned around the outside of the cylinder. However, the coil and control system configurations disclosed only allow current to flow through one individual winding at a time. This does not make effective use of the magnetic flux produced by each pole of the magnet in the piston. To maximize force applied to the piston in a given direction, current must flow in one direction in the coils surrounding the vicinity of the north pole of the permanent magnet while current flows in the opposite direction in the coils surrounding the vicinity of the south pole of the permanent magnet. Further, during starting of the pump disclosed by Delong, if the magnetic piston is not in the vicinity of the first coil energized, the sequence of coils that are subsequently energized will ultimately approach and repel the magnetic piston toward one end of the closed cylinder. Consequently, the piston must be driven into the end of the closed cylinder before the magnetic poles created by the external coils can become coupled with the poles of the magnetic piston in attraction.
Pat. No. 4,610,658 to Buchwald et al. discloses an implantable fluid displacement peritoneovenous shunt system. The system comprises a magnetically driven pump having a spool piston fitted with a disc flap valve.
Pat. No. 5,089,017 to Young et al. discloses a drive system for artificial hearts and left ventricular assist devices comprising one or more implantable pumps driven by external electromagnets. The pump utilizes working fluid, such as sulfur hexafluoride to apply pneumatic pressure to increase blood pressure and flow rate.
The invention also provides an electrical circuit for use in equipment requiring redundancy comprising redundant parallel current paths for current flow between a higher voltage level conductor and a lower voltage level conductor. A plurality of switches in each current path is connected in series between the higher and lower voltage level conductors for controlling current flow between the higher and lower voltage level conductors. Each of the parallel current paths has sensing points between adjacent switches. The current flowing through each path provides a voltage level at each sensing point. A comparator detects voltage differences between corresponding sensing points in the parallel current paths to indicate when one switch is not in the same state as another switch.
Further objects and advantages of the invention will be apparent from a reading of the following description in conjunction with the accompanying drawings, in which:
FIG. 1 is a longitudinal sectional view illustrating a representative surgically implantable pump with a reciprocating piston-valve arranged in accordance with the invention;
FIG. 2 is a perspective view illustrating a representative arrangement for attachment of vascular grafts to a surgically implantable pump in accordance with the invention;
FIG. 2(a) is an enlarged fragmentary view illustrating another alternative arrangement for attachment of the pump to a blood vessel;
FIG. 3 is an enlarged fragmentary sectional view illustrating a representative quick connect locking system for attaching a surgically implantable pump with a blood vessel arranged in accordance with the invention;
FIG. 4 is an exploded perspective view showing the arrangement of a typical piston-valve for use in a surgically implantable pump in accordance with the invention; and
FIG. 5 is an exploded view showing an alternate configuration for assembling a piston-valve for use in a surgically implantable pump in accordance with the invention.
FIG. 6 is a fragmentary cross-sectional view showing an alternate magnet arrangement for use in a surgically implantable pump in accordance with the invention;
FIGS. 7(a)-7(j) are fragmentary cross-sectional views illustrating the stages in the energization of the coils of a linear motor drive in accordance with the invention;
FIGS. 8 and 8(a) are graphical representatives showing the timing of the application potential to the coils of the linear motor of FIG. 1 in accordance with the invention and a typical electrocardiogram signal respectively;
FIGS. 9(a)-9(c) are schematic circuit diagrams of a controller circuit in accordance with the invention;
FIGS. 10(a) and 10(b) are perspective views showing the opposite sides of an implantable controller arrangement in accordance with the invention;
FIG. 11 is a schematic illustration showing the anatomical arrangement of a surgically implantable pump with a reciprocating piston-valve in accordance with the invention implanted as a left ventricular assist device;
FIG. 12 is a schematic illustration showing the anatomical arrangement of a surgically implantable pump with a reciprocating piston-valve in accordance with the invention implanted as a simplex right ventricular assist device;
FIG. 13 is a schematic illustration showing the anatomical arrangement of a surgically implantable pump arrangement in accordance with the invention implanted as a duplex right ventricular assist device;
FIG. 14 is a longitudinal sectional view illustrating another embodiment of a surgically implantable pump arranged in accordance with the invention;
FIG. 15 is a schematic illustration showing the anatomical disposition of a surgically implantable pump arrangement in accordance with the invention in a duplex total artificial heart implantation;
FIG. 16 is a representative alternate surgically implantable pump arrangement in accordance with the invention in a duplex total artificial heart implantation;
FIG. 17 is a longitudinal sectional view showing a surgically implantable pump arranged in accordance with the invention and configured as a simplex total artificial heart;
FIG. 18 is a schematic illustration showing the anatomical arrangement of the surgically implantable pump shown in FIG. 17 implanted in a simplex total artificial heart configuration;
In the representative embodiment of a pump according to the invention as shown in FIG. 1, a pump module arrangement 34, which is for example, no more than 6 cm in diameter and 7.5 cm long, includes a reciprocating piston-valve assembly 1 consisting of an annular piston with a central flow passage containing two pivoting valve leaflets 2 which act as a check valve to limit flow through the central passage during reciprocation to one direction only. The piston-valve assembly 1 is driven back and forth through an internal cylinder 3 in the pump module 34 to displace fluid from an inlet end to an outlet end. Smooth and vibration-free motion can be ensured by providing close-clearance, low friction interfaces between the cylinder inner diameter and the piston-valve.
The piston-valve 1, leaflets 2 and internal cylinder 3 are all preferably fabricated from highly corrosion-resistant material such as titanium or carbon, and are coated with low-friction, wear-resistant, non-thrombogenic material. One material which has been shown to have a good combination of biocompatibility and high strength is pyrolytic carbon, which is used to coat the housing and leaflets of various types of prosthetic heart valves, such as the St. Jude valve. The coating can be applied by a conventional vapor deposition process, resulting in a layer containing about 90% carbon and 10% silicon on the surface of a graphite structure.
When used as an implantable left ventricular assist device (LVAD), the pump module 34 is attached at its inlet end using a sewing cuff 4 to a patient's aorta 5 immediately downstream of the aortic valve (not shown in FIG. 1) using a suture 6. In this manner, the patient's own normally functioning aortic valve precludes back-flow of blood into the patient's left ventricle when the piston-valve makes its return stroke. Preferably the sewing cuff 4 is made from a synthetic surgical graft material such as woven Dacron™ available from the Dupont Corporation. The sewing cuff 4 can be attached to the LVAD using a retaining ring 7 which snaps into cantilevered barbs 8 or other similar retaining arrangements. The sewing cuff has an enlarged end 9 which becomes physically captured or entrapped by the retaining ring 7 when it is snapped into place. Compression of the sewing cuff 9 by the retaining ring 7 against the cylinder 3 forms a hemostatic seal.
At the outlet end of the cylinder 3 a retaining ring 15 is used in conjunction with a sewing cuff 16 in a similar manner as described herein above. The sewing cuff 16 is attached using a suture 17 to the patient's distal ascending aorta 18.
Returning to the pump arrangement shown in FIG. 1, a high energy density rare earth permanent magnet 19 having axially spaced north and south pole pieces 21 is mounted on the circumference of the piston-valve 1. A hermetically sealed enclosure 20 made from a highly corrosion-resistant material such as titanium surrounds the permanent magnet 19 and its pole pieces 21. Preferably, the high energy density rare earth material is neodymium-iron-boron. The pole pieces 21, which are made from soft ferromagnetic material, direct the magnetic flux so as to project outward radially from the axially oriented permanent magnet toward the circumference of the piston-valve. The radial magnetic flux thus intercepts the windings 12 of a linear motor that surrounds the cylinder 3 through which the piston-valve 1 slides, the windings being formed in slots separated by magnetically soft lamination material 14 of the type commonly used in commercial motors, generators and transformers. A magnetically soft backing 13 surrounds the winding slots to provide a low reluctance path for the flux generated by the piston-valve magnet to link the windings. The laminations are positioned so as to avoid slot harmonics which would cause non-uniform motion of the piston-valve and are sized to minimize the effective air gap across which the magnetic flux must pass. Particularly smooth motion is obtained by using odd/even ratios of winding slot pitch to magnetic pole pitch on the piston-valve, respectively, or vice versa. In this regard, multiple phase windings are required.
The linear motor windings and laminations are encased in a corrosion-resistant enclosure which includes a hermetically sealed penetration 26 for a linear motor lead bundle 30 leading to a linear motor controller 50 described hereinafter. This bundle further includes a pair of epicardial sensing leads 31. A seal weld 10 is provided at each end of the pump module 34 to form a hermetic seal between an outer housing 11 for the pump and the inner cylinder 3. The hermetic seal prevents moisture or other contaminants from attacking the linear motor windings 12, back iron material 13 or lamination material 14.
Suitable voltage is provided to the windings of the linear motor by wires in the bundle 30 which are connected to a battery associated with the controller 50. The wires which supply power to the motor are positioned outside the aorta and thus do not contact blood flowing through the aorta.
The outer housing 11 can be composed of any suitably hard biocompatible material, such as titanium, stainless steel, various other alloys, graphite, or plastic. It can be sealed with a standard waterproof epoxy coating.
In operation, as the piston-valve 1 moves toward the outlet end of the pump, i.e., the right end as viewed in FIG. 1, fluid on the downstream side of the piston-valve is ejected from the outlet end due to the fact that the piston-valve leaflets automatically move to their closed position 2 from their open position 25 shown in dotted lines when the piston-valve moves with respect to the fluid in the pump toward the outlet end of the pump or when fluid attempts to flow past the piston-valve in the direction toward the inlet. As the piston-valve 1 reaches the outlet end of its pumping stroke, its direction of travel is reversed by the controller 50 and, as the piston-valve begins its travel back toward the inlet end of the cylinder, i.e., the left end as viewed in FIG. 1, the piston-valve leaflets automatically move to the open position 25, allowing the fluid to flow from the upstream side of the piston-valve to the downstream side of the piston-valve as it moves along the cylinder.
If the linear motor malfunctions and attempts to drive the piston-valve beyond the ends of the cylinder 3, the retaining rings 7 and 15 are shaped so as to prevent the piston-valve from moving past the sewing cuffs 4. As another back-up mechanism, the shape of the retaining rings 7 and 15 is arranged so that the piston-valve will not become jammed in the sewing cuff or damage the sewing cuff in any way. In the outlet end of the pump used as a LVAD, a patient's aorta 32 bends sharply at the aorta arch 22. To smooth out the flow path, the retaining ring 15 may have a trimmed portion 23 at this location as shown in FIG. 1. The retaining rings 7 and 15 preferably have at least four equally spaced tool holes 24 to receive a tool for removing the retaining rings after they have been snapped into place as described above.
In LVAD applications, where the pump is positioned in the outflow duct of the left ventricle, the pump inlet is downstream of the left and right coronary artery ostia or openings. During normal operation, the piston travels back from the outlet end of the cylinder as slowly as possible during the patient's native heart diastole so that it arrives at the inlet end of the cylinder just before the patient's left ventricle begins to eject blood during systole. This ensures that the patient's coronary artery 32 receives adequate blood flow during diastole, when most of the blood that normally enters the coronary arteries is actually admitted. The slow motion of the piston-valve back toward the inlet end of the cylinder also limits shear stress in the blood flowing to the downstream side of the piston-valve and should result in a slight increased pressure at the inlet to the patient's coronary arteries, which will improve blood flow to the patient's native heart muscle during diastole. This is expected to compensate for the possibly slightly reduced pressure at the inlet to the patient's coronary arteries that will occur during systole caused by the pumping action of the piston-valve moving toward the outlet end of the cylinder. A seam 33 formed at the interfaces between each of the sewing cuffs 4 and 16 and the hollow cylinder 3 is compressed against the cylinder by the retaining rings 7 and 15. This ensures that the crevice formed at the seam will become covered with a smooth secure endothelial layer to preclude formation and release of blood clots in this area.
The hermetically sealed cable penetration 26 which is made from a highly corrosion-resistant material such as titanium houses the linear motor winding leads 27 and is seal welded to the outer housing 11. The main lead bundle 30 contains a shielded multi-conductor cable with a polyurethane jacket material similar to insulation currently used for pacemaker leads. Such cable is commercially available for machine tool and robotics application, and is rated in excess of 6 million bend cycles from straight to its minimum bend radius without failure of the insulation or conductors. The main lead bundle incorporates approximately 24 conductors required to drive the linear motor in VAD applications. The main lead bundle terminates at a hermetically sealed cylindrical connector at the linear motor controller 50. A molded polyurethane strain relief 29 attaches the polyurethane jacket of the shielded multi-conductor cable 30 which constitutes the main lead bundle to the linear motor to the cable penetration. An optional second strain relief attached to the polyurethane jacket includes the leads 31 which are routed to epicardial electrodes used to provide an ECG signal to the linear motor controller 50.
The operation of a linear motor pump module in accordance with the invention is described hereinafter in greater detail with reference to FIGS. 7(a)-7(j) which show a diagrammatic cross-section of the linear motor drive for the pump module. In these views, a piston 194, containing a magnet assembly 195 is free to slide through a cylinder 196 as previously discussed. Magnetic flux 197 generated by the magnet assembly 195 is made to link several of the windings 198 by the magnetically soft radial laminations 199 and circumferential laminations 200, which separate and surround the windings 198. The laminations 199 and 200 can be manufactured from thin sheets of material such as silicon iron or iron-cobalt bonded together to the proper thickness to accommodate the magnetic flux produced by the magnet 195. The radial laminations 199 also include an axially enlarged portion near the outer surface of the inner cylinder 196 to improve magnetic coupling between the piston magnet 195 and the windings. This enlargement may not be necessary if the motor performance otherwise satisfies the operation requirements.
FIG. 7(a) shows the piston 194 at the inlet end of the cylinder 196 with a series of windings 601-623 having energization leads 501-526 with the first five windings 601-605 all energized by current flowing in the same direction, i.e., into the plane of the drawings, represented by the symbol "+", and all other windings 606-623 with no current represented by "x". This current is produced by the "high" potentials applied at the leads 501 and 502 (e.g., 12 volts, designated by "H") and the "low" potential applied at the leads 507 and 508 (e.g., 0 volts designated by "L"). All other leads are connected to an open circuit (designated by "x"). This energization pattern provides a holding mode to hold the piston 194 in a given position in the cylinder 196 until the next pumping or return stroke is initiated. Current through the windings at this stage is limited to a nominal level using pulse width modulation (PWM) or another efficient current limiting method to avoid excessive winding heating and power consumption.
FIG. 7(b) shows the piston 194 at the inlet end of the cylinder with the first five windings 601-605 of the series of windings 601-623 energized to begin a pumping stroke. For this purpose, the windings 601 and 602 are energized with current flowing into the plane of the drawing "+" while the windings 604 and 605 are energized with current flowing out of the plane of the drawing, represented by "⊙". Given the orientation of the magnetic flux from the magnet 195 and the current in the energized windings, a force will be exerted on the piston driving it to the right. The controller 50 includes a current limiting arrangement to prevent damage to the windings as discussed earlier, but such current limitation is not expected to be required once the piston begins to move along the cylinder and generate a counter emf.
FIG. 7(c) shows the piston 194 progressing to the right. In this case, the winding 606 has been energized in the same direction as the windings 604 and 605 in anticipation of the leading edge of the magnet beginning to couple this winding. FIG. 7(d) shows a further progression of the piston to the right with the winding 603 energized like the windings 601 and 602 and the winding 604 being de-energized. All of the windings 601-623 are connected in series which allows the inductive flyback energy released when a winding such as the winding 604 is de-energized to be usefully transferred into the neighboring windings rather than being dissipated wastefully through the controller circuit. FIG. 7(e) shows the piston progressing still further along its stroke with the winding 601 now de-energized. The pattern of windings energized is now the same as it was in FIG. 7(b), except offset to the right by one winding. The pattern described by FIGS. 7(b) through 7(e) repeats until the piston reaches the end of its stroke, where it may be held momentarily as shown in FIG. 7(f). The pattern then begins again, except with current directions in the windings reversed, when the piston is driven back toward the inlet end of the cylinder as shown in FIG. 7(g).
In the arrangement shown in FIGS. 7(a)-7(j) the magnet pole pitch is not equal to an integral multiple of the winding slot pitch. This requires an out of phase energization of the coils which are being approached by the leading edge of the north pole of the magnet in contrast to those being approached by the south pole of the magnet. Although this complicates the timing used in the control circuit, the movement of the piston is smoother along its stroke when the energizing of approaching windings is divided into multiple transitions for a given displacement instead of one.
The timing used in the control circuit for the motor could be simplified if desired if both the magnetic pole width and the pole pitch were made equal to an integral multiple of the winding slot pitch. With this arrangement, the windings being approached by the leading edges of both magnetic poles can be energized at the same time that the windings being left behind by the trailing edges of both magnetic poles are de-energized. However, the piston will tend to move forward abruptly each time this combination of simultaneous energizing and de-energizing at multiple windings occurs. This would be undesirable for applications such as implantable circulatory assist devices where uniform motion of the piston is required to minimize vibration and high frequency pulsation of the fluid that could cause unnatural sensations. The most uniform motion of the piston can be obtained by making both the width and pitch of the magnetic poles unequal to an integral multiple of the slot pitch. This also results in the most complicated timing in the control circuit. In this case, the timing sequence proceeds as follows: the winding being approached by the leading edge of the first magnet pole is energized, then the winding being left by the trailing edge of the second magnet pole is de-energized, then the winding being left by the first pole is de-energized, then the winding being approached by the second pole is energized, and so on. However, with large scale programmable logic devices such as microcontrollers, programmable gate arrays, etc., it is possible to implement such complex winding energization timing algorithms without much difficulty.
It can be seen from FIG. 7(h) that the piston position will be automatically synchronized with the pattern of windings being energized during initial start-up of the motor, or if magnetic coupling between the piston and the windings is lost for some reason, without the piston ever being driven into the travel stops at the end of the cylinder. As shown in FIG. 7(h), the pattern of energized windings is initially that shown in FIG. 7(g). As the pattern of energized windings shown in FIG. 7(g) progresses to the left, it will approach the stationary piston in the middle of the cylinder. As the windings at the leading edge of the pattern of energized windings begins to interact with the flux emanating from the north pole of the stationary piston, as shown in FIG. 7(i), the piston will experience a force drawing it to the right, into the pattern of energized windings, even though the pattern is moving to the left. This is because the leading windings would normally act on the flux entering into the south pole of the piston magnet, which would cause the piston to experience a force drawing the piston to the left. The opposite direction of the magnetic flux emanating from the north pole causes the force acting on the piston to be reversed. The piston will continue to be drawn to the right until it becomes centered in the pattern of energized coils, as shown in FIG. 7(j), which is its normal synchronous position. Because of the energization pattern, it will continue, from that point on, to move synchronously in the same location with respect to the pattern of energized coils. This process of resynchronization will take place as long as the piston is anywhere within the travel limits of the cylinder which is physically ensured as long as end connections such as those depicted in FIGS. 2, 2(a) and 3 are provided.
It can also be seen that failure of a single lead in the series 501-526 will have no effect other than possibly to add an additional winding to the circuit that would not normally be energized. Referring to FIG. 7(b), if the lead 507 were to fail, the winding 606 would become energized in the direction ⊙, providing current out of plane of the drawing, which would have little effect on motor operation other than a slightly increased winding impedance. The same can be said for any other failure of an active lead for the pattern of lead potentials shown in FIG. 7.
A fault detection algorithm can be incorporated into the controller 50 for the linear motor drive by using a current sensor that provides a signal representing total current flowing through the motor windings to the controller logic circuit, which compares this value to an expected value or an average of previous values for the active set of windings. Any discontinuity as a result of a change in winding impedance due to a failed lead will be manifested as a departure from the expected or time averaged current level as the failed lead is energized. The fault can then be annunciated by the controller so that corrective action to repair the failed lead can be taken before a complete malfunction of the motor occurs.
The controller 50 can also be programmed to detect and flag a failed winding by monitoring for the associated discontinuity in electric current to the motor. The failed winding can then be selectively skipped over on subsequent cycles so that only one (i.e., the failed winding) out of the four or five windings in the pattern of energized windings influencing the piston at any one time will be lost. Further, the remaining windings may carry slightly greater current to compensate for the failed winding with no other adverse effects with the exception of slightly decreased efficiency and slightly increased winding operating temperature.
Referring to FIG. 7(c), if the winding 606 were to fail, then no current could pass from the leads 508 and 509 to the lead 505, but the windings 601 and 602 would still remain energized by the leads 501, 502 and 504. The current would be limited to these windings by the back emf generated by the moving magnetic pole or by the PWM current limiting feature discussed above. A motor designed for high reliability will incorporate windings rated to handle twice the normal current and permanent magnets that will not be demagnetized by this doubling of current so that a single failed winding will not cause a complete malfunction of the motor. Additionally, the motor controller 50 can be designed to detect a failed winding using an algorithm similar to that described above for detecting a failed lead, so that replacement of the motor can be accomplished before a complete malfunction occurs. A further improvement of the failed winding detection algorithm would be to use the magnitude of the current discontinuity detected by the controller 50 to distinguish between a failed lead 501-526 and a failed winding 601-623. This is advantageous for determining whether the pump module 34 must be replaced (i.e., due to winding failure) or possibly only the controller 50 must be replaced (i.e., due to a lead failure near or within the controller). This failed winding detection algorithm can be yet further enhanced by modifying the timing of lead potentials applied to the motor when a failed winding is identified such that only that winding is lost from the desired pattern of windings to be energized. For instance, referring to FIG. 7(b), if the winding 606 has been identified as a failed winding as described above, the controller 50 will maintain a high potential on the lead 507 in FIGS. 7(c), 7(d) and 7(e), instead of isolating current flow to this lead. A low potential will be applied to the lead 507 when this would normally have occurred in a subsequent transition of lead potentials. However, a low potential will also be applied to the lead 508 on the other side of the failed winding 606 at that time to maintain a current path on either side of the failed winding. A similar scheme will be used as the south pole of the piston magnet 195 passes by the failed winding except that the lead potentials will be reversed. This modification of the winding energization timing will ensure that all windings with the exception of the failed winding will receive electric current according to the desired timing sequence.
FIG. 8 comprises a series of timing diagrams that show the successive lead potentials required at the leads 501-526 to produce the normal pattern of energized windings described in connection with FIG. 7(a)-7(j). A typical ECG signal is also shown in FIG. 8(a).
The ECG signal shown in FIG. 8(a) illustrates the P, Q, R, S and T waves. This is an electrical signal generated by the heart and is sensed by ECG leads attached to the inner (endocardial) or outer (epicardial) surface of the heart muscles or may also be sensed on the outer surface of the body. The P wave is caused by the spread of depolarization of the atrial muscle, which initiates contraction of the atria. Approximately 0.16 seconds after the onset of the P wave, the QRS waves appear as a result of depolarization of the ventricular muscle, which initiates contraction of the ventricles. Finally, the T wave results from repolarization of the ventricles, which represents the onset of ventricular relaxation. The optimum starting point for the winding energization timing cycle in VAD applications to begin is expected to be on or about the R-wave peak 201. This peak value shown in FIG. 8(a) typically occurs just before the recipient's aortic (or pulmonary) valve would normally be pushed open by blood being ejected from the native left (or right) ventricle. For TAH applications, the entire QRST complex will be missing from the ECG signal. Therefore, the timing cycle shown will have to be initiated at some predetermined delay interval referenced to the P-wave peak 202 generated by the recipient's native sinus node. This predetermined delay interval will be a programmable setting that can be adjusted, if needed, via the controller's telemetry interface.
If the ventricular rate falls below a pre-set minimum (50-80 beats per minute), a pacemaker 39 (FIG. 11) may be used to trigger the timing cycle and restore heart rate. In the event the pacemaker becomes ineffective, the linear motor controller 50 may incorporate a telemetry programmable lower limit for the cycle rate of the piston-valve to ensure that adequate blood flow is maintained. This feature may also provide vital circulation in the event of total cardiac arrest. Accelerated heart rates such as premature ventricular contractions (PVC) and tachycardia may also occur. An implantable pacemaker alone does not have the ability to correct heart rates that are too rapid. However, the linear motor controller 50 may optionally incorporate features similar to currently available implantable cardioverter/defibrillators to restore normal cardiac rhythm. If this should prove unsuccessful in reducing heart rate, the controller 50 may be adjusted to alter the motion of the piston-valve to minimize the damage to the blood cells due to high velocity flow through the piston-valve. This alteration in motion may consist of slowing down or stopping the piston-valve momentarily on its return stroke if a PVC or any type of tachycardia is detected. If extended tachycardia is detected, the piston-valve cycle rate may be adjusted to synchronize with every other or every third, etc., heart beat as well as adjusted to slow down or stop on the return stroke as necessary to minimize high velocity blood flow during ventricular ejection.
FIGS. 9(a), 9(b) and 9(c) are schematic circuit diagrams of a controller circuit used to generate the lead outputs required, as shown in FIGS. 7(a)-7(j) and FIG. 8 as well as the failure mode correction, and fault indication previously discussed and the telemetry discussed hereinafter. The microcontroller 203 shown in FIG. 9(a) is used as the main logic unit. Many other types of programmable logic devices could be used in this application in place of the microcontroller 203, such as a programmable logic controller (PLC) or gate array (PGA) or even an application specific integrated circuit (ASIC). These could be arranged to perform the required control algorithms for the linear motor. However, the microcontroller products currently available provide a relatively complete set of the features required for a controller for an implantable circulatory assist device using the linear motor drive described in FIGS. 1, 7 and 8. The components of the microcontroller 203 include:
A Central Processing Unit (CPU)--A coded binary instruction based logic unit similar to that used in microprocessors, programmable using machine language, assembler and high level compiled code such as that designated "C".
A Read Only Memory (ROM), Electrically Programmable ROM (EPROM), and Erasable EPROM (EEPROM)--Memory spaces for program instructions, data and default values for variables.
A Random Access Memory (RAM)--Memory space for variables used by the program.
Input/Output (I/O) Ports A-H--Connections through which digital or analog data may be transferred to or from the microcontroller. These ports are used to control the switching sequence of the power semiconductors that control electrical current to the motor windings, send and receive serial data that can be used to adjust program variables within the microcontroller or send out information identifying faults or other performance data, as well as various related tasks.
An Analog and Digital (A/D) Converter--A portion of the microcontroller that converts analog signals acquired via the I/O ports, such as total current to the motor, to digital information that can be used by the CPU.
Pulse Width Modulators (PWM's)--Special output ports which can be programmed to rapidly switch on and off power semiconductors or other devices for programmable durations (pulse widths) that can vary in response to some feedback signal or other control. PWM's are useful in motor controls for current limiting algorithms as discussed above.
A Serial Communication Interface (SCI) and a Serial Peripheral Interface (SPI)--These interfaces transmit or receive serial information via the I/O ports. This serial information can be a digital representation of any of the analog signals being processed by the A/D converter being transmitted out to be interpreted for diagnostic purposes, or incoming data providing instructions to adjust variables in the linear motor control algorithm.
A Computer Operating Properly Watchdog Timer (COP)--This timer counts to a specified value and then resets the microcontroller to the beginning of the program currently being run, or one being pointed to by a reset vector, unless the program currently being run continually resets the timer to zero before it reaches the specified value. This serves to "free-up" a controller that has "locked-up" due to a corruption of program instructions due to a voltage transient or other outside influence.
The microcontroller 203 is provided with power from a regulated 5 volt voltage source. However, to minimize power consumption and heat generation, a 3 volt unit may be used, powered by a high efficiency 3 volt switching regulator. A reset circuit 205 with low voltage protection to avoid memory corruption is also used. The microcontroller shown includes a crystal or other timing reference 206 to drive the main clock. A voltage divider 207 provides a regulated voltage reference for the microcontroller's built-in analog-to-digital converter. A standby microcontroller 208 is included, which can automatically isolate power to the primary microcontroller 203 if more than a predetermined number of computer operating properly watchdog timer (COP) resets are detected on the primary microcontroller within a predetermined interval or it can be manually activated via a telemetry interface connected to the SCI on each microcontroller. The back-up microcontroller 208 operates in "stop-mode" until activated to ensure minimum power consumption. It requires a voltage regulator, reset circuit, reference crystal, and voltage reference, similar to the primary microcontroller 203.
The microcontroller I/O ports A through H are used to drive a power semiconductor array 213, which controls current flow through the motor windings. Each motor lead is provided with a thermal circuit breaker or other passive over-current protection device 214, a complementary pair of power transistors 215 which permits current flow in either direction through each motor lead, and associated driver electronics 216, required for operation of the power transistors 215 by the logic level outputs from the microcontroller. The array of power transistors 215 may optionally be configured to passively or actively permit current flow in the reverse direction from the applied potential, on selected or all leads, thereby permitting the linear motor to be regenerative (i.e., if the load on the piston reverses such that an applied force is assisting movement rather than opposing movement, the controller can use the assisting force to return energy to the rechargeable battery cells, thereby reducing power consumption). This may be useful near the end of the piston travel where piston momentum will tend to drive the piston forward while the motor is trying to slow it down. The stored kinetic energy in the piston can be partially recovered using regeneration.
Each microcontroller 203 and 208 is provided with independent signal conditioning and isolation arrangements 217 and 218 for all incoming analog signals. These analog signals comprise (1) an (amplified) ECG signal output from a separate implanted pacemaker (ECG1) which may be used as a synchronizing signal for reciprocation of the pump module in implantable applications (see FIG. 11), (2) an (amplified) marker channel signal output from a separate implanted pacemaker (MCH1) which may be used as an alternate synchronizing signal if ECG1 is not available (A marker channel output from a pacemaker is a logic signal that indicates when the pacemaker control logic has detected a particular electrocardiological event such as a P wave, a QRS wave, or when the pacemaker has transmitted its own electrical stimulus to the heart.), (3) an ECG signal acquired from the epicardial lead (ECG2), which can be used as a synchronizing signal, (4) a voltage signal from the current sensor or other device indicating total current to the motor windings (CUR1) which may be used in conjunction with a PWM algorithm to efficiently limit motor current, (5) a voltage signal from the current sensor or other device indicating total current delivered to the internal rechargeable battery by the charging circuit (CUR2), which can be used to control charging rate efficiently using a PWM algorithm, (6) a voltage signal indicating battery temperature (TEMP) generated by the voltage drop across a thermistor or other temperature indicating means which can be used to detect an overcharge condition in the internal rechargeable battery, (7) a voltage signal indicating total voltage output from the internal rechargeable battery (V1), which can be used to detect an overcharge condition or detect that one or more of the cells has reversed, and (8) a voltage signal sensed across all or a selected group of motor windings (V2), which can be used to detect movement of the piston caused by flow of fluid.
Because all of the windings shown in FIGS. 7(a)-7(j) are connected in series to each other, any movement of the piston will generate an emf that can be detected from motor leads on either side of the piston. The signal (V2) may thus be used to detect ejection by the recipient's native ventricle(s) in VAD applications or native atria in TAH applications so that the motor may be synchronized when all ECG and marker channel signals (ECG1, ECG2 and MCH1) are lost. If no signals are detected from analog inputs ECG1, ECG2, MCH1 or V2, the controller will default to a fixed cycle rate of the piston back and forth through the hollow cylinder based on a value programmed in the microcontroller. The microcontroller includes programming to sense when the motor current indicated by CUR1 increases or decreases during a given piston stroke relative to previous strokes and will delay or advance subsequent strokes to minimize the current being drawn by the motor. The changes in current drawn by the motor in VAD applications could be caused by residual functioning of the recipient's native heart. For example, if the piston is returning down the cylinder toward the proximal end with the pump implanted as a VAD in a ventricular outflow vessel and the ventricle ejects, the current drawn by the motor will increase due to the flow of blood moving in the opposite direction that the piston is moving.
By programming the controller to seek out the cycle rate of the piston that results in minimum current being drawn by the motor, the piston reciprocation can be indirectly synchronized with any residual cardiac function still present to the maximum extent possible. However, any adjustments made by the controller to the piston cycle rate in this mode of operation would not preclude the programmed minimum number of piston strokes per minute from being completed to maintain minimum circulatory system flow requirements. The reference ground for these analog inputs, as well as the reference ground for the microcontroller analog-to-digital converters, may be connected to an electrically conductive surface on the outside of the controller 50 so that charge equilibrium with the recipient's body is maintained.
Two analog outputs provided from pacemaker units 219 and 219(a) connected to each microcontroller in FIG. 9(a) may also be incorporated for providing single or dual chamber pacing. The output threshold voltage for these signals may be programmable via the telemetry interface discussed in more detail later.
Current to the motor windings is measured using a Hall effect current sensor 221 or other efficient current sensing means. This current signal is used by the active microcontroller 203 or 208 to PWM current to the motor using a power transistor bridge 222. The PWM current limiting algorithm in the microcontroller consists of a program segment that compares the current level indicated at analog input CUR1 to programmable upper and lower limits for current to the motor. As long as CUR1 is below the upper limit, no PWM current limiting will be active. Once the upper limit is exceeded, the PWM algorithm will shut off the power semiconductors in the bridge 222 until current drops below the lower limit, at which time, the power semiconductors in the bridge 222 will be turned back on. This will continue until CUR1 stops exceeding the upper limit for current.
The transistor bridge arrangement 222 is configured to provide one or more redundant back-ups for each power transistor. Comparators and logic gates 223 are incorporated to provide a logical fault indication back to the active microcontroller if one of the power transistors in the bridge has failed. In the configuration shown, two power transistors in series are placed in parallel with two other power transistors in series. A failure of any single power transistor will not cause the overall state of the bridge to be incorrect. The fault detection circuit relies on the fact that the potential at the midpoint between each pair of series power transistors should stay approximately half-way between the upper and lower rails of the bridge. A window comparator is used to detect when this potential deviates from the expected midpoint potential by more than an acceptable range. The motor current PWM algorithm is only expected to be active during lightly loaded conditions such as the piston return stroke or holding modes. During the piston drive stroke, it is expected that back emf generated by the motor will be sufficient to limit current through the windings without the use of PWM.
An internal rechargeable battery 224 shown in FIG. 9(b) consists of a number of high energy density secondary cells, such as nickel-metal-hydride. Charging current to these cells is indicated by a Hall effect current sensor 225 or other high efficiency current sensing device. The internal battery may also incorporate passive bypass diodes 226 which prevent the voltage drop and associated power loss resulting from a cell reversal from approaching an unacceptable level. The battery assembly may also incorporate one or more thermistors 227 or other temperature sensing devices which provide an indication of cell temperature to the active microcontroller for the purpose of terminating charging at a safe condition. This cell temperature indication may also be sensed by an optional independent battery charging supervisory circuit 228. This independent circuit may provide stand alone supervision of internal battery charging, thereby reducing demand on the active microcontroller, or simply act as a redundant back-up to provide additional protection from overcharging. In the latter configuration, the active microcontroller 203 or 208 and the independent charging supervisory circuit 228 can act through an OR gate to PWM or isolate current from the internal battery using a power transistor 229.
Power for the internal battery charging circuit is obtained via a subcutaneous secondary coil 230. This coil is connected to a capacitor/rectifier circuit 231 that is tuned to the carrier frequency being transmitted trancutaneously to the secondary coil 230. The rectifier may incorporate redundant diodes and a fault detection circuit as shown, which operates similar to the power transistor bridge 222 and logic circuit 223 of FIG. 9(a), except that the power transistors are replaced by diodes. This tuned capacitor/rectifier circuit may also incorporate a filter arrangement 211 to support serial communication interface (SCI) reception via the secondary coil 230. A level detection comparator 232 is provided to convert the analog signal produced by the filter 211 into a digital signal compatible with an SCI receiver 460. A power transistor 233 or other modulation device may also be incorporated to support SCI transmission via the secondary coil 230. A redundant transistor bridge such as the bridge 222 used for PWM current limiting may be used in place of the transistor 233 for improved fault tolerance. This SCI interface provides for changing programmable settings used by the control algorithm and monitoring of analog inputs to the microcontroller such as ECG1, ECG2, MCH1, CUR1, CUR2, TEMP, V1, and V2.
Although the invention has been described herein with reference to specific embodiments, many modifications and variations therein will readily occur to those skilled in the art. Accordingly, all such variations and modifications are included within the intended scope of the invention.
Claims (3)
1. An electrical circuit for use in equipment requiring redundancy comprising redundant parallel current paths for current flow between a higher voltage level conductor and a lower voltage level conductor, a plurality of switch means in each current path connected in series between the higher and lower voltage level conductors for controlling current flow between the higher and lower voltage level conductors, each of the parallel current paths having sensing points between adjacent switch means, the current flow through each path providing a voltage level at each sensing point, and comparison means for detecting voltage differences between corresponding sensing points in the parallel current paths to indicate when one switch means is not in the same state as another switch means.
2. A method for providing redundant parallel current paths in an electrical circuit comprising the steps of:
providing redundant parallel current paths, from a high voltage level conductor to a lower voltage level conductor,
providing a plurality of switch means in series in each current path, each switch means having a first state allowing current flow and a second state inhibiting current flow,
providing voltage sensing points between adjacent switch means in each current path to indicate when one switch means is not in the same state as another switch means, and
conducting current from the high voltage conductor to the low voltage conductor if any switch fails and is in the second state when remaining switches are in the first state and preventing current flow from the high voltage conductor to the low voltage conductor when the remaining switches are in the second state.
3. An electrical circuit for use in equipment requiring redundancy according to claim 1 wherein each switch means has a first state allowing current flow and a second state inhibiting current flow and further comprising a controller means for controlling the state of the switch means wherein the controller means indicates a switch means has failed based upon output received from comparison means.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/477,905 US5843129A (en) | 1992-08-06 | 1995-06-07 | Electrical circuit for equipment requiring redundant flow paths and method of use |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92677992A | 1992-08-06 | 1992-08-06 | |
US08/035,788 US5290227A (en) | 1992-08-06 | 1993-03-23 | Method of implanting blood pump in ascending aorta or main pulmonary artery |
US08/201,806 US5676651A (en) | 1992-08-06 | 1994-02-25 | Surgically implantable pump arrangement and method for pumping body fluids |
US08/477,905 US5843129A (en) | 1992-08-06 | 1995-06-07 | Electrical circuit for equipment requiring redundant flow paths and method of use |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/201,806 Division US5676651A (en) | 1992-08-06 | 1994-02-25 | Surgically implantable pump arrangement and method for pumping body fluids |
Publications (1)
Publication Number | Publication Date |
---|---|
US5843129A true US5843129A (en) | 1998-12-01 |
Family
ID=22747380
Family Applications (9)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/201,806 Expired - Fee Related US5676651A (en) | 1992-08-06 | 1994-02-25 | Surgically implantable pump arrangement and method for pumping body fluids |
US08/477,908 Expired - Fee Related US5722930A (en) | 1992-08-06 | 1995-06-07 | Reciprocating pump circulatory assist arrangement |
US08/477,906 Expired - Lifetime US5676162A (en) | 1992-08-06 | 1995-06-07 | Reciprocating pump and linear motor arrangement |
US08/480,824 Expired - Fee Related US5693091A (en) | 1992-08-06 | 1995-06-07 | Artificial heart and method of maintaining blood flow |
US08/477,905 Expired - Lifetime US5843129A (en) | 1992-08-06 | 1995-06-07 | Electrical circuit for equipment requiring redundant flow paths and method of use |
US08/477,904 Expired - Fee Related US5879375A (en) | 1992-08-06 | 1995-06-07 | Implantable device monitoring arrangement and method |
US08/477,909 Expired - Fee Related US5722429A (en) | 1992-08-06 | 1995-06-07 | Connecting arrangement for medical device |
US08/480,823 Expired - Lifetime US5758666A (en) | 1992-08-06 | 1995-06-07 | Reciprocating pump with imperforate piston |
US08/477,907 Expired - Fee Related US5702430A (en) | 1992-08-06 | 1995-06-07 | Surgically implantable power supply |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/201,806 Expired - Fee Related US5676651A (en) | 1992-08-06 | 1994-02-25 | Surgically implantable pump arrangement and method for pumping body fluids |
US08/477,908 Expired - Fee Related US5722930A (en) | 1992-08-06 | 1995-06-07 | Reciprocating pump circulatory assist arrangement |
US08/477,906 Expired - Lifetime US5676162A (en) | 1992-08-06 | 1995-06-07 | Reciprocating pump and linear motor arrangement |
US08/480,824 Expired - Fee Related US5693091A (en) | 1992-08-06 | 1995-06-07 | Artificial heart and method of maintaining blood flow |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/477,904 Expired - Fee Related US5879375A (en) | 1992-08-06 | 1995-06-07 | Implantable device monitoring arrangement and method |
US08/477,909 Expired - Fee Related US5722429A (en) | 1992-08-06 | 1995-06-07 | Connecting arrangement for medical device |
US08/480,823 Expired - Lifetime US5758666A (en) | 1992-08-06 | 1995-06-07 | Reciprocating pump with imperforate piston |
US08/477,907 Expired - Fee Related US5702430A (en) | 1992-08-06 | 1995-06-07 | Surgically implantable power supply |
Country Status (9)
Country | Link |
---|---|
US (9) | US5676651A (en) |
EP (1) | EP0748235B1 (en) |
JP (2) | JPH09509595A (en) |
AT (1) | ATE305316T1 (en) |
AU (1) | AU1971495A (en) |
CA (1) | CA2183666A1 (en) |
DE (1) | DE69534486D1 (en) |
TW (1) | TW290461B (en) |
WO (1) | WO1995023000A2 (en) |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6298269B1 (en) | 1999-04-19 | 2001-10-02 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with ultrasound for autocapture or other applications |
US6632169B2 (en) | 2001-03-13 | 2003-10-14 | Ltk Enterprises, L.L.C. | Optimized pulsatile-flow ventricular-assist device and total artificial heart |
US6770024B1 (en) | 2000-03-28 | 2004-08-03 | Stony Brook Surgical Innovations, Inc. | Implantable counterpulsation cardiac assist device |
US7228175B2 (en) | 2002-05-15 | 2007-06-05 | Cardiac Pacemakers, Inc. | Cardiac rhythm management systems and methods using acoustic contractility indicator |
WO2014113533A1 (en) * | 2013-01-16 | 2014-07-24 | Thoratec Corporation | Motor fault monitor for implantable blood pump |
US9089634B2 (en) | 2009-09-22 | 2015-07-28 | Ecp Entwicklungsgesellschaft Mbh | Fluid pump having at least one impeller blade and a support device |
US9556873B2 (en) | 2013-02-27 | 2017-01-31 | Tc1 Llc | Startup sequence for centrifugal pump with levitated impeller |
US9623161B2 (en) | 2014-08-26 | 2017-04-18 | Tc1 Llc | Blood pump and method of suction detection |
US9638202B2 (en) | 2010-09-14 | 2017-05-02 | Tc1 Llc | Centrifugal pump apparatus |
US9709061B2 (en) | 2013-01-24 | 2017-07-18 | Tc1 Llc | Impeller position compensation using field oriented control |
US9850906B2 (en) | 2011-03-28 | 2017-12-26 | Tc1 Llc | Rotation drive device and centrifugal pump apparatus employing same |
US10052420B2 (en) | 2013-04-30 | 2018-08-21 | Tc1 Llc | Heart beat identification and pump speed synchronization |
US10117983B2 (en) | 2015-11-16 | 2018-11-06 | Tc1 Llc | Pressure/flow characteristic modification of a centrifugal pump in a ventricular assist device |
US10166318B2 (en) | 2015-02-12 | 2019-01-01 | Tc1 Llc | System and method for controlling the position of a levitated rotor |
US10245361B2 (en) | 2015-02-13 | 2019-04-02 | Tc1 Llc | Impeller suspension mechanism for heart pump |
US10349982B2 (en) | 2011-11-01 | 2019-07-16 | Nuvasive Specialized Orthopedics, Inc. | Adjustable magnetic devices and methods of using same |
US10371152B2 (en) | 2015-02-12 | 2019-08-06 | Tc1 Llc | Alternating pump gaps |
US10478232B2 (en) | 2009-04-29 | 2019-11-19 | Nuvasive Specialized Orthopedics, Inc. | Interspinous process device and method |
US10506935B2 (en) | 2015-02-11 | 2019-12-17 | Tc1 Llc | Heart beat identification and pump speed synchronization |
US10617453B2 (en) | 2015-10-16 | 2020-04-14 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US10646262B2 (en) | 2011-02-14 | 2020-05-12 | Nuvasive Specialized Orthopedics, Inc. | System and method for altering rotational alignment of bone sections |
US10660675B2 (en) | 2010-06-30 | 2020-05-26 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10729470B2 (en) | 2008-11-10 | 2020-08-04 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10743794B2 (en) | 2011-10-04 | 2020-08-18 | Nuvasive Specialized Orthopedics, Inc. | Devices and methods for non-invasive implant length sensing |
US10751094B2 (en) | 2013-10-10 | 2020-08-25 | Nuvasive Specialized Orthopedics, Inc. | Adjustable spinal implant |
US10835290B2 (en) | 2015-12-10 | 2020-11-17 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10918425B2 (en) | 2016-01-28 | 2021-02-16 | Nuvasive Specialized Orthopedics, Inc. | System and methods for bone transport |
US11191579B2 (en) | 2012-10-29 | 2021-12-07 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US11202707B2 (en) | 2008-03-25 | 2021-12-21 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant system |
US11234849B2 (en) | 2006-10-20 | 2022-02-01 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
US11246694B2 (en) | 2014-04-28 | 2022-02-15 | Nuvasive Specialized Orthopedics, Inc. | System for informational magnetic feedback in adjustable implants |
US11357549B2 (en) | 2004-07-02 | 2022-06-14 | Nuvasive Specialized Orthopedics, Inc. | Expandable rod system to treat scoliosis and method of using the same |
US11439449B2 (en) | 2014-12-26 | 2022-09-13 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for distraction |
US11612416B2 (en) | 2015-02-19 | 2023-03-28 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for vertebral adjustment |
Families Citing this family (436)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5924975A (en) * | 1995-08-30 | 1999-07-20 | International Business Machines Corporation | Linear pump |
US5888242A (en) * | 1996-11-01 | 1999-03-30 | Nimbus, Inc. | Speed control system for implanted blood pumps |
US6123726A (en) * | 1997-07-25 | 2000-09-26 | Seiko Epson Corporation | Portable drive system for artificial heart |
DE69836495T3 (en) * | 1997-10-02 | 2015-08-06 | Micromed Technology, Inc. | Control module for implantable pumping system |
US6889082B2 (en) * | 1997-10-09 | 2005-05-03 | Orqis Medical Corporation | Implantable heart assist system and method of applying same |
US6610004B2 (en) * | 1997-10-09 | 2003-08-26 | Orqis Medical Corporation | Implantable heart assist system and method of applying same |
DE19753041A1 (en) * | 1997-11-19 | 1999-05-20 | Peter Neubacher | Servo-linear motor for driving pump |
US6695864B2 (en) * | 1997-12-15 | 2004-02-24 | Cardeon Corporation | Method and apparatus for cerebral embolic protection |
US8489200B2 (en) | 1998-07-06 | 2013-07-16 | Abiomed, Inc. | Transcutaneous energy transfer module with integrated conversion circuitry |
US6402689B1 (en) * | 1998-09-30 | 2002-06-11 | Sicel Technologies, Inc. | Methods, systems, and associated implantable devices for dynamic monitoring of physiological and biological properties of tumors |
US6149683A (en) * | 1998-10-05 | 2000-11-21 | Kriton Medical, Inc. | Power system for an implantable heart pump |
GB9824436D0 (en) * | 1998-11-06 | 1999-01-06 | Habib Nagy A | Methods of treatment |
US6528856B1 (en) * | 1998-12-15 | 2003-03-04 | Intel Corporation | High dielectric constant metal oxide gate dielectrics |
US6666875B1 (en) * | 1999-03-05 | 2003-12-23 | Olympus Optical Co., Ltd. | Surgical apparatus permitting recharge of battery-driven surgical instrument in noncontact state |
FR2792841A1 (en) * | 1999-04-30 | 2000-11-03 | Medtronic Inc | Implantable automated medication delivery device has reservoir whose contents are delivered by programmable injection pump having associated temperature sensor connected to control unit |
US6488689B1 (en) | 1999-05-20 | 2002-12-03 | Aaron V. Kaplan | Methods and apparatus for transpericardial left atrial appendage closure |
US6607485B2 (en) | 1999-06-03 | 2003-08-19 | Cardiac Intelligence Corporation | Computer readable storage medium containing code for automated collection and analysis of patient information retrieved from an implantable medical device for remote patient care |
US7429243B2 (en) * | 1999-06-03 | 2008-09-30 | Cardiac Intelligence Corporation | System and method for transacting an automated patient communications session |
US6312378B1 (en) * | 1999-06-03 | 2001-11-06 | Cardiac Intelligence Corporation | System and method for automated collection and analysis of patient information retrieved from an implantable medical device for remote patient care |
US6270457B1 (en) | 1999-06-03 | 2001-08-07 | Cardiac Intelligence Corp. | System and method for automated collection and analysis of regularly retrieved patient information for remote patient care |
US7134996B2 (en) | 1999-06-03 | 2006-11-14 | Cardiac Intelligence Corporation | System and method for collection and analysis of patient information for automated remote patient care |
AUPQ090499A0 (en) | 1999-06-10 | 1999-07-01 | Peters, William S | Heart assist device and system |
US6221011B1 (en) | 1999-07-26 | 2001-04-24 | Cardiac Intelligence Corporation | System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system |
CA2314513A1 (en) | 1999-07-26 | 2001-01-26 | Gust H. Bardy | System and method for providing normalized voice feedback from an individual patient in an automated collection and analysis patient care system |
CA2314517A1 (en) * | 1999-07-26 | 2001-01-26 | Gust H. Bardy | System and method for determining a reference baseline of individual patient status for use in an automated collection and analysis patient care system |
US6669726B2 (en) | 1999-08-03 | 2003-12-30 | Juan M. Giambruno | Orthotopic total artificial heart |
US6296450B1 (en) * | 1999-09-03 | 2001-10-02 | Baxter International Inc. | Systems and methods for control of pumps employing gravimetric sensing |
US6949079B1 (en) | 1999-09-03 | 2005-09-27 | Baxter International Inc. | Programmable, fluid pressure actuated blood processing systems and methods |
US6723062B1 (en) | 1999-09-03 | 2004-04-20 | Baxter International Inc. | Fluid pressure actuated blood pumping systems and methods with continuous inflow and pulsatile outflow conditions |
US6261065B1 (en) | 1999-09-03 | 2001-07-17 | Baxter International Inc. | System and methods for control of pumps employing electrical field sensing |
US6759007B1 (en) * | 1999-09-03 | 2004-07-06 | Baxter International Inc. | Blood processing systems and methods employing fluid pressure actuated pumps and valves |
US7313429B2 (en) | 2002-01-23 | 2007-12-25 | Stereotaxis, Inc. | Rotating and pivoting magnet for magnetic navigation |
US6702804B1 (en) * | 1999-10-04 | 2004-03-09 | Stereotaxis, Inc. | Method for safely and efficiently navigating magnetic devices in the body |
US6290640B1 (en) | 1999-11-02 | 2001-09-18 | International Business Machines Corporation | Uncoupled rotary linear pump |
EP1099484B1 (en) | 1999-11-11 | 2006-06-07 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | A dispensing method and assembly for liquid droplets |
US6398728B1 (en) * | 1999-11-16 | 2002-06-04 | Cardiac Intelligence Corporation | Automated collection and analysis patient care system and method for diagnosing and monitoring respiratory insufficiency and outcomes thereof |
US8369937B2 (en) | 1999-11-16 | 2013-02-05 | Cardiac Pacemakers, Inc. | System and method for prioritizing medical conditions |
US6440066B1 (en) * | 1999-11-16 | 2002-08-27 | Cardiac Intelligence Corporation | Automated collection and analysis patient care system and method for ordering and prioritizing multiple health disorders to identify an index disorder |
US6411840B1 (en) | 1999-11-16 | 2002-06-25 | Cardiac Intelligence Corporation | Automated collection and analysis patient care system and method for diagnosing and monitoring the outcomes of atrial fibrillation |
US6368284B1 (en) * | 1999-11-16 | 2002-04-09 | Cardiac Intelligence Corporation | Automated collection and analysis patient care system and method for diagnosing and monitoring myocardial ischemia and outcomes thereof |
US6336903B1 (en) * | 1999-11-16 | 2002-01-08 | Cardiac Intelligence Corp. | Automated collection and analysis patient care system and method for diagnosing and monitoring congestive heart failure and outcomes thereof |
ATE283077T1 (en) * | 2000-03-27 | 2004-12-15 | Cleveland Clinic Foundation | CHRONIC POWER CONTROL SYSTEM FOR ROTODYNAMIC BLOOD PUMP |
US7167756B1 (en) * | 2000-04-28 | 2007-01-23 | Medtronic, Inc. | Battery recharge management for an implantable medical device |
US6327504B1 (en) | 2000-05-10 | 2001-12-04 | Thoratec Corporation | Transcutaneous energy transfer with circuitry arranged to avoid overheating |
US6850803B1 (en) * | 2000-06-16 | 2005-02-01 | Medtronic, Inc. | Implantable medical device with a recharging coil magnetic shield |
US6454697B1 (en) | 2000-07-18 | 2002-09-24 | Dai-Yuan Wang | Cardiac support device and method |
CA2429127A1 (en) * | 2000-11-09 | 2002-05-16 | Sicel Technologies, Inc. | In vivo detection of biomolecule concentrations using fluorescent tags |
FR2816828B1 (en) * | 2000-11-23 | 2004-10-22 | Richard Cancel | DEVICE FOR THE REMOTE IMPLEMENTATION AND WITHOUT A MATERIAL LINK OF AN IMPLANT AND IMPLANT IMPLEMENTED BY THIS DEVICE |
US6481140B1 (en) | 2000-11-28 | 2002-11-19 | William Marshall | Firearm safety system with implanted computer chip |
US6464476B2 (en) | 2000-12-22 | 2002-10-15 | Anthony C. Ross | Linear pump and method |
US6669909B2 (en) | 2001-03-26 | 2003-12-30 | Allegro Technologies Limited | Liquid droplet dispensing |
ATE369885T1 (en) * | 2001-04-10 | 2007-09-15 | Medtronic Inc | FLAT PROFILE INLET VALVE FOR A PISTON PUMP BASED DEVICE FOR DELIVERING A MEDICAL SUBSTANCE |
US7201746B2 (en) * | 2001-04-10 | 2007-04-10 | Medtronic, Inc. | Implantable therapeutic substance delivery device having a piston pump with an anti-cavitation valve |
US7066915B2 (en) * | 2001-04-10 | 2006-06-27 | Medtronic, Inc. | Low profile inlet valve for a piston pump therapeutic substance delivery device |
US7288085B2 (en) | 2001-04-10 | 2007-10-30 | Medtronic, Inc. | Permanent magnet solenoid pump for an implantable therapeutic substance delivery device |
SE523852C2 (en) * | 2001-04-10 | 2004-05-25 | Azad Al-Najjar | Heart prosthesis |
US7011814B2 (en) | 2001-04-23 | 2006-03-14 | Sicel Technologies, Inc. | Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject |
US6723039B2 (en) * | 2001-04-27 | 2004-04-20 | The Foundry, Inc. | Methods, systems and devices relating to implantable fluid pumps |
DE10123138B4 (en) * | 2001-04-30 | 2007-09-27 | Berlin Heart Ag | Method for position control of a permanently magnetically mounted rotating component |
AU2002308409B2 (en) * | 2001-05-21 | 2005-12-01 | Thoratec Corporation | Staged implantation of ventricular assist devices |
AUPR514201A0 (en) * | 2001-05-21 | 2001-06-14 | Ventrassist Pty Ltd | Staged implantation of ventricular assist devices |
US7048680B2 (en) * | 2001-06-06 | 2006-05-23 | Orqis Medical Corporation | Multilumen catheter for minimizing limb ischemia |
US20020188167A1 (en) * | 2001-06-06 | 2002-12-12 | Anthony Viole | Multilumen catheter for minimizing limb ischemia |
WO2002098283A2 (en) * | 2001-06-06 | 2002-12-12 | Medquest Products, Inc. | Apparatus and method for reducing heart pump backflow |
US6626940B2 (en) * | 2001-06-15 | 2003-09-30 | Scimed Life Systems, Inc. | Medical device activation system |
US8292908B2 (en) * | 2001-06-29 | 2012-10-23 | World Heart Corporation | Endoscopic cannulation apparatus and method |
AU2002315480A1 (en) * | 2001-06-29 | 2003-03-03 | Medquest Products, Inc. | Cannulation apparatus and method |
AUPR669001A0 (en) * | 2001-07-30 | 2001-08-23 | Sunshine Heart Company Pty Ltd | A fluid pressure generating means |
US6607368B1 (en) | 2001-11-03 | 2003-08-19 | Anthony Ross | Linear pump and method |
US7557353B2 (en) * | 2001-11-30 | 2009-07-07 | Sicel Technologies, Inc. | Single-use external dosimeters for use in radiation therapies |
US6746416B2 (en) | 2001-12-05 | 2004-06-08 | Spin Corporation | Duplex blood pump for heart surgery |
US20030144574A1 (en) * | 2001-12-19 | 2003-07-31 | Heilman Marlin S. | Method and apparatus for providing limited back-flow in a blood pump during a non-pumping state |
JP2003230536A (en) * | 2002-02-07 | 2003-08-19 | Olympus Optical Co Ltd | Electric curving endoscope |
US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US7497827B2 (en) | 2004-07-13 | 2009-03-03 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10022078B2 (en) | 2004-07-13 | 2018-07-17 | Dexcom, Inc. | Analyte sensor |
US7238165B2 (en) * | 2002-02-21 | 2007-07-03 | Design Mentor, Inc. | Fluid pump |
US7238151B2 (en) * | 2002-02-26 | 2007-07-03 | Frazier O Howard | Permanent heart assist system |
US7029433B2 (en) * | 2002-03-16 | 2006-04-18 | Chang Sheldon S | Device for cardiac restoration |
US7610104B2 (en) * | 2002-05-10 | 2009-10-27 | Cerebral Vascular Applications, Inc. | Methods and apparatus for lead placement on a surface of the heart |
US7338521B2 (en) * | 2002-06-13 | 2008-03-04 | World Heart, Inc. | Low profile inlet for an implantable blood pump |
US6732501B2 (en) * | 2002-06-26 | 2004-05-11 | Heartware, Inc. | Ventricular connector |
US7241257B1 (en) | 2002-06-28 | 2007-07-10 | Abbott Cardiovascular Systems, Inc. | Devices and methods to perform minimally invasive surgeries |
US7338433B2 (en) | 2002-08-13 | 2008-03-04 | Allergan, Inc. | Remotely adjustable gastric banding method |
MXPA05002361A (en) | 2002-08-28 | 2005-09-30 | Inamed Medical Products Corp | Fatigue-resistant gastric banding device. |
JP2004138146A (en) * | 2002-10-17 | 2004-05-13 | Univ Hiroshima | Check valve, auxiliary circulation device, and method of driving auxiliary circulation device |
AU2002952691A0 (en) * | 2002-11-15 | 2002-11-28 | Sunshine Heart Company Pty Ltd | Heart assist device utilising aortic deformation |
WO2004052455A1 (en) | 2002-12-09 | 2004-06-24 | Medtronic, Inc. | Coupling module of a modular implantable medical device |
US7596408B2 (en) | 2002-12-09 | 2009-09-29 | Medtronic, Inc. | Implantable medical device with anti-infection agent |
US7009511B2 (en) | 2002-12-17 | 2006-03-07 | Cardiac Pacemakers, Inc. | Repeater device for communications with an implantable medical device |
US8721515B2 (en) * | 2003-01-31 | 2014-05-13 | L-Vad Technology, Inc. | Rigid body aortic blood pump implant |
US8540618B2 (en) | 2003-01-31 | 2013-09-24 | L-Vad Technology, Inc. | Stable aortic blood pump implant |
EP1594551A2 (en) * | 2003-02-19 | 2005-11-16 | Sicel Technologies, Inc. | In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes |
EP1613242B1 (en) * | 2003-03-26 | 2013-02-20 | The Foundry, LLC | Devices for treatment of abdominal aortic aneurysms |
US7263401B2 (en) | 2003-05-16 | 2007-08-28 | Medtronic, Inc. | Implantable medical device with a nonhermetic battery |
US7317947B2 (en) | 2003-05-16 | 2008-01-08 | Medtronic, Inc. | Headset recharger for cranially implantable medical devices |
AU2003903726A0 (en) * | 2003-07-18 | 2003-07-31 | Ventracor Limited | A device for detecting heart pumping state |
US9763609B2 (en) | 2003-07-25 | 2017-09-19 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
US8626257B2 (en) | 2003-08-01 | 2014-01-07 | Dexcom, Inc. | Analyte sensor |
US8886273B2 (en) | 2003-08-01 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US7547199B1 (en) | 2003-08-25 | 2009-06-16 | Ross Anthony C | Fluid pumping system and related methods |
US7682301B2 (en) * | 2003-09-18 | 2010-03-23 | Thoratec Corporation | Rotary blood pump |
US7846168B2 (en) | 2003-10-09 | 2010-12-07 | Sentreheart, Inc. | Apparatus and method for the ligation of tissue |
US20050085683A1 (en) * | 2003-10-15 | 2005-04-21 | Bolling Steven F. | Implantable heart assist system and method of applying same |
GB2423028B (en) * | 2003-10-30 | 2007-12-19 | Sunshine Heart Co Pty Ltd | A wrap |
US7887478B2 (en) * | 2003-10-31 | 2011-02-15 | Sunshine Heart Company Pty Ltd | Percutaneous gas-line |
AU2004284842B2 (en) * | 2003-10-31 | 2010-03-04 | Nuwellis, Inc. | Synchronisation control system |
JP5063112B2 (en) | 2003-11-11 | 2012-10-31 | サンシャイン・ハート・カンパニー・ピーティーワイ・リミテッド | Actuator for cardiac assist device |
US20050113631A1 (en) * | 2003-11-12 | 2005-05-26 | Bolling Steven F. | Cannulae having a redirecting tip |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US8364230B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8425416B2 (en) | 2006-10-04 | 2013-04-23 | Dexcom, Inc. | Analyte sensor |
US8425417B2 (en) | 2003-12-05 | 2013-04-23 | Dexcom, Inc. | Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device |
US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8774886B2 (en) | 2006-10-04 | 2014-07-08 | Dexcom, Inc. | Analyte sensor |
AU2005208721B2 (en) | 2004-01-23 | 2010-09-23 | Boston Scientific Scimed, Inc. | Releasably-securable one-piece adjustable gastric band |
US8025624B2 (en) | 2004-02-19 | 2011-09-27 | Cardiac Pacemakers, Inc. | System and method for assessing cardiac performance through cardiac vibration monitoring |
US7488290B1 (en) | 2004-02-19 | 2009-02-10 | Cardiac Pacemakers, Inc. | System and method for assessing cardiac performance through transcardiac impedance monitoring |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
DE602005016901D1 (en) | 2004-03-08 | 2009-11-12 | Allergan Medical S A | CLOSING SYSTEM FOR TUBULAR ORGANS |
JP4534026B2 (en) * | 2004-03-12 | 2010-09-01 | 学校法人東京理科大学 | Medical device including implantable drive unit and power supply control method thereof |
CA2569043C (en) | 2004-03-18 | 2010-08-17 | Allergan, Inc. | Apparatus and method for volume adjustment of intragastric balloons |
US7596399B2 (en) | 2004-04-29 | 2009-09-29 | Medtronic, Inc | Implantation of implantable medical device |
US20050245984A1 (en) | 2004-04-30 | 2005-11-03 | Medtronic, Inc. | Implantable medical device with lubricious material |
US20060025931A1 (en) * | 2004-07-30 | 2006-02-02 | Richard Rosen | Method and apparatus for real time predictive modeling for chronically ill patients |
US20050277804A1 (en) * | 2004-06-10 | 2005-12-15 | Robert Pecor | System including a cannula having reduced flow resistance |
US7445592B2 (en) * | 2004-06-10 | 2008-11-04 | Orqis Medical Corporation | Cannulae having reduced flow resistance |
US20050277870A1 (en) * | 2004-06-10 | 2005-12-15 | Robert Pecor | Cannula having reduced flow resistance |
US7329226B1 (en) | 2004-07-06 | 2008-02-12 | Cardiac Pacemakers, Inc. | System and method for assessing pulmonary performance through transthoracic impedance monitoring |
US7857760B2 (en) | 2004-07-13 | 2010-12-28 | Dexcom, Inc. | Analyte sensor |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
WO2006020273A2 (en) * | 2004-07-19 | 2006-02-23 | Vascor, Inc. | Devices, systems and methods for assisting blood flow |
ATE482731T1 (en) | 2004-08-13 | 2010-10-15 | Delgado Reynolds M Iii | DEVICE FOR LONG-TERM SUPPORT OF A LEFT VENTRICLE IN PUMPING BLOOD |
US7393181B2 (en) | 2004-09-17 | 2008-07-01 | The Penn State Research Foundation | Expandable impeller pump |
US20060127252A1 (en) * | 2004-12-13 | 2006-06-15 | Hamilton Sundstrand Corporation | Reciprocating pump system |
US8465500B2 (en) * | 2005-01-21 | 2013-06-18 | Mayo Foundation For Medical Education And Research | Thorascopic heart valve repair method and apparatus |
US7878966B2 (en) * | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
US20060184199A1 (en) * | 2005-02-14 | 2006-08-17 | O'leary Shawn | Apparatus and methods for reducing bleeding from a cannulation site |
US8165893B1 (en) * | 2005-02-16 | 2012-04-24 | Ideal Life Inc. | Medical monitoring and coordinated care system |
US7742817B2 (en) * | 2005-03-04 | 2010-06-22 | Boston Scientific Neuromodulation Corporation | Hermetic implantable stimulator |
US20060224110A1 (en) * | 2005-03-17 | 2006-10-05 | Scott Michael J | Methods for minimally invasive vascular access |
WO2006110734A2 (en) | 2005-04-07 | 2006-10-19 | Sentreheart, Inc. | Apparatus and method for the ligation of tissue |
US8251888B2 (en) | 2005-04-13 | 2012-08-28 | Mitchell Steven Roslin | Artificial gastric valve |
US20100063840A1 (en) * | 2005-05-03 | 2010-03-11 | Hoyme Kenneth P | System and method for managing coordination of collected patient data in an automated patient management system |
US20060253300A1 (en) * | 2005-05-03 | 2006-11-09 | Somberg Benjamin L | System and method for managing patient triage in an automated patient management system |
US8781847B2 (en) * | 2005-05-03 | 2014-07-15 | Cardiac Pacemakers, Inc. | System and method for managing alert notifications in an automated patient management system |
WO2006121698A2 (en) * | 2005-05-05 | 2006-11-16 | Dial Discoveries, Inc. | Devices and methods for displacing biological fluids incorporating stacked disc impeller systems |
ITMI20051420A1 (en) * | 2005-07-22 | 2007-01-23 | A N B Technology S R L | CARDIOCIRCULATORY ASSISTANCE DEVICE |
WO2007028226A1 (en) * | 2005-09-09 | 2007-03-15 | Ibm Canada Limited - Ibm Canada Limitee | Method and system for state machine translation |
US8043206B2 (en) | 2006-01-04 | 2011-10-25 | Allergan, Inc. | Self-regulating gastric band with pressure data processing |
US7798954B2 (en) | 2006-01-04 | 2010-09-21 | Allergan, Inc. | Hydraulic gastric band with collapsible reservoir |
CA2636418A1 (en) | 2006-01-13 | 2007-07-26 | Heartware, Inc. | Rotary blood pump |
US8672611B2 (en) | 2006-01-13 | 2014-03-18 | Heartware, Inc. | Stabilizing drive for contactless rotary blood pump impeller |
US7887508B2 (en) | 2006-03-14 | 2011-02-15 | The University Of Southern California | MEMS device and method for delivery of therapeutic agents |
EP3115070B8 (en) | 2006-03-23 | 2019-05-08 | The Penn State Research Foundation | Heart assist device with expandable impeller pump |
CA2647151A1 (en) * | 2006-03-31 | 2007-10-11 | Orqis Medical Corporation | Rotary blood pump |
CA2650570C (en) * | 2006-04-26 | 2017-06-06 | Eastern Virginia Medical School | Systems and methods for monitoring and controlling internal pressure of an eye or body part |
US9084901B2 (en) | 2006-04-28 | 2015-07-21 | Medtronic, Inc. | Cranial implant |
WO2008022379A1 (en) | 2006-08-21 | 2008-02-28 | Sunshine Heart Company Pty Ltd | An improved wrap for a heart assist device |
US8447376B2 (en) | 2006-10-04 | 2013-05-21 | Dexcom, Inc. | Analyte sensor |
US8298142B2 (en) | 2006-10-04 | 2012-10-30 | Dexcom, Inc. | Analyte sensor |
US8562528B2 (en) | 2006-10-04 | 2013-10-22 | Dexcom, Inc. | Analyte sensor |
US8449464B2 (en) | 2006-10-04 | 2013-05-28 | Dexcom, Inc. | Analyte sensor |
US8478377B2 (en) | 2006-10-04 | 2013-07-02 | Dexcom, Inc. | Analyte sensor |
US8275438B2 (en) | 2006-10-04 | 2012-09-25 | Dexcom, Inc. | Analyte sensor |
US20080281249A1 (en) * | 2006-10-30 | 2008-11-13 | Michael Gertner | Valves and Conduits for Vascular Access |
US8219207B2 (en) * | 2007-03-08 | 2012-07-10 | Medtronic, Inc. | Thermal switch for implantable medical devices |
US7669883B2 (en) * | 2007-03-29 | 2010-03-02 | Newfrey Llc | Air bag bracket/fastener |
PT2142107E (en) | 2007-03-30 | 2013-04-10 | Sentreheart Inc | Devices and systems for closing the left atrial appendage |
US20200037875A1 (en) | 2007-05-18 | 2020-02-06 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
EP2148623A1 (en) * | 2007-05-21 | 2010-02-03 | Epitek, Inc. | Left atrial appendage closure |
US20080294175A1 (en) * | 2007-05-21 | 2008-11-27 | Epitek, Inc. | Left atrial appendage closure |
EP2000159A1 (en) * | 2007-06-07 | 2008-12-10 | NewCorTec S.p.A. | A duct for a ventricular assistance device |
CA2688184A1 (en) | 2007-06-08 | 2008-12-18 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
EP3272297B1 (en) | 2007-09-20 | 2020-04-22 | Sentreheart, Inc. | Devices for remote suture management |
US9452258B2 (en) | 2007-10-09 | 2016-09-27 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
WO2009052528A2 (en) | 2007-10-18 | 2009-04-23 | Neochord Inc. | Minimially invasive repair of a valve leaflet in a beating heart |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US20090112263A1 (en) | 2007-10-30 | 2009-04-30 | Scott Pool | Skeletal manipulation system |
US9839395B2 (en) | 2007-12-17 | 2017-12-12 | Dexcom, Inc. | Systems and methods for processing sensor data |
JP5542691B2 (en) | 2007-12-20 | 2014-07-09 | ユニバーシティ オブ サザン カリフォルニア | Devices and methods for delivering therapeutic agents |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
US20090248148A1 (en) | 2008-03-25 | 2009-10-01 | Ellipse Technologies, Inc. | Systems and methods for adjusting an annuloplasty ring with an integrated magnetic drive |
US8396528B2 (en) | 2008-03-25 | 2013-03-12 | Dexcom, Inc. | Analyte sensor |
JP2011515174A (en) * | 2008-03-26 | 2011-05-19 | カーディオ アシスト リミテッド | Cardiac assist device |
CN104353150A (en) | 2008-05-08 | 2015-02-18 | 迷你泵有限责任公司 | Implantable pums and cannulas therefor |
ES2603027T3 (en) | 2008-05-08 | 2017-02-23 | Minipumps, Llc | Methods of manufacturing drug delivery pumps |
US9333297B2 (en) | 2008-05-08 | 2016-05-10 | Minipumps, Llc | Drug-delivery pump with intelligent control |
WO2009152122A1 (en) | 2008-06-11 | 2009-12-17 | Allergan, Inc. | Implantable pump system |
US8423378B1 (en) | 2008-07-24 | 2013-04-16 | Ideal Life, Inc. | Facilitating health care management of subjects |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
WO2010033878A2 (en) | 2008-09-19 | 2010-03-25 | David Brown | Solute concentration measurement device and related methods |
US8317677B2 (en) | 2008-10-06 | 2012-11-27 | Allergan, Inc. | Mechanical gastric band with cushions |
JP2012505021A (en) * | 2008-10-10 | 2012-03-01 | ミルックス・ホールディング・エスエイ | Temporary contraceptive device for men |
US11241257B2 (en) | 2008-10-13 | 2022-02-08 | Nuvasive Specialized Orthopedics, Inc. | Spinal distraction system |
US20100185049A1 (en) | 2008-10-22 | 2010-07-22 | Allergan, Inc. | Dome and screw valves for remotely adjustable gastric banding systems |
US9393432B2 (en) | 2008-10-31 | 2016-07-19 | Medtronic, Inc. | Non-hermetic direct current interconnect |
EP2194278A1 (en) | 2008-12-05 | 2010-06-09 | ECP Entwicklungsgesellschaft mbH | Fluid pump with a rotor |
EP2216059A1 (en) | 2009-02-04 | 2010-08-11 | ECP Entwicklungsgesellschaft mbH | Catheter device with a catheter and an actuation device |
US8197490B2 (en) | 2009-02-23 | 2012-06-12 | Ellipse Technologies, Inc. | Non-invasive adjustable distraction system |
US20100222878A1 (en) * | 2009-02-27 | 2010-09-02 | Thoratec Corporation | Blood pump system with arterial pressure monitoring |
US8562507B2 (en) | 2009-02-27 | 2013-10-22 | Thoratec Corporation | Prevention of aortic valve fusion |
US20100222633A1 (en) * | 2009-02-27 | 2010-09-02 | Victor Poirier | Blood pump system with controlled weaning |
US20100222635A1 (en) * | 2009-02-27 | 2010-09-02 | Thoratec Corporation | Maximizing blood pump flow while avoiding left ventricle collapse |
US8449444B2 (en) * | 2009-02-27 | 2013-05-28 | Thoratec Corporation | Blood flow meter |
EP2229965A1 (en) | 2009-03-18 | 2010-09-22 | ECP Entwicklungsgesellschaft mbH | Fluid pump with particular form of a rotor blade |
AU2010232589B2 (en) | 2009-04-01 | 2014-11-27 | Atricure, Inc. | Tissue ligation devices and controls therefor |
US8271089B2 (en) * | 2009-04-03 | 2012-09-18 | Medtronic, Inc. | Hybrid rectification for recharging an implantable medical device |
EP2246078A1 (en) | 2009-04-29 | 2010-11-03 | ECP Entwicklungsgesellschaft mbH | Shaft assembly with a shaft which moves within a fluid-filled casing |
EP2248544A1 (en) | 2009-05-05 | 2010-11-10 | ECP Entwicklungsgesellschaft mbH | Fluid pump with variable circumference, particularly for medical use |
WO2010132451A2 (en) | 2009-05-11 | 2010-11-18 | Mayo Foundation For Medical Education And Research | Treating congestive heart failure |
EP2266640A1 (en) | 2009-06-25 | 2010-12-29 | ECP Entwicklungsgesellschaft mbH | Compressible and expandable turbine blade for a fluid pump |
AU2010266166B2 (en) | 2009-07-01 | 2015-09-03 | The Penn State Research Foundation | Blood pump with expandable cannula |
US9351677B2 (en) | 2009-07-02 | 2016-05-31 | Dexcom, Inc. | Analyte sensor with increased reference capacity |
WO2011003036A2 (en) | 2009-07-02 | 2011-01-06 | Dexcom, Inc. | Continuous analyte sensors and methods of making same |
US8926561B2 (en) | 2009-07-30 | 2015-01-06 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
EP2282070B1 (en) | 2009-08-06 | 2012-10-17 | ECP Entwicklungsgesellschaft mbH | Catheter device with a coupling device for a drive device |
JP5758388B2 (en) | 2009-08-18 | 2015-08-05 | ミニパンプス, エルエルシー | Electrolyte drug delivery pump with adaptive control |
JP5751642B2 (en) | 2009-09-04 | 2015-07-22 | エリプス テクノロジーズ, インク.Ellipse Technologies, Inc. | Bone growth apparatus and method |
US9125982B2 (en) * | 2009-09-09 | 2015-09-08 | Flowonix Medical Incorporated | Methods and systems for providing metered doses of a compound to an individual |
EP2298371A1 (en) | 2009-09-22 | 2011-03-23 | ECP Entwicklungsgesellschaft mbH | Function element, in particular fluid pump with a housing and a transport element |
EP4215752A1 (en) | 2009-09-22 | 2023-07-26 | ECP Entwicklungsgesellschaft mbH | Compressible rotor for a fluid pump |
EP2298372A1 (en) | 2009-09-22 | 2011-03-23 | ECP Entwicklungsgesellschaft mbH | Rotor for an axial pump for transporting a fluid |
WO2011047160A2 (en) * | 2009-10-16 | 2011-04-21 | University Of Rochester | Transcutaneous magnetic energy transfer device |
EP2314331B1 (en) | 2009-10-23 | 2013-12-11 | ECP Entwicklungsgesellschaft mbH | Catheter pump arrangement and flexible shaft arrangement with a cable core |
EP2314330A1 (en) | 2009-10-23 | 2011-04-27 | ECP Entwicklungsgesellschaft mbH | Flexible shaft arrangement |
EP2338539A1 (en) | 2009-12-23 | 2011-06-29 | ECP Entwicklungsgesellschaft mbH | Pump device with a detection device |
EP2338540A1 (en) | 2009-12-23 | 2011-06-29 | ECP Entwicklungsgesellschaft mbH | Delivery blade for a compressible rotor |
EP2338541A1 (en) | 2009-12-23 | 2011-06-29 | ECP Entwicklungsgesellschaft mbH | Radial compressible and expandable rotor for a fluid pump |
EP2347778A1 (en) | 2010-01-25 | 2011-07-27 | ECP Entwicklungsgesellschaft mbH | Fluid pump with a radially compressible rotor |
US8678993B2 (en) | 2010-02-12 | 2014-03-25 | Apollo Endosurgery, Inc. | Remotely adjustable gastric banding system |
US20110201874A1 (en) | 2010-02-12 | 2011-08-18 | Allergan, Inc. | Remotely adjustable gastric banding system |
US8758221B2 (en) | 2010-02-24 | 2014-06-24 | Apollo Endosurgery, Inc. | Source reservoir with potential energy for remotely adjustable gastric banding system |
US8764624B2 (en) | 2010-02-25 | 2014-07-01 | Apollo Endosurgery, Inc. | Inductively powered remotely adjustable gastric banding system |
US8840541B2 (en) | 2010-02-25 | 2014-09-23 | Apollo Endosurgery, Inc. | Pressure sensing gastric banding system |
EP2363157A1 (en) | 2010-03-05 | 2011-09-07 | ECP Entwicklungsgesellschaft mbH | Device for exerting mechanical force on a medium, in particular fluid pump |
US20110270331A1 (en) | 2010-04-02 | 2011-11-03 | Sunshine Heart Company Pty Ltd | Combination heart assist systems, methods, and devices |
WO2011129894A2 (en) | 2010-04-13 | 2011-10-20 | Sentreheart, Inc. | Methods and devices for accessing and delivering devices to a heart |
US9265422B2 (en) | 2010-04-27 | 2016-02-23 | Apollo Endosurgery, Inc. | System and method for determining an adjustment to a gastric band based on satiety state data and weight loss data |
CN101856521B (en) * | 2010-04-28 | 2011-12-28 | 湖南人文科技学院 | Heart assisting blood pumping device |
US20110270024A1 (en) | 2010-04-29 | 2011-11-03 | Allergan, Inc. | Self-adjusting gastric band having various compliant components |
US9028394B2 (en) | 2010-04-29 | 2015-05-12 | Apollo Endosurgery, Inc. | Self-adjusting mechanical gastric band |
US9044298B2 (en) | 2010-04-29 | 2015-06-02 | Apollo Endosurgery, Inc. | Self-adjusting gastric band |
US8594806B2 (en) | 2010-04-30 | 2013-11-26 | Cyberonics, Inc. | Recharging and communication lead for an implantable device |
US20110270025A1 (en) | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Remotely powered remotely adjustable gastric band system |
EP2388029A1 (en) | 2010-05-17 | 2011-11-23 | ECP Entwicklungsgesellschaft mbH | Pump array |
US9226840B2 (en) | 2010-06-03 | 2016-01-05 | Apollo Endosurgery, Inc. | Magnetically coupled implantable pump system and method |
US8517915B2 (en) | 2010-06-10 | 2013-08-27 | Allergan, Inc. | Remotely adjustable gastric banding system |
EP2399639A1 (en) | 2010-06-25 | 2011-12-28 | ECP Entwicklungsgesellschaft mbH | System for introducing a pump |
EP2407186A1 (en) | 2010-07-15 | 2012-01-18 | ECP Entwicklungsgesellschaft mbH | Rotor for a pump, produced with an initial elastic material |
EP2407185A1 (en) | 2010-07-15 | 2012-01-18 | ECP Entwicklungsgesellschaft mbH | Radial compressible and expandable rotor for a pump with a turbine blade |
EP2407187A3 (en) | 2010-07-15 | 2012-06-20 | ECP Entwicklungsgesellschaft mbH | Blood pump for invasive application within the body of a patient |
US8734488B2 (en) | 2010-08-09 | 2014-05-27 | Ellipse Technologies, Inc. | Maintenance feature in magnetic implant |
US8698373B2 (en) | 2010-08-18 | 2014-04-15 | Apollo Endosurgery, Inc. | Pare piezo power with energy recovery |
US9211207B2 (en) | 2010-08-18 | 2015-12-15 | Apollo Endosurgery, Inc. | Power regulated implant |
EP2422735A1 (en) | 2010-08-27 | 2012-02-29 | ECP Entwicklungsgesellschaft mbH | Implantable blood transportation device, manipulation device and coupling device |
US20120059216A1 (en) | 2010-09-07 | 2012-03-08 | Allergan, Inc. | Remotely adjustable gastric banding system |
US9757502B2 (en) | 2010-09-24 | 2017-09-12 | Tci Llc | Control of circulatory assist systems |
TW201219072A (en) | 2010-09-24 | 2012-05-16 | Thoratec Corp | Generating artificial pulse |
US8961393B2 (en) | 2010-11-15 | 2015-02-24 | Apollo Endosurgery, Inc. | Gastric band devices and drive systems |
US8419789B2 (en) | 2010-11-23 | 2013-04-16 | Patentsplus Llc | Artificial heart |
CN103347464B (en) | 2010-12-29 | 2016-02-03 | 尼奥绰德有限公司 | The replaceable system of beating heart valve leaflet is repaired by Wicresoft |
US8597170B2 (en) | 2011-01-05 | 2013-12-03 | Thoratec Corporation | Catheter pump |
US8485961B2 (en) | 2011-01-05 | 2013-07-16 | Thoratec Corporation | Impeller housing for percutaneous heart pump |
US9138518B2 (en) | 2011-01-06 | 2015-09-22 | Thoratec Corporation | Percutaneous heart pump |
US8591393B2 (en) | 2011-01-06 | 2013-11-26 | Thoratec Corporation | Catheter pump |
US20130041203A1 (en) * | 2011-02-18 | 2013-02-14 | Marlin Stephen Heilman | Blood flow assist devices, systems and methods |
US8876686B2 (en) | 2011-02-18 | 2014-11-04 | Vascor, Inc | Control of blood flow assist systems |
EP2497521A1 (en) | 2011-03-10 | 2012-09-12 | ECP Entwicklungsgesellschaft mbH | Push device for axial insertion of a string-shaped, flexible body |
US20120265036A1 (en) | 2011-04-15 | 2012-10-18 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
CN103813757A (en) | 2011-06-01 | 2014-05-21 | 尼奥绰德有限公司 | Minimally Invasive Repair of heart valve leaflets |
US9925394B2 (en) * | 2011-06-08 | 2018-03-27 | Varian Medical Systems, Inc. | Automatic health detection for motion axes in medical linear accelerators |
EP3391834A3 (en) | 2011-06-08 | 2019-01-23 | Sentreheart, Inc. | Tissue ligation devices and tensioning devices therefor |
WO2013009881A2 (en) * | 2011-07-11 | 2013-01-17 | Vascor, Inc. | Transcutaneous power transmission and communication for implanted heart assist and other devices |
EP2564771A1 (en) | 2011-09-05 | 2013-03-06 | ECP Entwicklungsgesellschaft mbH | Medicinal product with a functional element for invasive use in the body of a patient |
US8926492B2 (en) | 2011-10-11 | 2015-01-06 | Ecp Entwicklungsgesellschaft Mbh | Housing for a functional element |
WO2013082053A1 (en) | 2011-11-28 | 2013-06-06 | MI-VAD, Inc. | Ventricular assist device and method |
US8876694B2 (en) | 2011-12-07 | 2014-11-04 | Apollo Endosurgery, Inc. | Tube connector with a guiding tip |
US8961394B2 (en) | 2011-12-20 | 2015-02-24 | Apollo Endosurgery, Inc. | Self-sealing fluid joint for use with a gastric band |
US9327067B2 (en) | 2012-05-14 | 2016-05-03 | Thoratec Corporation | Impeller for catheter pump |
US9446179B2 (en) | 2012-05-14 | 2016-09-20 | Thoratec Corporation | Distal bearing support |
EP4218887A1 (en) | 2012-05-14 | 2023-08-02 | Tc1 Llc | Mechanical circulatory support device for stabilizing a patient after cardiogenic shock |
US9872947B2 (en) | 2012-05-14 | 2018-01-23 | Tc1 Llc | Sheath system for catheter pump |
US8721517B2 (en) | 2012-05-14 | 2014-05-13 | Thoratec Corporation | Impeller for catheter pump |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US8827890B2 (en) | 2012-05-17 | 2014-09-09 | Thoratec Corporation | Touch screen interface and infrared communication system integrated into a battery |
US9381297B2 (en) | 2012-06-07 | 2016-07-05 | Tandem Diabetes Care, Inc. | Sealed infusion device with electrical connector port |
US20130338714A1 (en) | 2012-06-15 | 2013-12-19 | Arvin Chang | Magnetic implants with improved anatomical compatibility |
US9421311B2 (en) | 2012-07-03 | 2016-08-23 | Thoratec Corporation | Motor assembly for catheter pump |
EP4186557A1 (en) | 2012-07-03 | 2023-05-31 | Tc1 Llc | Motor assembly for catheter pump |
US9744287B2 (en) * | 2012-07-03 | 2017-08-29 | Oran Bulent | Pulsatile flow blood pump |
US9358329B2 (en) | 2012-07-03 | 2016-06-07 | Thoratec Corporation | Catheter pump |
US9343923B2 (en) | 2012-08-23 | 2016-05-17 | Cyberonics, Inc. | Implantable medical device with backscatter signal based communication |
EP2895215A4 (en) | 2012-09-13 | 2016-08-31 | Circulite Inc | Blood flow system with variable speed control |
US9935498B2 (en) | 2012-09-25 | 2018-04-03 | Cyberonics, Inc. | Communication efficiency with an implantable medical device using a circulator and a backscatter signal |
US9528532B2 (en) * | 2012-09-27 | 2016-12-27 | William Davis Simmons | Hydraulic actuator |
US9044281B2 (en) | 2012-10-18 | 2015-06-02 | Ellipse Technologies, Inc. | Intramedullary implants for replacing lost bone |
US9132015B2 (en) | 2012-11-05 | 2015-09-15 | Empire Technology Development Llc | Tumid implant and pump |
WO2014120101A2 (en) * | 2013-01-29 | 2014-08-07 | Bulent Oran | Permanent total artificial heart device |
US9179938B2 (en) | 2013-03-08 | 2015-11-10 | Ellipse Technologies, Inc. | Distraction devices and method of assembling the same |
AU2014249724B2 (en) | 2013-03-12 | 2017-09-07 | Atricure, Inc. | Tissue ligation devices and methods therefor |
US11077294B2 (en) | 2013-03-13 | 2021-08-03 | Tc1 Llc | Sheath assembly for catheter pump |
JP6530367B2 (en) | 2013-03-13 | 2019-06-12 | ティーシーワン エルエルシー | Fluid outlet / inlet system |
US11033728B2 (en) | 2013-03-13 | 2021-06-15 | Tc1 Llc | Fluid handling system |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US20140276569A1 (en) | 2013-03-15 | 2014-09-18 | Tandem Diabetes Care, Inc. | System and method for detecting presence of an infusion cartridge in an infusion pump |
WO2014146016A2 (en) | 2013-03-15 | 2014-09-18 | Alfred E. Mann Foundation For Scientific Research | Current sensing multiple output current stimulators with fast turn on time |
US9308302B2 (en) | 2013-03-15 | 2016-04-12 | Thoratec Corporation | Catheter pump assembly including a stator |
FR3004112A1 (en) * | 2013-04-08 | 2014-10-10 | Harobase Innovations Inc | ASSEMBLY AND METHOD FOR PROVIDING A LEFT VENTRICULAR HEART ASSISTING PUMPING UNIT |
US9780596B2 (en) | 2013-07-29 | 2017-10-03 | Alfred E. Mann Foundation For Scientific Research | Microprocessor controlled class E driver |
US10226242B2 (en) | 2013-07-31 | 2019-03-12 | Nuvasive Specialized Orthopedics, Inc. | Noninvasively adjustable suture anchors |
EP3027242B1 (en) | 2013-08-02 | 2017-04-26 | CircuLite, Inc. | Implantable system with secure remote control |
US9801734B1 (en) | 2013-08-09 | 2017-10-31 | Nuvasive, Inc. | Lordotic expandable interbody implant |
EP3062711B1 (en) | 2013-10-31 | 2023-06-21 | AtriCure, Inc. | Devices for left atrial appendage closure |
US9793624B2 (en) | 2013-12-24 | 2017-10-17 | Ppc Broadband, Inc. | Connector having an inner conductor engager |
US9878080B2 (en) * | 2014-01-14 | 2018-01-30 | CardioFlow Technologies, LLC | Apparatus and methods for optimizing intra cardiac filling pressures, heart rate, and cardiac output |
WO2015130768A2 (en) | 2014-02-25 | 2015-09-03 | KUSHWAHA, Sudhir | Ventricular assist device and method |
EP3131599B1 (en) | 2014-04-15 | 2019-02-20 | Tc1 Llc | Catheter pump with access ports |
US10583232B2 (en) | 2014-04-15 | 2020-03-10 | Tc1 Llc | Catheter pump with off-set motor position |
WO2015160991A1 (en) | 2014-04-15 | 2015-10-22 | Thoratec Corporation | Methods and systems for controlling a blood pump |
EP3791920B1 (en) | 2014-04-15 | 2024-07-03 | Tc1 Llc | Catheter pump introducer system |
EP3799918A1 (en) | 2014-04-15 | 2021-04-07 | Tc1 Llc | Sensors for catheter pumps |
US20150364861A1 (en) * | 2014-06-17 | 2015-12-17 | Minnetronix, Inc. | Implantable connection mechanisms for continuous high power delivery |
DE102015112098A1 (en) | 2014-07-25 | 2016-01-28 | Minnetronix, Inc. | Coil parameters and control |
DE102015112097A1 (en) | 2014-07-25 | 2016-01-28 | Minnetronix, Inc. | power scale |
AU2015301402B2 (en) | 2014-08-15 | 2020-06-04 | Axonics Modulation Technologies, Inc. | Integrated electromyographic clinician programmer for use with an implantable neurostimulator |
US9802051B2 (en) | 2014-08-15 | 2017-10-31 | Axonics Modulation Technologies, Inc. | External pulse generator device and associated methods for trial nerve stimulation |
CN107073257B (en) | 2014-08-15 | 2020-04-10 | 艾克索尼克斯调制技术股份有限公司 | EMG lead positioning and stimulation titration in a neurostimulation system for treating overactive bladder |
JP6878269B2 (en) | 2014-08-15 | 2021-05-26 | アクソニクス モジュレーション テクノロジーズ インコーポレイテッド | Systems and Methods for Nerve Stimulation Electrode Configuration Based on Nerve Positioning |
CN112657054A (en) | 2014-08-15 | 2021-04-16 | 艾克索尼克斯调制技术股份有限公司 | Implantable lead attachment structures for neurostimulation to alleviate bladder dysfunction and other indications |
DE102014219815A1 (en) | 2014-09-30 | 2016-03-31 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Method for supplying an electrical energy converting implant with electrical energy |
EP3209226B1 (en) | 2014-10-23 | 2020-11-25 | NuVasive Specialized Orthopedics, Inc. | Remotely adjustable interactive bone reshaping implant |
US9717832B2 (en) | 2015-01-06 | 2017-08-01 | HeartWave, Inc. | Axial flow rotor with downstream bearing wash flow |
AU2016205049B2 (en) | 2015-01-09 | 2020-05-14 | Axonics Modulation Technologies, Inc. | Improved antenna and methods of use for an implantable nerve stimulator |
JP6751718B2 (en) | 2015-01-09 | 2020-09-09 | アクソニクス モジュレーション テクノロジーズ インコーポレイテッド | Mounting devices and related methods for use with neurostimulation charging devices |
AU2016205047B2 (en) | 2015-01-09 | 2020-07-02 | Axonics Modulation Technologies, Inc. | Patient remote and associated methods of use with a nerve stimulation system |
US10342908B2 (en) | 2015-01-14 | 2019-07-09 | Minnetronix, Inc. | Distributed transformer |
US10406267B2 (en) | 2015-01-16 | 2019-09-10 | Minnetronix, Inc. | Data communication in a transcutaneous energy transfer system |
EP3247420B1 (en) | 2015-01-22 | 2019-10-02 | Tc1 Llc | Reduced rotational mass motor assembly for catheter pump |
US9414909B1 (en) | 2015-01-22 | 2016-08-16 | Patentsplus Llc | Gentle artificial heart valve with improved wear characteristics |
EP3598986B1 (en) | 2015-01-22 | 2021-02-17 | Tc1 Llc | Motor assembly with heat exchanger for catheter pump |
WO2016118784A1 (en) | 2015-01-22 | 2016-07-28 | Thoratec Corporation | Attachment mechanisms for motor of catheter pump |
AU2016238332B2 (en) | 2015-03-24 | 2020-05-07 | Atricure, Inc. | Devices and methods for left atrial appendage closure |
EP4285843A3 (en) | 2015-03-24 | 2024-05-22 | AtriCure, Inc. | Tissue ligation devices |
US10193395B2 (en) | 2015-04-14 | 2019-01-29 | Minnetronix, Inc. | Repeater resonator |
US9907890B2 (en) | 2015-04-16 | 2018-03-06 | Tc1 Llc | Catheter pump with positioning brace |
WO2016187286A1 (en) | 2015-05-18 | 2016-11-24 | Tandem Diabetes Care, Inc. | Patch pump cartridge attachment |
WO2016196412A1 (en) * | 2015-05-30 | 2016-12-08 | CardioFlow Technologies, LLC | Apparatus and methods for optimizing intra-cardiac filling pressures through controlled regurgitation |
WO2017011305A1 (en) | 2015-07-10 | 2017-01-19 | Axonics Modulation Technologies, Inc. | Implantable nerve stimulator having internal electronics without asic and methods of use |
US11235138B2 (en) | 2015-09-25 | 2022-02-01 | Procyrion, Inc. | Non-occluding intravascular blood pump providing reduced hemolysis |
WO2017059406A1 (en) | 2015-10-01 | 2017-04-06 | Neochord, Inc. | Ringless web for repair of heart valves |
DE102015219263A1 (en) * | 2015-10-06 | 2017-04-06 | Robert Bosch Gmbh | Pump for a tribological load sensor ventricular assist device and use |
US10492141B2 (en) | 2015-11-17 | 2019-11-26 | Tandem Diabetes Care, Inc. | Methods for reduction of battery usage in ambulatory infusion pumps |
AU2017212551B2 (en) | 2016-01-29 | 2021-05-27 | Axonics, Inc. | Methods and systems for frequency adjustment to optimize charging of implantable neurostimulator |
JP6948335B2 (en) | 2016-02-10 | 2021-10-13 | スカンジナビアン・リアル・ハート・アクチエボラーグ | Blood pump housing device |
WO2017139548A1 (en) | 2016-02-10 | 2017-08-17 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for controlling multiple surgical variables |
US10376704B2 (en) | 2016-02-12 | 2019-08-13 | Axonics Modulation Technologies, Inc. | External pulse generator device and associated methods for trial nerve stimulation |
CN108882949B (en) | 2016-02-26 | 2021-11-09 | 森特里心脏股份有限公司 | Device and method for left atrial appendage closure |
US9968720B2 (en) * | 2016-04-11 | 2018-05-15 | CorWave SA | Implantable pump system having an undulating membrane |
US10188778B2 (en) | 2016-06-23 | 2019-01-29 | Stephen K. Shu | Artificial heart |
IL269446B2 (en) * | 2017-03-21 | 2024-02-01 | Abiomed Inc | System and method for determining native cardiac output while continuing support to the heart with a catheter-mounted intracardiac blood pump having an imbedded thermistor |
US10213306B2 (en) | 2017-03-31 | 2019-02-26 | Neochord, Inc. | Minimally invasive heart valve repair in a beating heart |
EP3634528B1 (en) | 2017-06-07 | 2023-06-07 | Shifamed Holdings, LLC | Intravascular fluid movement devices, systems, and methods of use |
US11273300B2 (en) * | 2017-10-04 | 2022-03-15 | Heartware, Inc. | Magnetically suspended blood driving piston circulatory assist device |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
EP4442197A1 (en) | 2017-10-24 | 2024-10-09 | DexCom, Inc. | Pre-connected analyte sensors |
US11511103B2 (en) | 2017-11-13 | 2022-11-29 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US10568999B2 (en) | 2017-12-05 | 2020-02-25 | Rainbow Medical Ltd. | Reciprocating intravascular blood pump |
US11013906B2 (en) | 2017-12-05 | 2021-05-25 | Rainbow Medical Ltd. | Reciprocating intravascular blood pump |
WO2019152875A1 (en) | 2018-02-01 | 2019-08-08 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use and manufacture |
AU2019224043B2 (en) | 2018-02-22 | 2024-12-19 | Axonics, Inc. | Neurostimulation leads for trial nerve stimulation and methods of use |
EP3768176B1 (en) | 2018-03-23 | 2024-03-20 | NeoChord, Inc. | Device for suture attachment for minimally invasive heart valve repair |
DE102018206750A1 (en) | 2018-05-02 | 2019-11-07 | Kardion Gmbh | Device for inductive energy transfer into a human body and its use |
DE102018206731A1 (en) | 2018-05-02 | 2019-11-07 | Kardion Gmbh | Device for inductive energy transmission in a human body and use of the device |
US11173030B2 (en) | 2018-05-09 | 2021-11-16 | Neochord, Inc. | Suture length adjustment for minimally invasive heart valve repair |
US11253360B2 (en) | 2018-05-09 | 2022-02-22 | Neochord, Inc. | Low profile tissue anchor for minimally invasive heart valve repair |
DE102018208550A1 (en) | 2018-05-30 | 2019-12-05 | Kardion Gmbh | A lead device for directing blood flow to a cardiac assist system, cardiac assist system, and method of making a lead device |
DE102018208538A1 (en) | 2018-05-30 | 2019-12-05 | Kardion Gmbh | Intravascular blood pump and process for the production of electrical conductors |
DE102018208929A1 (en) | 2018-06-06 | 2019-12-12 | Kardion Gmbh | A method of determining a flow rate of fluid flowing through an implanted vascular support system |
US11369784B2 (en) * | 2018-06-06 | 2022-06-28 | The Regents Of The University Of California | Synchronizing a pulsatile cardiac assist device with a pacemaker |
DE102018208931A1 (en) * | 2018-06-06 | 2019-12-12 | Kardion Gmbh | Apparatus for determining cardiac output for a cardiac assist system, cardiac assistive system and method for determining cardiac output |
DE102018208936A1 (en) | 2018-06-06 | 2019-12-12 | Kardion Gmbh | Determining device and method for determining a viscosity of a fluid |
DE102018208945A1 (en) | 2018-06-06 | 2019-12-12 | Kardion Gmbh | An analysis device and method for analyzing a viscosity of a fluid |
DE102018208913A1 (en) | 2018-06-06 | 2019-12-12 | Kardion Gmbh | A method of operating an implanted ventricular assist device |
DE102018210058A1 (en) | 2018-06-21 | 2019-12-24 | Kardion Gmbh | Stator blade device for guiding the flow of a fluid flowing out of an outlet opening of a heart support system, heart support system with stator blade device, method for operating a stator blade device and manufacturing method |
DE102018210076A1 (en) | 2018-06-21 | 2019-12-24 | Kardion Gmbh | Method and device for detecting a state of wear of a cardiac support system, method and device for operating a cardiac support system and cardiac support system |
CN111405914B (en) | 2018-06-26 | 2024-12-03 | 罗伯特·E·道格拉斯 | Intracardiac pump |
US12161857B2 (en) | 2018-07-31 | 2024-12-10 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of use |
US11632015B2 (en) | 2018-08-28 | 2023-04-18 | Boston Scientific Scimed, Inc. | Axial flux motor for percutaneous circulatory support device |
WO2020051583A1 (en) | 2018-09-07 | 2020-03-12 | Neochord, Inc. | Device for suture attachment for minimally invasive heart valve repair |
WO2020058910A1 (en) * | 2018-09-19 | 2020-03-26 | Caltech Innovations Private Limited | A fluid supply source for a device to determine a pulmonary function of a subject |
EP4360691A3 (en) | 2018-09-25 | 2024-07-17 | Tc1 Llc | Adaptive speed control algorithms and controllers for optimizing flow in ventricular assist devices |
EP3860675A4 (en) | 2018-10-05 | 2022-07-13 | Shifamed Holdings, LLC | Intravascular blood pumps and methods of use |
CN109412288B (en) * | 2018-11-19 | 2020-05-15 | 浙江大学 | A motor with non-metal rotor structure and its application in pipeline |
WO2020163792A1 (en) | 2019-02-07 | 2020-08-13 | 171Nuvasive Specialized Orthopedics, Inc. | Ultrasonic communication in medical devices |
US11589901B2 (en) | 2019-02-08 | 2023-02-28 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device |
EP3921010A4 (en) * | 2019-02-08 | 2023-03-08 | NXT Biomedical, LLC | Left atrial appendage stasis reduction |
EP3934709A4 (en) * | 2019-03-08 | 2022-12-28 | Summacor, Inc. | DISPLACEMENT SHUTTLE PUMP HEART AND VAD |
WO2020185902A1 (en) | 2019-03-11 | 2020-09-17 | Axonics Modulation Technologies, Inc. | Charging device with off-center coil |
WO2020214818A1 (en) | 2019-04-16 | 2020-10-22 | Neochord, Inc. | Transverse helical cardiac anchor for minimally invasive heart valve repair |
EP3733223A1 (en) * | 2019-04-30 | 2020-11-04 | Rainbow Medical Ltd. | Reciprocating intravascular blood pump |
WO2020236750A1 (en) | 2019-05-20 | 2020-11-26 | The Regents Of The University Of California | Percutaneous medical device delivery system |
WO2020242900A1 (en) | 2019-05-24 | 2020-12-03 | Axonics Modulation Technologies, Inc. | Trainer device for a neurostimulator programmer and associated methods of use with a neurostimulation system |
US11439829B2 (en) | 2019-05-24 | 2022-09-13 | Axonics, Inc. | Clinician programmer methods and systems for maintaining target operating temperatures |
US11964145B2 (en) | 2019-07-12 | 2024-04-23 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of manufacture and use |
WO2021016372A1 (en) | 2019-07-22 | 2021-01-28 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
WO2021062265A1 (en) | 2019-09-25 | 2021-04-01 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
US12121713B2 (en) | 2019-09-25 | 2024-10-22 | Shifamed Holdings, Llc | Catheter blood pumps and collapsible blood conduits |
US12102815B2 (en) | 2019-09-25 | 2024-10-01 | Shifamed Holdings, Llc | Catheter blood pumps and collapsible pump housings |
CA3154839A1 (en) | 2019-10-19 | 2021-04-22 | Steve C. Smith | Linear cardiac assist pulsatile pump |
JP2023505211A (en) | 2019-12-03 | 2023-02-08 | プロシリオン インコーポレイテッド | blood pump |
AU2020403115A1 (en) | 2019-12-13 | 2022-07-14 | Procyrion, Inc. | Support structures for intravascular blood pumps |
AU2021208019B2 (en) | 2020-01-16 | 2023-10-26 | Neochord, Inc. | Helical cardiac anchors for minimally invasive heart valve repair |
US12121714B2 (en) | 2020-05-04 | 2024-10-22 | Heartware, Inc. | Sewing ring with quick connect to inflow |
US11896814B2 (en) | 2020-05-04 | 2024-02-13 | Heartware, Inc. | Toolless quick connect sewing ring |
US11497905B2 (en) * | 2020-05-13 | 2022-11-15 | Medtronic, Inc. | Algorithm for utilizing multiple inputs to modulate the charging rate of a fully implantable system |
US12213708B2 (en) | 2020-09-08 | 2025-02-04 | Nuvasive Specialized Orthopedics, Inc. | Remote control module for adjustable implants |
CN112316297A (en) * | 2020-11-03 | 2021-02-05 | 四川大学华西医院 | Hollow heart auxiliary pump |
CN112386792A (en) * | 2020-12-18 | 2021-02-23 | 李建朝 | Magnetic field drive type blood pump |
JP2024507841A (en) | 2021-02-22 | 2024-02-21 | サマコア, インコーポレイテッド | linear cardiac assist pulsatile pump |
US20220265324A1 (en) | 2021-02-23 | 2022-08-25 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant, system and methods |
US11737787B1 (en) | 2021-05-27 | 2023-08-29 | Nuvasive, Inc. | Bone elongating devices and methods of use |
JP2024528989A (en) | 2021-08-03 | 2024-08-01 | ニューベイシブ スペシャライズド オーソペディックス,インコーポレイテッド | Adjustable implants |
US11565104B1 (en) | 2021-08-09 | 2023-01-31 | Yossi Gross | Magnetically-driven reciprocating intravascular blood pump |
WO2024039746A1 (en) * | 2022-08-17 | 2024-02-22 | SummaCor, Inc. | Linearly reciprocating blood pump |
EP4501392A1 (en) * | 2023-07-31 | 2025-02-05 | Charité - Universitätsmedizin Berlin | Control device for a heart pump |
CN118711930B (en) * | 2024-08-28 | 2024-12-24 | 杭州神络医疗科技有限公司 | Pulse generator and nerve stimulator |
CN119093785B (en) * | 2024-11-08 | 2025-03-04 | 善彤医疗科技(湖南)有限公司 | Control method of electric anastomat and electric anastomat |
Citations (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US424535A (en) * | 1890-04-01 | Signments | ||
US458872A (en) * | 1891-09-01 | Electro-magnetic reciprocating engine | ||
US1684468A (en) * | 1926-08-26 | 1928-09-18 | Warren G Brown | Pump |
US1822242A (en) * | 1928-07-27 | 1931-09-08 | Schongut Gustav | Pump for liquids |
US2061869A (en) * | 1930-04-19 | 1936-11-24 | Gilbert James Walter | Refrigerating system |
US2515110A (en) * | 1949-05-24 | 1950-07-11 | Alfred B Bornstein | Electromagnetically operating refrigeration compressor |
US2690128A (en) * | 1950-03-24 | 1954-09-28 | North American Solvay Inc | Electromagnetic pumping device |
US2701331A (en) * | 1949-08-29 | 1955-02-01 | Lynn W Bennie | Pumping apparatus with electromagnetically propelled piston |
US3134938A (en) * | 1962-07-05 | 1964-05-26 | Exxon Research Engineering Co | Reciprocating motor control system |
US3172027A (en) * | 1961-06-05 | 1965-03-02 | Universal Oil Prod Co | Sequentially energized solenoids reciprocating motor system |
US3233607A (en) * | 1962-06-20 | 1966-02-08 | Iowa State University Of Scien | Automatic heart massage device |
US3282219A (en) * | 1964-12-28 | 1966-11-01 | Wayne V Blackwell | Double-acting solenoid pump |
US3287616A (en) * | 1963-08-12 | 1966-11-22 | Dalph C Mcneil | Solenoid motor |
US3328656A (en) * | 1964-04-24 | 1967-06-27 | Sarah E Dotson | Reciprocating motor control system for motors having high q solenoid coils |
US3443128A (en) * | 1965-09-14 | 1969-05-06 | Nasa | Superconducting alternator |
US3492819A (en) * | 1968-09-10 | 1970-02-03 | Konsonlas John | Magnetic fluid pressure converter |
US3739943A (en) * | 1971-02-04 | 1973-06-19 | Sherwood Medical Ind Inc | Infusion system |
US3791770A (en) * | 1973-05-24 | 1974-02-12 | R Farkos | Electromagnetic pump or motor device with axially spaced piston members |
US3836289A (en) * | 1972-09-06 | 1974-09-17 | E Wolford | Magnetic pump |
US3842440A (en) * | 1972-09-01 | 1974-10-22 | E Karlson | Implantable linear motor prosthetic heart and control system therefor |
US3884125A (en) * | 1971-02-08 | 1975-05-20 | Philip E Massie | Variable displacement sealed pump |
US3911898A (en) * | 1974-04-05 | 1975-10-14 | Jr Frank A Leachman | Heart assist method and device |
US3911897A (en) * | 1974-04-05 | 1975-10-14 | Jr Frank A Leachman | Heart assist device |
US3919722A (en) * | 1973-03-06 | 1975-11-18 | Us Health | Totally implantable artificial replacement heart |
US4005346A (en) * | 1975-10-29 | 1977-01-25 | Hsia Tsang Chen | Direct electromagnetic reciprocating motor |
US4016871A (en) * | 1975-03-06 | 1977-04-12 | Peter Schiff | Electronic synchronizer-monitor system for controlling the timing of mechanical assistance and pacing of the heart |
US4101816A (en) * | 1976-11-03 | 1978-07-18 | Vibra-Metrics, Inc. | Switch control system |
US4102610A (en) * | 1976-09-03 | 1978-07-25 | John Taboada | Constant volume seal-free reciprocating pump |
FR2309206B3 (en) | 1975-04-28 | 1978-11-17 | Bensilum Guy | |
US4127134A (en) * | 1977-04-11 | 1978-11-28 | Cordis Corporation | Gas-absorbing pacer and method of fabrication |
DE2812481A1 (en) | 1978-03-22 | 1979-09-27 | Teichmann Joachim | Piston pump permanent ring magnet system - has magnets inside thrust rod body, fitted to pump piston, with intermediate dividers |
US4210409A (en) * | 1978-05-19 | 1980-07-01 | Child Laboratories Inc. | Solenoid operating pump |
US4213207A (en) * | 1978-04-07 | 1980-07-22 | Wilson Frederick M | Artificial heart and method of pumping blood |
US4220899A (en) * | 1977-09-19 | 1980-09-02 | Papst-Motoren Kg | Polyphase linear motor |
US4221548A (en) * | 1978-03-20 | 1980-09-09 | Child Frank W | Dual action solenoid pump |
US4234831A (en) * | 1978-07-18 | 1980-11-18 | Josef Kemmer | Compound rotary and/or linear motor |
US4233690A (en) * | 1978-05-19 | 1980-11-18 | Carbomedics, Inc. | Prosthetic device couplings |
US4262414A (en) * | 1978-08-11 | 1981-04-21 | General Electric Company | Method for manufacturing a hermetically sealed electrochemical storage cell |
US4272226A (en) * | 1979-01-08 | 1981-06-09 | Osborne Harry E | Fluid pump and method for operating same |
US4299544A (en) * | 1978-07-13 | 1981-11-10 | Jidosha Kiki Co., Ltd. | Electromagnetic pumps |
US4332541A (en) * | 1979-11-27 | 1982-06-01 | Hermann Berstorff Maschinenbau Gmbh | Filtering arrangement for thermoplastics materials |
US4344022A (en) * | 1979-03-29 | 1982-08-10 | Papst Motoren Kg | Linear motor |
US4370577A (en) * | 1980-07-22 | 1983-01-25 | Matsushita Electric Industrial Co., Ltd. | Linear motor |
US4375941A (en) * | 1978-03-20 | 1983-03-08 | Child Frank W | Method and apparatus for pumping blood |
US4389169A (en) * | 1980-03-10 | 1983-06-21 | Alessandro Nicoletti | Pump for fluids |
US4397049A (en) * | 1981-09-15 | 1983-08-09 | Foxcroft Associates | Hydraulically actuated cardiac prosthesis with three-way ventricular valving |
US4397919A (en) * | 1979-03-22 | 1983-08-09 | Standard Oil Company | Explosion resistant battery cells |
US4434389A (en) * | 1980-10-28 | 1984-02-28 | Kollmorgen Technologies Corporation | Motor with redundant windings |
US4500827A (en) * | 1984-06-11 | 1985-02-19 | Merritt Thomas D | Linear reciprocating electrical generator |
US4506394A (en) * | 1983-01-13 | 1985-03-26 | Molrose Management, Ltd. | Cardiac valve prosthesis holder |
US4516567A (en) * | 1982-07-26 | 1985-05-14 | Sagem | Sequential pneumatic control device, supplied with electric energy |
US4535483A (en) * | 1983-01-17 | 1985-08-20 | Hemex, Inc. | Suture rings for heart valves |
US4541787A (en) * | 1982-02-22 | 1985-09-17 | Energy 76, Inc. | Electromagnetic reciprocating pump and motor means |
US4583525A (en) * | 1982-03-30 | 1986-04-22 | Aisin Seiki K.K. | Artificial heart driving apparatus |
US4610658A (en) * | 1985-02-21 | 1986-09-09 | Henry Buchwald | Automated peritoneovenous shunt |
EP0203222A1 (en) | 1985-05-22 | 1986-12-03 | Barry W. Hultman | Electromagnetic linear motor and pump apparatus |
US4638192A (en) * | 1981-12-11 | 1987-01-20 | Papst-Motoren Gmbh & Co. Kg | Linear DC motor |
US4642882A (en) * | 1985-08-21 | 1987-02-17 | Mechanical Technology Incorporated | Method of making a laminated stator |
US4650486A (en) * | 1983-11-09 | 1987-03-17 | Societe Nationale Industrielle Aerospatiale | Quick connect system for connecting a blood vessel and a cardiac prosthesis |
US4687623A (en) * | 1985-10-31 | 1987-08-18 | Westinghouse Electric Corp. | Self-compensating voted logic power interface with tester |
US4692673A (en) * | 1982-02-22 | 1987-09-08 | Sanford D. DeLong | Electromagnetic reciprocating pump and motor means |
US4705516A (en) * | 1983-04-20 | 1987-11-10 | Barone Hector D | Setting for a cardiac valve |
EP0237145A3 (en) | 1986-01-14 | 1988-01-27 | Framo Developments (U.K.) Limited | Electrically powered pump unit |
US4775301A (en) * | 1986-06-27 | 1988-10-04 | Cartwright Garry E | Oscillating electromagnetic pump with one-way diaphragm valves |
US4790843A (en) * | 1986-06-16 | 1988-12-13 | Baxter Travenol Laboratories, Inc. | Prosthetic heart valve assembly |
EP0310254A2 (en) | 1987-09-07 | 1989-04-05 | Framo Developments (U.K.) Limited | Reciprocating pump unit |
US4824337A (en) * | 1987-12-24 | 1989-04-25 | The Gorman-Rupp Company | Valve assembly for an oscillating pump |
US4846831A (en) * | 1988-04-27 | 1989-07-11 | Skillin David E | Manual back-up drive for artificial heart |
US4868431A (en) * | 1987-03-05 | 1989-09-19 | Shinko Electric Co., Ltd. | Linear motor with an elongated core using oppositely polarized magnets to maximize perpendicular flux lines |
US4870306A (en) * | 1981-10-08 | 1989-09-26 | Polaroid Corporation | Method and apparatus for precisely moving a motor armature |
EP0198617B1 (en) | 1985-04-01 | 1989-11-23 | Shanghai New Mechanical Technology Development Centre | Non-linear electromagnetic vibration fluid compression device |
US4892541A (en) * | 1982-11-29 | 1990-01-09 | Tascon Medical Technology Corporation | Heart valve prosthesis |
US4896088A (en) * | 1989-03-31 | 1990-01-23 | General Electric Company | Fault-tolerant switched reluctance machine |
US4897563A (en) * | 1988-08-01 | 1990-01-30 | Itt Corporation | N-way MMIC redundant switch |
US4924123A (en) * | 1987-12-18 | 1990-05-08 | Aisin Seiki Kabushiki Kaisha | Linear generator |
US4935030A (en) * | 1985-06-17 | 1990-06-19 | Medtronic, Inc. | Mechanical heart valve prosthesis |
US4957504A (en) * | 1988-12-02 | 1990-09-18 | Chardack William M | Implantable blood pump |
US4965864A (en) * | 1987-12-07 | 1990-10-23 | Roth Paul E | Linear motor |
US4973892A (en) * | 1989-02-28 | 1990-11-27 | Tsubakimoto Chain Co. | Energization system for linear motor transient reduction |
US4979955A (en) * | 1988-06-06 | 1990-12-25 | Smith Robert M | Power assisted prosthetic heart valve |
US5035709A (en) * | 1990-03-29 | 1991-07-30 | Baxter International Inc. | Mechanical heart valve with compliant sewing ring |
US5041773A (en) * | 1989-04-26 | 1991-08-20 | Citiaen Watch Co., Ltd. | Drive circuit for stepping motor |
US5063342A (en) * | 1988-09-19 | 1991-11-05 | U.S. Philips Corporation | Temperature threshold sensing circuit |
US5064353A (en) * | 1989-02-03 | 1991-11-12 | Aisin Seiki Kabushiki Kaisha | Pressure responsive linear motor driven pump |
US5071431A (en) * | 1990-11-07 | 1991-12-10 | Carbomedics, Inc. | Suture rings for heart valves and method of securing suture rings to heart valves |
US5081381A (en) * | 1990-02-19 | 1992-01-14 | National Space Development Agency Of Japan | Electromagnetic actuator with linear control |
US5085563A (en) * | 1990-01-26 | 1992-02-04 | Collins Development Corporation | Reciprocating pump or motor |
US5089014A (en) * | 1987-05-18 | 1992-02-18 | Holfert John W | Tubular interconnect device for use within the circulatory system |
US5089017A (en) * | 1989-01-17 | 1992-02-18 | Young David B | Drive system for artificial hearts and left-ventricular assist devices |
US5091665A (en) * | 1989-09-05 | 1992-02-25 | Kelly H P G | Linear motors |
US5123919A (en) * | 1991-11-21 | 1992-06-23 | Carbomedics, Inc. | Combined prosthetic aortic heart valve and vascular graft |
US5136194A (en) * | 1989-06-16 | 1992-08-04 | Moving Magnet Technologies S.A. | Single-phased compact linear electromagnetic actuator |
US5146123A (en) * | 1990-11-06 | 1992-09-08 | Yarr George A | Linear reciprocating alternator |
US5163954A (en) * | 1990-02-21 | 1992-11-17 | Sorin Biomedica Spa | Suture ring for heart valve prostheses |
US5166563A (en) * | 1990-03-02 | 1992-11-24 | Stuart Bassine | Magnetically actuated linear displacement compressor |
US5179306A (en) * | 1990-01-10 | 1993-01-12 | Escue Research And Development Company | Small diameter brushless direct current linear motor and method of using same |
US5178633A (en) * | 1992-04-21 | 1993-01-12 | Carbon Implants Inc. | Suture ring for heart valve prosthesis |
US5193985A (en) * | 1990-01-10 | 1993-03-16 | Uniflo Oilcorp, Ltd. | Pump control system for a downhole motor-pump assembly and method of using same |
US5208498A (en) * | 1990-09-28 | 1993-05-04 | Aisien Seiki Kabushiki Kaisha | Linear actuator |
US5207707A (en) * | 1992-01-16 | 1993-05-04 | Carbomedics, Inc. | Tri-leaflet all carbon heart valve |
US5214323A (en) * | 1988-03-22 | 1993-05-25 | Sharp Kabushiki Kaisha | Linear motor with reduced cogging |
EP0350302B1 (en) | 1988-07-07 | 1993-06-02 | Medtronic, Inc. | Heart valve prosthesis |
US5225725A (en) * | 1990-02-13 | 1993-07-06 | Hitachi Metals, Ltd. | Linear direct current motor |
US5236451A (en) * | 1991-07-15 | 1993-08-17 | Onx, Inc. | Prosthetic heart valve |
US5242995A (en) * | 1991-01-07 | 1993-09-07 | Korea Institute Of Science And Technology | Perfluorocarbon-grafted polyurethane with improved blood compatibility and process for their preparation |
US5246453A (en) * | 1991-03-25 | 1993-09-21 | Onx, Inc. | Prosthetic heart valve |
US5252043A (en) * | 1990-01-10 | 1993-10-12 | Uniflo Oilcorp Ltd. | Linear motor-pump assembly and method of using same |
US5263979A (en) | 1991-03-19 | 1993-11-23 | Kou Imachi | Artificial heart |
US5360445A (en) | 1991-11-06 | 1994-11-01 | International Business Machines Corporation | Blood pump actuator |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1144142A (en) * | 1965-03-13 | 1969-03-05 | Walter Eberspacher | Reciprocating fuel pump, particularly for oil-fired furnaces |
US3833005A (en) * | 1971-07-26 | 1974-09-03 | Medtronic Inc | Compared count digitally controlled pacemaker |
US3942535A (en) * | 1973-09-27 | 1976-03-09 | G. D. Searle & Co. | Rechargeable tissue stimulating system |
US3923060A (en) * | 1974-04-23 | 1975-12-02 | Jr Everett H Ellinwood | Apparatus and method for implanted self-powered medication dispensing having timing and evaluator means |
US3943937A (en) * | 1974-07-05 | 1976-03-16 | Medtronic, Inc. | Gas absorbing implantable electrical medical device |
US3968387A (en) * | 1975-05-16 | 1976-07-06 | Lawrence Peska Associates, Inc. | Linear magnetic generator |
US4014346A (en) * | 1975-06-26 | 1977-03-29 | Research Corporation | Hermetically sealed cardiac pacer system and recharging system therefor |
US4071032A (en) * | 1976-01-29 | 1978-01-31 | Pacesetter Systems Inc. | Implantable living tissue stimulators |
US4082097A (en) * | 1976-05-20 | 1978-04-04 | Pacesetter Systems Inc. | Multimode recharging system for living tissue stimulators |
WO1981000888A1 (en) * | 1979-09-27 | 1981-04-02 | J Mcmullen | A pump,and an apparatus incorporating such a pump for infusing liquid medicine |
US4561443A (en) * | 1983-03-08 | 1985-12-31 | The Johns Hopkins University | Coherent inductive communications link for biomedical applications |
US4666443A (en) * | 1986-04-18 | 1987-05-19 | Novacor Medical Corporation | Biventricular circulatory assist system and method |
US4987897A (en) * | 1989-09-18 | 1991-01-29 | Medtronic, Inc. | Body bus medical device communication system |
US5129789A (en) * | 1990-04-23 | 1992-07-14 | Advanced Medical Systems, Inc. | Means and method of pumping fluids, particularly biological fluids |
US5203172A (en) * | 1990-05-17 | 1993-04-20 | Simpson Alvin B | Electromagnetically powered hydraulic engine |
US5368445A (en) * | 1993-11-03 | 1994-11-29 | Lasko Metal Products, Inc. | Pedestal fan |
-
1994
- 1994-02-25 US US08/201,806 patent/US5676651A/en not_active Expired - Fee Related
-
1995
- 1995-02-24 DE DE69534486T patent/DE69534486D1/en not_active Expired - Lifetime
- 1995-02-24 AU AU19714/95A patent/AU1971495A/en not_active Abandoned
- 1995-02-24 CA CA002183666A patent/CA2183666A1/en not_active Abandoned
- 1995-02-24 AT AT95912623T patent/ATE305316T1/en not_active IP Right Cessation
- 1995-02-24 EP EP95912623A patent/EP0748235B1/en not_active Expired - Lifetime
- 1995-02-24 WO PCT/US1995/002416 patent/WO1995023000A2/en active IP Right Grant
- 1995-02-24 JP JP7522505A patent/JPH09509595A/en not_active Ceased
- 1995-03-17 TW TW084102591A patent/TW290461B/zh active
- 1995-06-07 US US08/477,908 patent/US5722930A/en not_active Expired - Fee Related
- 1995-06-07 US US08/477,906 patent/US5676162A/en not_active Expired - Lifetime
- 1995-06-07 US US08/480,824 patent/US5693091A/en not_active Expired - Fee Related
- 1995-06-07 US US08/477,905 patent/US5843129A/en not_active Expired - Lifetime
- 1995-06-07 US US08/477,904 patent/US5879375A/en not_active Expired - Fee Related
- 1995-06-07 US US08/477,909 patent/US5722429A/en not_active Expired - Fee Related
- 1995-06-07 US US08/480,823 patent/US5758666A/en not_active Expired - Lifetime
- 1995-06-07 US US08/477,907 patent/US5702430A/en not_active Expired - Fee Related
-
2005
- 2005-01-20 JP JP2005013401A patent/JP2005199076A/en active Pending
Patent Citations (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US458872A (en) * | 1891-09-01 | Electro-magnetic reciprocating engine | ||
US424535A (en) * | 1890-04-01 | Signments | ||
US1684468A (en) * | 1926-08-26 | 1928-09-18 | Warren G Brown | Pump |
US1822242A (en) * | 1928-07-27 | 1931-09-08 | Schongut Gustav | Pump for liquids |
US2061869A (en) * | 1930-04-19 | 1936-11-24 | Gilbert James Walter | Refrigerating system |
US2515110A (en) * | 1949-05-24 | 1950-07-11 | Alfred B Bornstein | Electromagnetically operating refrigeration compressor |
US2701331A (en) * | 1949-08-29 | 1955-02-01 | Lynn W Bennie | Pumping apparatus with electromagnetically propelled piston |
US2690128A (en) * | 1950-03-24 | 1954-09-28 | North American Solvay Inc | Electromagnetic pumping device |
US3172027A (en) * | 1961-06-05 | 1965-03-02 | Universal Oil Prod Co | Sequentially energized solenoids reciprocating motor system |
US3233607A (en) * | 1962-06-20 | 1966-02-08 | Iowa State University Of Scien | Automatic heart massage device |
US3134938A (en) * | 1962-07-05 | 1964-05-26 | Exxon Research Engineering Co | Reciprocating motor control system |
US3287616A (en) * | 1963-08-12 | 1966-11-22 | Dalph C Mcneil | Solenoid motor |
US3328656A (en) * | 1964-04-24 | 1967-06-27 | Sarah E Dotson | Reciprocating motor control system for motors having high q solenoid coils |
US3282219A (en) * | 1964-12-28 | 1966-11-01 | Wayne V Blackwell | Double-acting solenoid pump |
US3443128A (en) * | 1965-09-14 | 1969-05-06 | Nasa | Superconducting alternator |
US3492819A (en) * | 1968-09-10 | 1970-02-03 | Konsonlas John | Magnetic fluid pressure converter |
US3739943A (en) * | 1971-02-04 | 1973-06-19 | Sherwood Medical Ind Inc | Infusion system |
US3884125A (en) * | 1971-02-08 | 1975-05-20 | Philip E Massie | Variable displacement sealed pump |
US3842440A (en) * | 1972-09-01 | 1974-10-22 | E Karlson | Implantable linear motor prosthetic heart and control system therefor |
US3836289A (en) * | 1972-09-06 | 1974-09-17 | E Wolford | Magnetic pump |
US3919722A (en) * | 1973-03-06 | 1975-11-18 | Us Health | Totally implantable artificial replacement heart |
US3791770A (en) * | 1973-05-24 | 1974-02-12 | R Farkos | Electromagnetic pump or motor device with axially spaced piston members |
US3911898A (en) * | 1974-04-05 | 1975-10-14 | Jr Frank A Leachman | Heart assist method and device |
US3911897A (en) * | 1974-04-05 | 1975-10-14 | Jr Frank A Leachman | Heart assist device |
US4016871A (en) * | 1975-03-06 | 1977-04-12 | Peter Schiff | Electronic synchronizer-monitor system for controlling the timing of mechanical assistance and pacing of the heart |
FR2309206B3 (en) | 1975-04-28 | 1978-11-17 | Bensilum Guy | |
US4005346A (en) * | 1975-10-29 | 1977-01-25 | Hsia Tsang Chen | Direct electromagnetic reciprocating motor |
US4102610A (en) * | 1976-09-03 | 1978-07-25 | John Taboada | Constant volume seal-free reciprocating pump |
US4101816A (en) * | 1976-11-03 | 1978-07-18 | Vibra-Metrics, Inc. | Switch control system |
US4127134A (en) * | 1977-04-11 | 1978-11-28 | Cordis Corporation | Gas-absorbing pacer and method of fabrication |
US4220899A (en) * | 1977-09-19 | 1980-09-02 | Papst-Motoren Kg | Polyphase linear motor |
US4375941A (en) * | 1978-03-20 | 1983-03-08 | Child Frank W | Method and apparatus for pumping blood |
US4221548A (en) * | 1978-03-20 | 1980-09-09 | Child Frank W | Dual action solenoid pump |
DE2812481A1 (en) | 1978-03-22 | 1979-09-27 | Teichmann Joachim | Piston pump permanent ring magnet system - has magnets inside thrust rod body, fitted to pump piston, with intermediate dividers |
US4213207A (en) * | 1978-04-07 | 1980-07-22 | Wilson Frederick M | Artificial heart and method of pumping blood |
US4210409A (en) * | 1978-05-19 | 1980-07-01 | Child Laboratories Inc. | Solenoid operating pump |
US4233690A (en) * | 1978-05-19 | 1980-11-18 | Carbomedics, Inc. | Prosthetic device couplings |
US4299544A (en) * | 1978-07-13 | 1981-11-10 | Jidosha Kiki Co., Ltd. | Electromagnetic pumps |
US4234831A (en) * | 1978-07-18 | 1980-11-18 | Josef Kemmer | Compound rotary and/or linear motor |
US4262414A (en) * | 1978-08-11 | 1981-04-21 | General Electric Company | Method for manufacturing a hermetically sealed electrochemical storage cell |
US4272226A (en) * | 1979-01-08 | 1981-06-09 | Osborne Harry E | Fluid pump and method for operating same |
US4397919A (en) * | 1979-03-22 | 1983-08-09 | Standard Oil Company | Explosion resistant battery cells |
US4344022A (en) * | 1979-03-29 | 1982-08-10 | Papst Motoren Kg | Linear motor |
US4332541A (en) * | 1979-11-27 | 1982-06-01 | Hermann Berstorff Maschinenbau Gmbh | Filtering arrangement for thermoplastics materials |
US4389169A (en) * | 1980-03-10 | 1983-06-21 | Alessandro Nicoletti | Pump for fluids |
US4370577A (en) * | 1980-07-22 | 1983-01-25 | Matsushita Electric Industrial Co., Ltd. | Linear motor |
US4434389A (en) * | 1980-10-28 | 1984-02-28 | Kollmorgen Technologies Corporation | Motor with redundant windings |
US4397049A (en) * | 1981-09-15 | 1983-08-09 | Foxcroft Associates | Hydraulically actuated cardiac prosthesis with three-way ventricular valving |
US4870306A (en) * | 1981-10-08 | 1989-09-26 | Polaroid Corporation | Method and apparatus for precisely moving a motor armature |
US4638192A (en) * | 1981-12-11 | 1987-01-20 | Papst-Motoren Gmbh & Co. Kg | Linear DC motor |
US4541787A (en) * | 1982-02-22 | 1985-09-17 | Energy 76, Inc. | Electromagnetic reciprocating pump and motor means |
US4692673A (en) * | 1982-02-22 | 1987-09-08 | Sanford D. DeLong | Electromagnetic reciprocating pump and motor means |
US4583525A (en) * | 1982-03-30 | 1986-04-22 | Aisin Seiki K.K. | Artificial heart driving apparatus |
US4516567A (en) * | 1982-07-26 | 1985-05-14 | Sagem | Sequential pneumatic control device, supplied with electric energy |
US4892541A (en) * | 1982-11-29 | 1990-01-09 | Tascon Medical Technology Corporation | Heart valve prosthesis |
US4506394A (en) * | 1983-01-13 | 1985-03-26 | Molrose Management, Ltd. | Cardiac valve prosthesis holder |
US4535483A (en) * | 1983-01-17 | 1985-08-20 | Hemex, Inc. | Suture rings for heart valves |
US4705516A (en) * | 1983-04-20 | 1987-11-10 | Barone Hector D | Setting for a cardiac valve |
US4650486A (en) * | 1983-11-09 | 1987-03-17 | Societe Nationale Industrielle Aerospatiale | Quick connect system for connecting a blood vessel and a cardiac prosthesis |
US4500827A (en) * | 1984-06-11 | 1985-02-19 | Merritt Thomas D | Linear reciprocating electrical generator |
US4610658A (en) * | 1985-02-21 | 1986-09-09 | Henry Buchwald | Automated peritoneovenous shunt |
EP0198617B1 (en) | 1985-04-01 | 1989-11-23 | Shanghai New Mechanical Technology Development Centre | Non-linear electromagnetic vibration fluid compression device |
EP0203222A1 (en) | 1985-05-22 | 1986-12-03 | Barry W. Hultman | Electromagnetic linear motor and pump apparatus |
US4935030A (en) * | 1985-06-17 | 1990-06-19 | Medtronic, Inc. | Mechanical heart valve prosthesis |
US4642882A (en) * | 1985-08-21 | 1987-02-17 | Mechanical Technology Incorporated | Method of making a laminated stator |
US4687623A (en) * | 1985-10-31 | 1987-08-18 | Westinghouse Electric Corp. | Self-compensating voted logic power interface with tester |
EP0237145A3 (en) | 1986-01-14 | 1988-01-27 | Framo Developments (U.K.) Limited | Electrically powered pump unit |
US4790843A (en) * | 1986-06-16 | 1988-12-13 | Baxter Travenol Laboratories, Inc. | Prosthetic heart valve assembly |
US4775301A (en) * | 1986-06-27 | 1988-10-04 | Cartwright Garry E | Oscillating electromagnetic pump with one-way diaphragm valves |
US4868431A (en) * | 1987-03-05 | 1989-09-19 | Shinko Electric Co., Ltd. | Linear motor with an elongated core using oppositely polarized magnets to maximize perpendicular flux lines |
US5089014A (en) * | 1987-05-18 | 1992-02-18 | Holfert John W | Tubular interconnect device for use within the circulatory system |
EP0310254A2 (en) | 1987-09-07 | 1989-04-05 | Framo Developments (U.K.) Limited | Reciprocating pump unit |
US4965864A (en) * | 1987-12-07 | 1990-10-23 | Roth Paul E | Linear motor |
US4924123A (en) * | 1987-12-18 | 1990-05-08 | Aisin Seiki Kabushiki Kaisha | Linear generator |
US4824337A (en) * | 1987-12-24 | 1989-04-25 | The Gorman-Rupp Company | Valve assembly for an oscillating pump |
US5214323A (en) * | 1988-03-22 | 1993-05-25 | Sharp Kabushiki Kaisha | Linear motor with reduced cogging |
US4846831A (en) * | 1988-04-27 | 1989-07-11 | Skillin David E | Manual back-up drive for artificial heart |
US4979955A (en) * | 1988-06-06 | 1990-12-25 | Smith Robert M | Power assisted prosthetic heart valve |
EP0350302B1 (en) | 1988-07-07 | 1993-06-02 | Medtronic, Inc. | Heart valve prosthesis |
US4897563A (en) * | 1988-08-01 | 1990-01-30 | Itt Corporation | N-way MMIC redundant switch |
US5063342A (en) * | 1988-09-19 | 1991-11-05 | U.S. Philips Corporation | Temperature threshold sensing circuit |
US4957504A (en) * | 1988-12-02 | 1990-09-18 | Chardack William M | Implantable blood pump |
US5089017A (en) * | 1989-01-17 | 1992-02-18 | Young David B | Drive system for artificial hearts and left-ventricular assist devices |
US5064353A (en) * | 1989-02-03 | 1991-11-12 | Aisin Seiki Kabushiki Kaisha | Pressure responsive linear motor driven pump |
US4973892A (en) * | 1989-02-28 | 1990-11-27 | Tsubakimoto Chain Co. | Energization system for linear motor transient reduction |
US4896088A (en) * | 1989-03-31 | 1990-01-23 | General Electric Company | Fault-tolerant switched reluctance machine |
US5041773A (en) * | 1989-04-26 | 1991-08-20 | Citiaen Watch Co., Ltd. | Drive circuit for stepping motor |
US5136194A (en) * | 1989-06-16 | 1992-08-04 | Moving Magnet Technologies S.A. | Single-phased compact linear electromagnetic actuator |
US5091665A (en) * | 1989-09-05 | 1992-02-25 | Kelly H P G | Linear motors |
US5193985A (en) * | 1990-01-10 | 1993-03-16 | Uniflo Oilcorp, Ltd. | Pump control system for a downhole motor-pump assembly and method of using same |
US5252043A (en) * | 1990-01-10 | 1993-10-12 | Uniflo Oilcorp Ltd. | Linear motor-pump assembly and method of using same |
US5179306A (en) * | 1990-01-10 | 1993-01-12 | Escue Research And Development Company | Small diameter brushless direct current linear motor and method of using same |
US5085563A (en) * | 1990-01-26 | 1992-02-04 | Collins Development Corporation | Reciprocating pump or motor |
US5225725A (en) * | 1990-02-13 | 1993-07-06 | Hitachi Metals, Ltd. | Linear direct current motor |
US5081381A (en) * | 1990-02-19 | 1992-01-14 | National Space Development Agency Of Japan | Electromagnetic actuator with linear control |
US5163954A (en) * | 1990-02-21 | 1992-11-17 | Sorin Biomedica Spa | Suture ring for heart valve prostheses |
US5166563A (en) * | 1990-03-02 | 1992-11-24 | Stuart Bassine | Magnetically actuated linear displacement compressor |
US5035709A (en) * | 1990-03-29 | 1991-07-30 | Baxter International Inc. | Mechanical heart valve with compliant sewing ring |
US5208498A (en) * | 1990-09-28 | 1993-05-04 | Aisien Seiki Kabushiki Kaisha | Linear actuator |
US5146123A (en) * | 1990-11-06 | 1992-09-08 | Yarr George A | Linear reciprocating alternator |
US5071431A (en) * | 1990-11-07 | 1991-12-10 | Carbomedics, Inc. | Suture rings for heart valves and method of securing suture rings to heart valves |
US5242995A (en) * | 1991-01-07 | 1993-09-07 | Korea Institute Of Science And Technology | Perfluorocarbon-grafted polyurethane with improved blood compatibility and process for their preparation |
US5263979A (en) | 1991-03-19 | 1993-11-23 | Kou Imachi | Artificial heart |
US5246453A (en) * | 1991-03-25 | 1993-09-21 | Onx, Inc. | Prosthetic heart valve |
US5236451A (en) * | 1991-07-15 | 1993-08-17 | Onx, Inc. | Prosthetic heart valve |
US5360445A (en) | 1991-11-06 | 1994-11-01 | International Business Machines Corporation | Blood pump actuator |
US5123919A (en) * | 1991-11-21 | 1992-06-23 | Carbomedics, Inc. | Combined prosthetic aortic heart valve and vascular graft |
US5207707A (en) * | 1992-01-16 | 1993-05-04 | Carbomedics, Inc. | Tri-leaflet all carbon heart valve |
US5178633A (en) * | 1992-04-21 | 1993-01-12 | Carbon Implants Inc. | Suture ring for heart valve prosthesis |
Non-Patent Citations (104)
Title |
---|
Article entitled: Engineering A Replacement For the Human Heart, Mechanical Engineering, Jul. 1991, pp. 36 43. * |
Article entitled: Engineering A Replacement For the Human Heart, Mechanical Engineering, Jul. 1991, pp. 36-43. |
Cathey, Jimmie J. et al., "A Tubular Self-Synchronous Motor for Artificial Heart Pump Drive", IEEE Transactionsl on Biomedical Engineering, Mar. 1996, vol. BME-33, No. 3, pp. 315-319. |
Cathey, Jimmie J. et al., A Tubular Self Synchronous Motor for Artificial Heart Pump Drive , IEEE Transactionsl on Biomedical Engineering, Mar. 1996, vol. BME 33, No. 3, pp. 315 319. * |
D o rp, E., et al., The measurement of blood density to investigate protein deposition at the blood/hollow fiber membrane interface during ultrafiltration, Int J Artif Organs 1991; 14:424 429. * |
Daniel, Michael A., et al., "Clinical Evaluation of the Novacor Totally Implantable Ventricular Assist System", ASAIO Transactions 1991; 37:M423-M425. |
Daniel, Michael A., et al., Clinical Evaluation of the Novacor Totally Implantable Ventricular Assist System , ASAIO Transactions 1991; 37:M423 M425. * |
Dorp, E., et al., The measurement of blood density to investigate protein deposition at the blood/hollow fiber membrane interface during ultrafiltration, Int J Artif Organs 1991; 14:424-429. |
Drasler, William J., et al., "A Unique Vascular Graft Concept for Coronary and Peripheral Applications", ASAIO Transactions 1988; 34:769-772. |
Drasler, William J., et al., A Unique Vascular Graft Concept for Coronary and Peripheral Applications , ASAIO Transactions 1988; 34:769 772. * |
English language abstract of FR 2 309 206. * |
English language abstract of Soviet Union patent No. 1,284,556, Jan. 23, 1987. * |
Fischel, R.J., et al., "Couette Membrane Filtration with Constant Shear Stress", ASAIO Transactions 1988; 34:375-385. |
Fischel, R.J., et al., Couette Membrane Filtration with Constant Shear Stress , ASAIO Transactions 1988; 34:375 385. * |
Frazier, O.H., M.D., et al., "First Human Use of the Hemopump, a Catheter-Mounted Ventricular Assist Device", Ann Thorac Surg 1990; 49:299-304. |
Frazier, O.H., M.D., et al., First Human Use of the Hemopump, a Catheter Mounted Ventricular Assist Device , Ann Thorac Surg 1990; 49:299 304. * |
Haas, G., et al., "Effect of head-down bedrest on blood/plasma density after intravenous fluid load", Acta Physiol Scand 1992, 144, S604:113-120. |
Haas, G., et al., Effect of head down bedrest on blood/plasma density after intravenous fluid load , Acta Physiol Scand 1992, 144, S604:113 120. * |
Hashimoto, Shigehiro, "Erythrocyte Destruction under Periodically Fluctuating Shear Rate: Comparative Study with Constant Shear Rate", Artif Organs 1989; 13(5):458-463. |
Hashimoto, Shigehiro, Erythrocyte Destruction under Periodically Fluctuating Shear Rate: Comparative Study with Constant Shear Rate , Artif Organs 1989; 13(5):458 463. * |
Hung, Ting Cheng, et al., Effects of Long term Novacor Artificial Heart Support on Blood Rheology , ASAIO Transactions 1991; 37:M312 M313. * |
Hung, Ting-Cheng, et al., "Effects of Long-term Novacor Artificial Heart Support on Blood Rheology", ASAIO Transactions 1991; 37:M312-M313. |
Imachi, Kou, et al., "A New Pulsatile Total Artificial Heart Using a Single Centrifugal Pump", ASAIO Transactions 1991; 37:M242-M243. |
Imachi, Kou, et al., A New Pulsatile Total Artificial Heart Using a Single Centrifugal Pump , ASAIO Transactions 1991; 37:M242 M243. * |
Jurmann, Michael J., et al., "In Vivo Determinants of Energy Consumption in Electric Motor Driven Artificial Hearts", ASAIO Transactions 1989; 35:745-747. |
Jurmann, Michael J., et al., In Vivo Determinants of Energy Consumption in Electric Motor Driven Artificial Hearts , ASAIO Transactions 1989; 35:745 747. * |
Kenner, I., "The measurement of blood density and its meaning", Basic Res Cardiol 1989; 84:111-124. |
Kenner, I., The measurement of blood density and its meaning , Basic Res Cardiol 1989; 84:111 124. * |
Kim, Hee Chan, et al., "Development of An Automatic Control Algorithm for the Electrohydraulic Total Artificial Heart Without Transducers", ASAIO Transactions 1991; 37:M501-M503. |
Kim, Hee Chan, et al., Development of An Automatic Control Algorithm for the Electrohydraulic Total Artificial Heart Without Transducers , ASAIO Transactions 1991; 37:M501 M503. * |
Kresh, J. Yasha, "Myocardial Mechanics and Energetics Revisited", Trans Am Soc Artif Intern Organs 1991; 37:537-539. |
Kresh, J. Yasha, Myocardial Mechanics and Energetics Revisited , Trans Am Soc Artif Intern Organs 1991; 37:537 539. * |
Lamson, Theodore C., et al., "Real-Time In Vitro Observation of Cavitation in a Prosthetic Heart Valve", ASAIO Transactions 1991; 37:M351-M353. |
Lamson, Theodore C., et al., Real Time In Vitro Observation of Cavitation in a Prosthetic Heart Valve , ASAIO Transactions 1991; 37:M351 M353. * |
Lee, Jen shih and Lee, Lian pin, A Density Method for Determining Plasma and Red Blood Cell Volume , Annals of Biomedical Engineering 1992; 20:195 204. * |
Lee, Jen-shih and Lee, Lian-pin, "A Density Method for Determining Plasma and Red Blood Cell Volume", Annals of Biomedical Engineering 1992; 20:195-204. |
Lee, Sang H., et al., "Development of A Totally Implantable Total Artificial Heart Controller", ASAIO Transactions 1991; 37:M505-M507. |
Lee, Sang H., et al., Development of A Totally Implantable Total Artificial Heart Controller , ASAIO Transactions 1991; 37:M505 M507. * |
Levinson, Mark M., M.D., et al., "Indexes of Hemolysis in Human Recipients of the Jarvik-7 Total Artificial Heart: A Cooperative Report of Fifteen Patients", J. Heart Transplant 1986; 5:236-248. |
Levinson, Mark M., M.D., et al., Indexes of Hemolysis in Human Recipients of the Jarvik 7 Total Artificial Heart: A Cooperative Report of Fifteen Patients , J. Heart Transplant 1986; 5:236 248. * |
Lioi, Anthony P., "In Vitro Development of Automatic Control for the Actively Filled Electrohydraulic Heart", Artif Organs 1988; 12(2)152-162. |
Lioi, Anthony P., In Vitro Development of Automatic Control for the Actively Filled Electrohydraulic Heart , Artif Organs 1988; 12(2)152 162. * |
McGee, Michael G. et al., "Extended Support with a Left Ventricular Assist Device as a Bridge to Heart Transplantation", ASAIO Transactions 1991; 37:M425-M426. |
McGee, Michael G. et al., Extended Support with a Left Ventricular Assist Device as a Bridge to Heart Transplantation , ASAIO Transactions 1991; 37:M425 M426. * |
Miller, Douglas L., et al., "Mechanisms For Hemolysis By Ultrasonic Cavitation In The Rotating Exposure System", Ultrasound in Med & Biol 1991; 17(2);171-178. |
Miller, Douglas L., et al., Mechanisms For Hemolysis By Ultrasonic Cavitation In The Rotating Exposure System , Ultrasound in Med & Biol 1991; 17(2);171 178. * |
Mitamura, Yoshinori, et al., "The Valvo-Pump: An Axial, Nonpulsatile Blood Pump", ASAIO Transactions 1991; 37:M510-M512. |
Mitamura, Yoshinori, et al., The Valvo Pump: An Axial, Nonpulsatile Blood Pump , ASAIO Transactions 1991; 37:M510 M512. * |
Nakahara, Toro and Yoshida, Fumitake, "Mechanical effects on rates of hemolysis", Journal of Biomedical Materials Research 1986; 20:363-374. |
Nakahara, Toro and Yoshida, Fumitake, Mechanical effects on rates of hemolysis , Journal of Biomedical Materials Research 1986; 20:363 374. * |
Oaks, Timothy E., "Combined Registry for the Clinical Use of Mechanical Ventricular Assist Pumps and the Total Artificial Heart in Conjunction with Heart Transplantation: Fifth Official Report--1990", The Journal of Heart & Lung Transplantation 1991, vol. 10, No. 5, Part 1, pp. 621-625. |
Oaks, Timothy E., Combined Registry for the Clinical Use of Mechanical Ventricular Assist Pumps and the Total Artificial Heart in Conjunction with Heart Transplantation: Fifth Official Report 1990 , The Journal of Heart & Lung Transplantation 1991, vol. 10, No. 5, Part 1, pp. 621 625. * |
Perrone, B., "Evidence of Fluid Shifts during Dialysis Sessions with Sodium and Ultrafiltration Profiles", Contrib Nephrol. Basel, Karger 1989; 74:191-199. |
Perrone, B., Evidence of Fluid Shifts during Dialysis Sessions with Sodium and Ultrafiltration Profiles , Contrib Nephrol. Basel, Karger 1989; 74:191 199. * |
Pierce, William S., M.D., et al., "An Electric Artificial Heart for Clinical Use", Ann Surg 1990, pp. 339-344. |
Pierce, William S., M.D., et al., An Electric Artificial Heart for Clinical Use , Ann Surg 1990, pp. 339 344. * |
Poirier, Victor L., "Can Our Society Afford Mechanical Hearts?", ASAIO Transactions 1991; 37:540-544. |
Poirier, Victor L., Can Our Society Afford Mechanical Hearts , ASAIO Transactions 1991; 37:540 544. * |
Qian, K.X., et al., "The Realization of a Pulsatile Implantable Impeller Pump with Low Hemolysis", ASAIO Transactions 1989; 13:162-169. |
Qian, K.X., et al., "Toward an Implantable Impeller Total Heart", ASAIO Transactions 1987; 33:704-707. |
Qian, K.X., et al., The Realization of a Pulsatile Implantable Impeller Pump with Low Hemolysis , ASAIO Transactions 1989; 13:162 169. * |
Qian, K.X., et al., Toward an Implantable Impeller Total Heart , ASAIO Transactions 1987; 33:704 707. * |
Qian, Kun xi, Experience in Reducing the Hemolysis of an Impeller Assist Heart , ASAIO Transactions 1989; 35:46 53. * |
Qian, Kun xi, Haemodynamic approach to reducing thrombosis and haemolysis in an impeller pump , Biomechs 1990; 12:533 535. * |
Qian, Kun-xi, "Experience in Reducing the Hemolysis of an Impeller Assist Heart", ASAIO Transactions 1989; 35:46-53. |
Qian, Kun-xi, "Haemodynamic approach to reducing thrombosis and haemolysis in an impeller pump", Biomechs 1990; 12:533-535. |
Sasaki, Tatsuya, et al., "A Biolized, Compact, Low Noise, High Performance Implantable Electromechanical Ventricular Assist System", ASAIO Transactions 1991; 37:M249-251. |
Sasaki, Tatsuya, et al., A Biolized, Compact, Low Noise, High Performance Implantable Electromechanical Ventricular Assist System , ASAIO Transactions 1991; 37:M249 251. * |
Schneditz, D., "Sound Speed, Density and Total Protein Concentration of Blood", J. Clin. Chem. Clin. Biochem. 1989; 27:803-806. |
Schneditz, D., et al., "Methods in clinical hemorheology: The continuous measurement of arterial blood density and blood sound speed in man", Biorheology 1990; 27:895-902. |
Schneditz, D., et al., Methods in clinical hemorheology: The continuous measurement of arterial blood density and blood sound speed in man , Biorheology 1990; 27:895 902. * |
Schneditz, D., Sound Speed, Density and Total Protein Concentration of Blood , J. Clin. Chem. Clin. Biochem. 1989; 27:803 806. * |
Schoen, Frederick J., "Biomaterials Science, Medical Devices, and Artificial Organs", ASAIO Transactions 1991; 37:44-48. |
Schoen, Frederick J., Biomaterials Science, Medical Devices, and Artificial Organs , ASAIO Transactions 1991; 37:44 48. * |
Schoephoerster, Richard T. and Chandran, Krishnan B., "Velocity and Turbulence Measurements Past Mitral Valve Prostheses In A Model Left Ventricle", J. Biomechanics 1991; 24(7):549-562. |
Schoephoerster, Richard T. and Chandran, Krishnan B., Velocity and Turbulence Measurements Past Mitral Valve Prostheses In A Model Left Ventricle , J. Biomechanics 1991; 24(7):549 562. * |
Shah, Aamir S., et al., "Intraoperative Determination of Mediastinal Constraints for a Total Artificial Heart", Trans Am Soc Artif Intern Organs 1991, vol. XXXVII, pp. 76-79. |
Shah, Aamir S., et al., Intraoperative Determination of Mediastinal Constraints for a Total Artificial Heart , Trans Am Soc Artif Intern Organs 1991, vol. XXXVII, pp. 76 79. * |
Shiono, Motomi, et al., "Anatomic Fit Study for Development of a One Piece Total Artificial Heart", ASAIO Transactions 1991; 37:M254-M255. |
Shiono, Motomi, et al., Anatomic Fit Study for Development of a One Piece Total Artificial Heart , ASAIO Transactions 1991; 37:M254 M255. * |
Snyder, A., et al., "A Completely Implantable Total Artificial Heart System", ASAIO Transactions 1991; 37:M237-M238. |
Snyder, A., et al., A Completely Implantable Total Artificial Heart System , ASAIO Transactions 1991; 37:M237 M238. * |
Taenaka, Yoshiyuki, et al., "Chronic Evaluation of a Compact Nonseal Magnet Pump as a Nonpulsatile Pump for Long-term Use", ASAIO Transactions 1991; 37:M243-M245. |
Taenaka, Yoshiyuki, et al., Chronic Evaluation of a Compact Nonseal Magnet Pump as a Nonpulsatile Pump for Long term Use , ASAIO Transactions 1991; 37:M243 M245. * |
Takatani, S., et al., "A Unique, Efficient, Implantable, Electromechanical, Total Artificial Heart", ASAIO Transactions 1991; 37:M238-M240. |
Takatani, S., et al., A Unique, Efficient, Implantable, Electromechanical, Total Artificial Heart , ASAIO Transactions 1991; 37:M238 M240. * |
Trinkl, J., et al., "Control of Pulsatile Rotary Pumps Without Pressure Sensors", ASAIO Transactions 1991; 37:M208-M210. |
Trinkl, J., et al., Control of Pulsatile Rotary Pumps Without Pressure Sensors , ASAIO Transactions 1991; 37:M208 M210. * |
Tsach, Uri, et al., "Minimum Power Consumption of the Electric Ventricular Assist Device Through the Design of an Optimal Output Controller", ASAIO Transactions 1987; 38:714-719. |
Tsach, Uri, et al., Minimum Power Consumption of the Electric Ventricular Assist Device Through the Design of an Optimal Output Controller , ASAIO Transactions 1987; 38:714 719. * |
Van Meurs, Krisa P., et al., "Maximum Blood Flow Rates for Arterial Cannulae Used in Neonatal ECMO", ASAIO Transactions 1990; 36:M679-M681. |
Van Meurs, Krisa P., et al., Maximum Blood Flow Rates for Arterial Cannulae Used in Neonatal ECMO , ASAIO Transactions 1990; 36:M679 M681. * |
Wampler, Richard K., et al., "In Vivo Evaluation of a Peripheral Vascular Access Axial Flow Blood Pump", Trans Am Soc Artif Intern Organs 1988, vol. XXXIV, pp. 450-454. |
Wampler, Richard K., et al., In Vivo Evaluation of a Peripheral Vascular Access Axial Flow Blood Pump , Trans Am Soc Artif Intern Organs 1988, vol. XXXIV, pp. 450 454. * |
Weiss, William J., et al., "In Vivo Performance of a Transcutaneous Energy Transmission System with the Penn State Motor Driven Ventricular Assist Device", ASAIO Transactions 1989; 35:284-288. |
Weiss, William J., et al., "Permanent Circulatory Support Systems at The Pennsylvania State University", IEE Transactions on Biomedical Engineering 1990, vol. 37, No. 2, pp. 138-145. |
Weiss, William J., et al., In Vivo Performance of a Transcutaneous Energy Transmission System with the Penn State Motor Driven Ventricular Assist Device , ASAIO Transactions 1989; 35:284 288. * |
Weiss, William J., et al., Permanent Circulatory Support Systems at The Pennsylvania State University , IEE Transactions on Biomedical Engineering 1990, vol. 37, No. 2, pp. 138 145. * |
Wipf, Stefan L., "Spherical Rotary Piston Machine as an Artificial Heart", ASAIO Transactions 1991; 37:M246-M247. |
Wipf, Stefan L., Spherical Rotary Piston Machine as an Artificial Heart , ASAIO Transactions 1991; 37:M246 M247. * |
Woodard, John C., et al., "A Sophisticated Electromechanical Ventricular Simulator for Ventricular Assist System Testing", ASAIO Transactions 1991; 37:M210-M211. |
Woodard, John C., et al., A Sophisticated Electromechanical Ventricular Simulator for Ventricular Assist System Testing , ASAIO Transactions 1991; 37:M210 M211. * |
Yoganathan, Ajit P., Ph.D., et al., "In vitro velocity and turbulence measurements in the vicinity of three new mechanical aortic heart valve prostheses: Bjork-Shiley Monostrut, Omni-Carbon, and Duromedics", J. Thoracic Cardiovasc Surg 1988; 95:929-939. |
Yoganathan, Ajit P., Ph.D., et al., In vitro velocity and turbulence measurements in the vicinity of three new mechanical aortic heart valve prostheses: Bj o rk Shiley Monostrut, Omni Carbon, and Duromedics , J. Thoracic Cardiovasc Surg 1988; 95:929 939. * |
Cited By (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6757563B2 (en) | 1999-04-19 | 2004-06-29 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with ultrasound for autocapture or other applications |
US6539262B2 (en) | 1999-04-19 | 2003-03-25 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with ultrasound for autocapture or other applications |
US6298269B1 (en) | 1999-04-19 | 2001-10-02 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with ultrasound for autocapture or other applications |
US8286656B2 (en) | 2000-03-28 | 2012-10-16 | Pptt Llc | Implantable counterpulsation cardiac assist device |
US6770024B1 (en) | 2000-03-28 | 2004-08-03 | Stony Brook Surgical Innovations, Inc. | Implantable counterpulsation cardiac assist device |
US20040236171A1 (en) * | 2000-03-28 | 2004-11-25 | Rastegar Jahangir S. | Implantable counterpulsation cardiac assist device |
US7481760B2 (en) | 2000-03-28 | 2009-01-27 | Pptt Llc | Implantable counterpulsation cardiac assist device |
US20090118568A1 (en) * | 2000-03-28 | 2009-05-07 | Pptt Llc | Implantable counterpulsation cardiac assist device |
US6632169B2 (en) | 2001-03-13 | 2003-10-14 | Ltk Enterprises, L.L.C. | Optimized pulsatile-flow ventricular-assist device and total artificial heart |
US20040097782A1 (en) * | 2001-03-13 | 2004-05-20 | Theodosios Korakianitis | Optimized pulsatile-flow ventricular-assist device and total artificial heart |
US7228175B2 (en) | 2002-05-15 | 2007-06-05 | Cardiac Pacemakers, Inc. | Cardiac rhythm management systems and methods using acoustic contractility indicator |
US11357549B2 (en) | 2004-07-02 | 2022-06-14 | Nuvasive Specialized Orthopedics, Inc. | Expandable rod system to treat scoliosis and method of using the same |
US11672684B2 (en) | 2006-10-20 | 2023-06-13 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
US11234849B2 (en) | 2006-10-20 | 2022-02-01 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant and method of use |
US11202707B2 (en) | 2008-03-25 | 2021-12-21 | Nuvasive Specialized Orthopedics, Inc. | Adjustable implant system |
US10729470B2 (en) | 2008-11-10 | 2020-08-04 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10478232B2 (en) | 2009-04-29 | 2019-11-19 | Nuvasive Specialized Orthopedics, Inc. | Interspinous process device and method |
US12066030B2 (en) | 2009-09-22 | 2024-08-20 | Ecp Entwicklungsgesellschaft Mbh | Fluid pump having at least one impeller blade and a support device |
US9089634B2 (en) | 2009-09-22 | 2015-07-28 | Ecp Entwicklungsgesellschaft Mbh | Fluid pump having at least one impeller blade and a support device |
US11592028B2 (en) | 2009-09-22 | 2023-02-28 | Ecp Entwicklungsgesellschaft Mbh | Fluid pump having at least one impeller blade and a support device |
US10208763B2 (en) | 2009-09-22 | 2019-02-19 | Ecp Entwicklungsgesellschaft Mbh | Fluid pump having at least one impeller blade and a support device |
US10660675B2 (en) | 2010-06-30 | 2020-05-26 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US9638202B2 (en) | 2010-09-14 | 2017-05-02 | Tc1 Llc | Centrifugal pump apparatus |
US10646262B2 (en) | 2011-02-14 | 2020-05-12 | Nuvasive Specialized Orthopedics, Inc. | System and method for altering rotational alignment of bone sections |
US9850906B2 (en) | 2011-03-28 | 2017-12-26 | Tc1 Llc | Rotation drive device and centrifugal pump apparatus employing same |
US10743794B2 (en) | 2011-10-04 | 2020-08-18 | Nuvasive Specialized Orthopedics, Inc. | Devices and methods for non-invasive implant length sensing |
US10349982B2 (en) | 2011-11-01 | 2019-07-16 | Nuvasive Specialized Orthopedics, Inc. | Adjustable magnetic devices and methods of using same |
US11123107B2 (en) | 2011-11-01 | 2021-09-21 | Nuvasive Specialized Orthopedics, Inc. | Adjustable magnetic devices and methods of using same |
US11213330B2 (en) | 2012-10-29 | 2022-01-04 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US11191579B2 (en) | 2012-10-29 | 2021-12-07 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US8968174B2 (en) | 2013-01-16 | 2015-03-03 | Thoratec Corporation | Motor fault monitor for implantable blood pump |
WO2014113533A1 (en) * | 2013-01-16 | 2014-07-24 | Thoratec Corporation | Motor fault monitor for implantable blood pump |
US9709061B2 (en) | 2013-01-24 | 2017-07-18 | Tc1 Llc | Impeller position compensation using field oriented control |
US9556873B2 (en) | 2013-02-27 | 2017-01-31 | Tc1 Llc | Startup sequence for centrifugal pump with levitated impeller |
US10052420B2 (en) | 2013-04-30 | 2018-08-21 | Tc1 Llc | Heart beat identification and pump speed synchronization |
US10751094B2 (en) | 2013-10-10 | 2020-08-25 | Nuvasive Specialized Orthopedics, Inc. | Adjustable spinal implant |
US11246694B2 (en) | 2014-04-28 | 2022-02-15 | Nuvasive Specialized Orthopedics, Inc. | System for informational magnetic feedback in adjustable implants |
US9623161B2 (en) | 2014-08-26 | 2017-04-18 | Tc1 Llc | Blood pump and method of suction detection |
US11439449B2 (en) | 2014-12-26 | 2022-09-13 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for distraction |
US11712167B2 (en) | 2015-02-11 | 2023-08-01 | Tc1 Llc | Heart beat identification and pump speed synchronization |
US12213766B2 (en) | 2015-02-11 | 2025-02-04 | Tc1 Llc | Heart beat identification and pump speed synchronization |
US10856748B2 (en) | 2015-02-11 | 2020-12-08 | Tc1 Llc | Heart beat identification and pump speed synchronization |
US10506935B2 (en) | 2015-02-11 | 2019-12-17 | Tc1 Llc | Heart beat identification and pump speed synchronization |
US10166318B2 (en) | 2015-02-12 | 2019-01-01 | Tc1 Llc | System and method for controlling the position of a levitated rotor |
US10371152B2 (en) | 2015-02-12 | 2019-08-06 | Tc1 Llc | Alternating pump gaps |
US11724097B2 (en) | 2015-02-12 | 2023-08-15 | Tc1 Llc | System and method for controlling the position of a levitated rotor |
US11015605B2 (en) | 2015-02-12 | 2021-05-25 | Tc1 Llc | Alternating pump gaps |
US10874782B2 (en) | 2015-02-12 | 2020-12-29 | Tc1 Llc | System and method for controlling the position of a levitated rotor |
US11781551B2 (en) | 2015-02-12 | 2023-10-10 | Tc1 Llc | Alternating pump gaps |
US10245361B2 (en) | 2015-02-13 | 2019-04-02 | Tc1 Llc | Impeller suspension mechanism for heart pump |
US12076051B2 (en) | 2015-02-19 | 2024-09-03 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for vertebral adjustment |
US11612416B2 (en) | 2015-02-19 | 2023-03-28 | Nuvasive Specialized Orthopedics, Inc. | Systems and methods for vertebral adjustment |
US10617453B2 (en) | 2015-10-16 | 2020-04-14 | Nuvasive Specialized Orthopedics, Inc. | Adjustable devices for treating arthritis of the knee |
US10117983B2 (en) | 2015-11-16 | 2018-11-06 | Tc1 Llc | Pressure/flow characteristic modification of a centrifugal pump in a ventricular assist device |
US11639722B2 (en) | 2015-11-16 | 2023-05-02 | Tc1 Llc | Pressure/flow characteristic modification of a centrifugal pump in a ventricular assist device |
US10888645B2 (en) | 2015-11-16 | 2021-01-12 | Tc1 Llc | Pressure/flow characteristic modification of a centrifugal pump in a ventricular assist device |
US10835290B2 (en) | 2015-12-10 | 2020-11-17 | Nuvasive Specialized Orthopedics, Inc. | External adjustment device for distraction device |
US10918425B2 (en) | 2016-01-28 | 2021-02-16 | Nuvasive Specialized Orthopedics, Inc. | System and methods for bone transport |
Also Published As
Publication number | Publication date |
---|---|
CA2183666A1 (en) | 1995-08-31 |
JPH09509595A (en) | 1997-09-30 |
DE69534486D1 (en) | 2006-02-09 |
EP0748235B1 (en) | 2005-09-28 |
EP0748235A1 (en) | 1996-12-18 |
ATE305316T1 (en) | 2005-10-15 |
US5879375A (en) | 1999-03-09 |
US5676651A (en) | 1997-10-14 |
US5722930A (en) | 1998-03-03 |
US5758666A (en) | 1998-06-02 |
US5702430A (en) | 1997-12-30 |
US5722429A (en) | 1998-03-03 |
TW290461B (en) | 1996-11-11 |
US5693091A (en) | 1997-12-02 |
WO1995023000A3 (en) | 1996-01-11 |
WO1995023000A2 (en) | 1995-08-31 |
AU1971495A (en) | 1995-09-11 |
US5676162A (en) | 1997-10-14 |
JP2005199076A (en) | 2005-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5843129A (en) | Electrical circuit for equipment requiring redundant flow paths and method of use | |
US5613935A (en) | High reliability cardiac assist system | |
US11185678B2 (en) | Blood pump | |
US7037253B2 (en) | Methods, systems and devices relating to implantable fluid pumps | |
CN105517590B (en) | Artificial ventricle | |
US4957504A (en) | Implantable blood pump | |
US10286134B2 (en) | Ventricular assist device | |
US20030147754A1 (en) | Blood pump | |
US20230270993A1 (en) | Unloading blood pump system and the blood pump thereof | |
JP7605482B2 (en) | Volumetric Shuttle Pump Heart and VAD | |
Pierce et al. | An electric artificial heart for clinical use | |
WO2020006324A1 (en) | Peristalsis artificial heart and ventricular assist device | |
WO2024202395A1 (en) | Wireless auxiliary artificial heart system | |
Imachi et al. | Compact ventricular assist device and total artificial heart using undulation pump |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
REMI | Maintenance fee reminder mailed | ||
FPAY | Fee payment |
Year of fee payment: 8 |
|
REMI | Maintenance fee reminder mailed | ||
FEPP | Fee payment procedure |
Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 12 |